                                         ABSTRACT
The present invention relates to discovery of the ectopic expression of EDEM2 in a
production cell to improve the yield of a useful multi-subunit protein. Thus, the present
invention   provides    for production  cell lines,  such    as  the canonical     mammalian
biopharmaceutical production cell - the CHO cell, containing recombinant polynucleotides
encoding EDEM2. Also disclosed is a production cell containing both an EDEM2-encoding
polynucleotide as well an XBP1-encoding polynucleotide. Improved titers of antibodies
produced by these cell lines are disclosed, as well as the improved cell densities attained by
these cells in culture.

                                PRODUCTION CELL LINE ENHANCERS
   The present application is a divisional application from Australian patent application number
   2013267525, the entire disclosure of which is incorporated herein by reference.
 5 CROSS-REFERENCE TO RELATED APPLICATIONS
   This application claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent
   Application No. 61/652,549 filed 29 May 2012, which application is herein specifically
   incorporated by reference in its entirety.
    FIELD
10         The invention relates to a cell or cells expressing a recombinant stress-response lectin
   for the improved production of a multi-subunit protein. Specifically, the invention provides a
   mammalian cell and cell-line derived therefrom containing a gene encoding EDEM2, and
   which yields antibody at a high titer.
   BACKGROUND
15         The manufacture of therapeutically active proteins requires proper folding and
   processing prior to secretion. Proper folding is particularly relevant for proteins, such as
   antibodies, which consist of multiple subunits that must be properly assembled before
   secretion. Eukaryotic cells have adapted a system that ensures the proper folding of proteins
   and the removal of misfolded proteins from the secretory pathway. This system is called the
20 unfolded protein response (UPR) pathway, and it is triggered by the accumulation of
   misfolded proteins in the endoplasmic reticulum (ER).
           An early event of the UPR is the activation of the transcription factor Xbpl, which in
   turn   activates    the   transcription   of   endoplasmic    reticulum   degradation-enhancing
   alphamannosidase-like protein 2 (EDEM2),            a member of the endoplasmic reticulum
25 associated degradation (ERAD)          pathway. EDEM2 facilitates the removal of misfolded
   proteins. The ERAD pathway comprises five steps: (1) chaperone-mediated recognition of
   malformed proteins, (2) targeting of malformed proteins to the retrotranslocation machinery or
   E3-ligases, which involves EDEM2, (3) intitiation of retrotranslocation; (4) ubiquitylation and
   further retrotranslocation; and (5) proteosome targeting and degradation.
30         Antibodies are multi-subunit proteins comprising two heavy chains and two light
   chains, which must be properly folded and associated to form a functional heterotetramer.
   Any improvement in the efficient and accurate processing of the heavy and light chains to
   improve the yield or titer of functional antibody heterotetramers is desired.
   SUMMARY
                                                     1

        WO 2013/181253                                                             PCT/US2013/043116
         Applicants made the surprising discovery that the ectopic expression of EDEM2 in a
    protein-manufacturing cell line increases the average output of protein per cell, increases the
    titer of protein secreted into the media, and increases the integrated cell density of
    production cell lines.
  5      Thus, in one aspect, the invention provides a cell containing (a) a recombinant
    polynucleotide that encodes a stress-induced mannose-binding lectin and (b) a
    polynucleotide that encodes a multi-subunit protein. In some embodiments, the stress
    induced mannose-binding lectin is an EDEM2 protein, non-limiting examples of which are
    provided in Table 1, and the multi-subunit protein is an antibody. In other embodiments, the
 .0 cell also contains a polynucleotide that encodes the active spliced form of XBP1, non-limiting
    examples of which are provided in Table 2. In one embodiment, the cell is a mammalian
    cell, such as a CHO cell used in the manufacture of biopharmaceuticals.
         In another aspect, the invention provides a cell line derived from the cell described in the
    previous aspect. By "derived from", what is meant is a population of cells clonally
 .5 descended from an individual cell and having some select qualities, such as the ability to
    produce active protein at a given titer, or the ability to proliferate to a particular density. In
    some embodiments, the cell line, which is derived from a cell harboring the recombinant
    polynucleotide encoding a stress-induced mannose-binding lectin and a polynucleotide
    encoding a multi-subunit protein, is capable of producing the multi-subunit protein at a titer of
 10 at least 3 grams per liter of media (g/L), at least 5 g/L, or at least 8 g/L. In some
    embodiments, the cell line can attain an integrated cell density (ICD) that is at least 30%
    greater, at least 50% greater, at least 60% greater, or at least 90% greater than the
    integrated cell density attainable by a cell line derived from what is essentially the same cell
    but without the recombinant polynucleotide encoding the stress-induced mannose-binding
25  lectin.
         In another aspect, the invention provides an isolated or recombinant polynucleotide
    comprising a nucleic acid sequence encoding an EDEM2 protein, which is operably linked
    (cis) to a constitutive and ubiquitously expressed mammalian promoter, such as the ubiquitin
    C promoter. In some embodiments, the EDEM2 protein has the amino acid of SEQ ID NO: 8,
30  or an amino acid sequence that is at least 92% identical to any one of SEQ ID NO: 1-7. In
    some embodiments, the polynucleotide comprises a nucleic acid sequence of SEQ ID NO:
    16. In one particular embodiment, the polynucleotide consists of a nucleic acid sequence of
    SEQ ID NO: 14; and in another particular embodiment, SEQ ID NO: 15.
         In another aspect, the invention provides an isolated or recombinant polynucleotide
35  comprising a nucleic acid sequence encoding an XBP1 protein, which is operably linked to
    (in cis) a constitutive and ubiquitously expressed mammalian promoter, such as the ubiquitin
    C promoter. In some embodiments, the XBP1 protein has the amino acid of SEQ ID NO: 13,
                                                        2

        WO 2013/181253                                                        PCT/US2013/043116
    or an amino acid sequence that is at least 86% identical to any one of SEQ ID NO: 9-12. In
    some embodiments, the polynucleotide comprises a nucleic acid sequence of SEQ ID NO:
    18. In one particular embodiment, the polynucleotide consists of a nucleic acid sequence of
    SEQ ID NO: 17.
  5      In another aspect, the invention provides a cell that contains an EDEM2-encoding
    polynucleotide, as described in the prior aspect, and a polynucleotide that encodes a multi
    subunit protein, such as an antibody. In some embodiments, the cell also contains an XBP1
    encoding polynucleotide, as described in the preceding aspect. In one embodiment, the
    multi-subunit protein is an antibody, and the heavy chain of the antibody comprises an amino
 .0 acid sequence of SEQ ID NO: 43 and SEQ ID NO: 44, and the light chain of the antibody
    comprises an amino acid sequence of SEQ ID NO: 45 and SEQ ID NO: 46. In this and
    several embodiments, each polypeptide subunit of the multi-subunit protein is encoded by a
    separate polynucleotide. Thus, for example, a polynucleotide encoding an antibody may
    include a polynucleotide encoding a heavy chain and a polynucleotide encoding a light
 .5 chain, hence two subunits. In some embodiments, the cell is a chinese hamster ovary
    (CHO) cell.
         In one embodiment, the encoded multi-subunit protein is an anti-GDF8 antibody having a
    heavy chain variable region amino acid sequence of SEQ ID NO: 20 and a light chain
    variable region amino acid sequence of SEQ ID NO: 22. In one embodiment, the anti-GDF8
  0 antibody comprises a heavy chain having an amino acid sequence of SEQ ID NO: 19 and a
    light chain having an amino acid sequence of SEQ ID NO: 21. In one embodiment, the
    polynucleotide that encodes the heavy chain of the anti-GDF8 antibody comprises a nucleic
    acid sequence of SEQ ID NO: 23; and the polynucleotide that encodes the light chain of the
    anti-GDF8 antibody comprises a nucleic acid sequence of SEQ ID NO: 25. In one
25  embodiment, the polynucleotide that encodes the heavy chain of the anti-GDF8 antibody
    consists of a nucleic acid sequence of SEQ ID NO: 24; and the polynucleotide that encodes
    the light chain of the anti-GDF8 antibody consists of a nucleic acid sequence of SEQ ID NO:
    25.
         In another embodiment, the encoded multi-subunit protein is an anti-ANG2 antibody
30  having a heavy chain variable region amino acid sequence of SEQ ID NO: 28 and a light
    chain variable region amino acid sequence of SEQ ID NO: 30. In one embodiment, the anti
    ANG2 antibody comprises a heavy chain having an amino acid sequence of SEQ ID NO: 27
    and a light chain having an amino acid sequence of SEQ ID NO: 29. In one embodiment, the
    polynucleotide that encodes the heavy chain of the anti-ANG2 antibody comprises a nucleic
35  acid sequence of SEQ ID NO: 31; and the polynucleotide that encodes the light chain of the
    anti-ANG2 antibody comprises a nucleic acid sequence of SEQ ID NO: 33. In one
    embodiment, the polynucleotide that encodes the heavy chain of the anti-ANG2 antibody
                                                      3

        WO 2013/181253                                                              PCT/US2013/043116
    consists of a nucleic acid sequence of SEQ ID NO: 32; and the polynucleotide that encodes
    the light chain of the anti-ANG2 antibody consists of a nucleic acid sequence of SEQ ID NO:
    34.
         In another embodiment, the encoded multi-subunit protein is an anti-ANGPTL4 antibody
  5 having a heavy chain variable region amino acid sequence of SEQ ID NO: 36 and a light
    chain variable region amino acid sequence of SEQ ID NO: 38. In one embodiment, the anti
    ANGPTL4 antibody comprises a heavy chain having an amino acid sequence of SEQ ID
    NO: 35 and a light chain having an amino acid sequence of SEQ ID NO: 37. In one
    embodiment, the polynucleotide that encodes the heavy chain of the anti-ANGPTL4 antibody
 .0 comprises a nucleic acid sequence of SEQ ID NO: 39; and the polynucleotide that encodes
    the light chain of the anti-ANGPTL4 antibody comprises a nucleic acid sequence of SEQ ID
    NO: 41. In one embodiment, the polynucleotide that encodes the heavy chain of the anti
    ANGPTL4 antibody consists of a nucleic acid sequence of SEQ ID NO: 40; and the
    polynucleotide that encodes the light chain of the anti-ANGPTL4 antibody consists of a
 .5 nucleic acid sequence of SEQ ID NO: 42.
         In another aspect, the invention provides a method of manufacturing a multi-subunit
    protein, by culturing a cell of the previous aspect in a medium, wherein the multi-subunit
    protein is synthesized in the cell and subsequently secreted into the medium. In some
    embodiments, the multi-subunit protein is an antibody, such as for example anti-GDF8, anti
 10 ANG2, anti-ANGPTL4, or an antibody having a heavy chain sequence of SEQ ID NO: 43
    and 44, and a light chain sequence of SEQ ID NO: 45 and 46. In some embodiments, the
    multi-subunit protein attains a titer of at least 3 g/L, at least 5 g/L, at least 6 g/L, or at least 8
    g/L. In some embodiments, the cell proliferates in the medium and establishes an integrated
    cell density of about   5x   10 7 cell-day/mL, about     1 x 108 cell-day/mL, or about      1.5 x 108
25  cell-day/mL.
         In another aspect, the invention provides a multi-subunit protein, which is manufactured
    according to the method described in the preceding aspect. In one embodiment, the
    manufactured protein is an antibody. In some embodiments, the antibody consists of a
    heavy chain, which comprises an amino acid sequence of SEQ ID NO: 43 and SEQ ID NO:
30  44, and a light chain, which comprises an amino acid sequence of SEQ ID NO: 45 and SEQ
    ID NO: 46. In one specific embodiment, the manufactured multi-subunit protein is an anti
    GDF8 antibody having a heavy chain variable region amino acid sequence of SEQ ID NO:
    20 and a light chain variable region amino acid sequence of SEQ ID NO: 22. In another
    specific embodiment, the manufactured multi-subunit protein is an anti-ANG2 antibody
35  having a heavy chain variable region amino acid sequence of SEQ ID NO: 28 and a light
    chain variable region amino acid sequence of SEQ ID NO: 30. In yet another specific
    embodiment, the manufactured multi-subunit protein is an anti-ANGPTL4 antibody having a
                                                         4

        WO 2013/181253                                                          PCT/US2013/043116
    heavy chain variable region amino acid sequence of SEQ ID NO: 36 and a light chain
    variable region amino acid sequence of SEQ ID NO: 38.
    DESCRIPTION
         Before the present invention is described, it is to be understood that this invention is not
  5 limited to particular methods and experimental conditions described, as such methods and
    conditions may vary. It is also to be understood that the terminology used herein is for the
    purpose of describing particular embodiments only, and is not intended to be limiting, since
    the scope of the present invention will be limited only by the appended claims.
         Unless defined otherwise, all technical and scientific terms used herein have the same
 .0 meaning as commonly understood by one of ordinary skill in the art to which this invention
    belongs. As used herein, the term "about", when used in reference to a particular recited
    numerical value or range of values, means that the value may vary from the recited value by
    no more than 1%. For example, as used herein, the expression "about 100" includes 99 and
    101 and all values in between (e.g., 99.1, 99.2, 99.3, 99.4, etc.).
 .5     Although any methods and materials similar or equivalent to those described herein can
    be used in the practice or testing of the present invention, the preferred methods and
    materials are now described. All publications mentioned herein are incorporated herein by
    reference in their entirety.
        As used herein, the term "recombinant polynucleotide", which is used interchangeably
  0 with "isolated polynucleotide", means a nucleic acid polymer such as a ribonucleic acid or a
    deoxyribonucleic acid, either single stranded or double stranded, originating by genetic
    engineering manipulations. A recombinant polynucleotide may be a circular plasmid or a
    linear construct existing in vitro or within a cell as an episome. A recombinant polynucleotide
    may be a construct that is integrated within a larger polynucleotide molecule or
25  supermolecular structure, such as a linear or circular chromosome. The larger
    polynucleotide molecule or supermolecular structure may be within a cell or within the
    nucleus of a cell. Thus, a recombinant polynucleotide may be integrated within a
    chromosome of a cell.
        As used herein, the term "stress-induced mannose-binding lectin" refers to a mannose
30  binding protein, which means a protein that binds or is capable of binding mannose,
    derivatives of mannose, such as mannose-6-phosphate, or a glycoprotein that expresses
    mannose or a mannose derivative in its glycocalyx; and whose activity is upregulated during
    stress. Cellular stress includes inter alia starvation, DNA damage, hypoxia, poisoning, shear
    stress and other mechanical stresses, tumor stress, and the accumulation of misfolded
35  proteins in the endoplasmic reticulum. Exemplary stress-induced mannose-binding lectins
                                                         5

        WO 2013/181253                                                       PCT/US2013/043116
    include the EDEM proteins EDEM1, EDEM2 and EDEM3, Yos 9, OS9, and XTP3-B (see
    Vembar and Brodsky, Nat. Rev. Mol. Cell. Biol. 9(12): 944-957, 2008, and references cited
    therein).
        As used herein, the term "EDEM2" means any ortholog, homolog, or conservatively
  5 substituted variant of endoplasmic reticulum degradation-enhancing alpha-mannosidase-like
    protein. EDEM2 proteins are generally known in the art to be involved endoplasmic
    reticulum-associated degradation (ERAD), being up-regulated by Xbp-1 and facilitating the
    extraction of misfolded glycoproteins from the calnexin cycle for removal. (See Mast et al.,
    Glycobiology 15(4): 421-436, 2004; Olivari and Molinari, FEBS Lett. 581: 3658-3664, 2007;
 .0 Olivari et al., J. Biol. Chem. 280(4): 2424-2428, 2005; and Vembar and Brodsky 2008, which
    are herein incorporated by reference.) Exemplary EDEM2 sequences are depicted in Table
    1, which is cross-referenced to the Sequence Listing.
    TABLE 1
    Animal                SEQ ID NO:        %id human       %id mouse          %id hamster
    Mouse                 1                 93               100               96
    Rat                   2                 94              98                 96
    Hamster               3                 93              96                 100
    Human                 4                 100             93                 93
    Chimpanzee            5                 99              94                 93
    Orangutan             6                 97              92                 92
    Zebra fish            7                 69              70                 69
    Consensus             8                 100              100               100
15      As used herein, the term "Xbpl", also known as XBP1 or X-box binding protein 1, means
    any ortholog, homolog, or conservatively substituted variant of Xbpl. Xbp1 is a transcription
    factor and functional element of the UPR. ER stress activates both (1) the transcription factor
    ATF6, which in turn upregulates the transcription of Xbp1 mRNA, and (2) the ER membrane
    protein IRE1, which mediates the splicing of the precursor Xbp1 mRNA to produce active
20  Xbpl. As mentioned above, activated Xbp1 in turn upregulates the activity of EDEM2. (See
    Yoshida et al., Cell Structure and Function 31(2): 117-125, 2006; and Olivari, 2005.)
    Exemplary Xbp1 amino acid sequences are depicted in Table 2, which is cross-referenced to
    the Sequence Listing.
    TABLE 2
                                                      6

        WO 2013/181253                                                          PCT/US2013/043116
    Animal              SEQ ID NO           %id human         %id mouse          %id hamster
    Mouse               9                   86                100                92
    Hamster             10                  86                92                 100
    Human               11                  100               86                 86
    Zebra fish          12                  47                47                 48
    Consensus           13                  100               100                100
         As used herein, the term "antibody" is generally intended to refer to immunoglobulin
    molecules comprising four polypeptide chains, two heavy (H) chains and two light (L) chains
    inter-connected by disulfide bonds, as well as multimers thereof (e.g., IgM); however,
  5 immunoglobulin molecules consisting of only heavy chains (i.e., lacking light chains) are also
    encompassed within the definition of the term "antibody".      Each heavy chain comprises a
    heavy chain variable region (abbreviated herein as HCVR or VH) and a heavy chain
    constant region. The heavy chain constant region comprises three domains, CH1, CH2 and
    CH3. Each light chain comprises a light chain variable region (abbreviated herein as LCVR
 .0 or VL) and a light chain constant region. The light chain constant region comprises one
    domain (CL1). The VH and VL regions can be further subdivided into regions of
    hypervariability, termed complementary determining regions (CDRs), interspersed with
    regions that are more conserved, termed framework regions (FR). Each VH and VL is
    composed of three CDRs and four FRs, arranged from amino-terminus to carboxy-terminus
 .5 in the following order: FR1, CDR1, FR2, CDR2, FR3, CDR3, FR4. An "isolated antibody" or
    "purified antibody" may be substantially free of other cellular material or chemicals.
         The term "specifically binds", or the like, means that an antibody or antigen-binding
    fragment thereof forms a complex with an antigen that is relatively stable under physiologic
    conditions. Specific binding can be characterized by a dissociation constant of at least about
20  1x 10-6 M or greater. Methods for determining whether two molecules specifically bind are
    well known in the art and include, for example, equilibrium dialysis, surface plasmon
    resonance, and the like. An isolated antibody that specifically binds human GDF8 (for
    example) may, however, have cross-reactivity to other antigens, such as GDF8 molecules
    from other species (orthologs).
25       Various antibodies are used as examples of multi-subunit proteins secreted by cells
    harboring the polynucleotide encoding a stress-induced mannose-binding lectin. Those
    examples include anti-GDF8, anti-ANG2, and anti-ANGPTL4 antibodies. These and similar
    antibodies are described in US Pat. Apps. No. 20110293630, 20110027286, and
    20110159015 respectively, which are incorporated herein by reference.
                                                        7

        WO 2013/181253                                                          PCT/US2013/043116
        As used herein, the term "cell" refers to a prokaryotic or eukaryotic cell capable of
    replicating DNA, transcribing RNA, translating polypeptides, and secreting proteins. Cells
    include animal cells used in the commercial production of biological products, such as insect
    cells (e.g., Schneider cells, Sf9 cells, Sf21 cells, Tn-368 cells, BTI-TN-5B1-4 cells; see
  5 Jarvis, Methods Enzymol. 463: 191-222, 2009; and Potter et al., Int. Rev. Immunol. 10(2-3):
    103-112,1993) and mammalian cells (e.g., CHO or CHO-K1 cells, COS or COS-7cells,
    HEK293 cells, PC12 cells, HeLa cells, Hybridoma cells; Trill et al., Curr. Opin. Biotechnol.
    6(5): 553-560, 1995; Kipriyanov and Little, Mo. Biotechnol. 12(2): 173-201, 1999). In one
    embodiment, the cell is a CHO-K1 cell containing the described UPR pathway
 .0 polynucleotides. For a description of CHO-K1 cells, see also Kao et al., Proc. Nat'l. Acad.
    Sci. USA 60: 1275-1281, 1968.
        As used herein, the term "promoter" means a genetic sequence generally in cis and
    located upstream of a protein coding sequence, and which facilitates the transcription of the
    protein coding sequence. Promoters can be regulated (developmental, tissue specific, or
 .5 inducible (chemical, temperature)) or constitutively active. In certain embodiments, the
    polynucleotides that encode proteins are operably linked to a constitutive promoter. By
    "operably linked", what is meant is that the protein-encoding polynucleotide is located three
    prime (downstream) and cis of the promoter, and under control of the promoter. In certain
    embodiments, the promoter is a constitutive mammalian promoter, such as the ubiquitin C
 10 promoter (see Schorpp et al., Nucl. Acids Res. 24(9): 1787-1788, 1996); Byun et al.,
    Biochem. Biophys. Res. Comm. 332(2): 518-523, 2005) or the CMV-IE promoter (see
    Addison et al., J. Gen. Virol. 78(7): 1653-1661, 1997; Hunninghake et al., J. Virol. 63(7):
    3026-3033, 1989), or the hCMV-IE promoter (human cytomegalovirus immediate early gene
    promoter) (see Stinski & Roehr, J. Virol. 55(2): 431-441, 1985; Hunninghake et al., J. Virol.
25  63(7): 3026-3033, 1989).
        As used herein, the phrase "integrated cell density", or "ICD" means the density of cells
    in a culture medium taken as an integral over a period of time, expressed as cell-days per
    mL. In some embodiments, the ICD is measured around the twelfth day of cells in culture.
        As used herein, the term "culture" means both (1) the composition comprising cells,
30  medium, and secreted multi-subunit protein, and (2) the act of incubating the cells in
    medium, regardless of whether the cells are actively dividing or not. Cells can be cultured in
    a vessel as small as a 25 mL flask or smaller, and as large as a commercial bioreactor of
    10,000 liters or larger . "Medium" refers to the culture medium, which comprises inter alia
    nutrients, lipids, amino acids, nucleic acids, buffers and trace elements to allow the growth,
35  proliferation, or maintenance of cells, and the production of the multi-subunit protein by the
    cells. Cell culture media include serum-free and hydrolysate-free defined media as well as
    media supplemented with sera (e.g., fetal bovine serum (FBS)) or protein hydrolysates.
                                                        8

        WO 2013/181253                                                           PCT/US2013/043116
    Non-limiting examples of media, which can be commercially acquired, include RPMI medium
    1640, Dulbecco's Modified Eagle Medium (DMEM), DMEM/F12 mixture, F10 nutrient
    mixture, Ham's F12 nutrient mixture, and minimum essential media (MEM).
         As used herein, the phrase "conservatively substituted variant", as applied to
  5 polypeptides, means a polypeptide having an amino acid sequence with one of more
    conservative amino acid substitutions. A "conservative amino acid substitution" is one in
    which an amino acid residue is substituted by another amino acid residue having a side
    chain (R group) with similar chemical properties (e.g., charge or hydrophobicity). In general,
    a conservative amino acid substitution will not substantially change the functional properties
 .0 of a protein. In cases where two or more amino acid sequences differ from each other by
    conservative substitutions, the percent or degree of similarity may be adjusted upwards to
    correct for the conservative nature of the substitution. Means for making this adjustment are
    well known to those of skill in the art. See, e.g., Pearson (1994) Methods Mol. Biol. 24: 307
    331, which is herein incorporated by reference. Examples of groups of amino acids that have
 .5 side chains with similar chemical properties include 1) aliphatic side chains: glycine, alanine,
    valine, leucine and isoleucine; 2) aliphatic-hydroxyl side chains: serine and threonine; 3)
    amide-containing side chains: asparagine and glutamine; 4) aromatic side chains:
    phenylalanine, tyrosine, and tryptophan; 5) basic side chains: lysine, arginine, and histidine;
    6) acidic side chains: aspartate and glutamate, and 7) sulfur-containing side chains: cysteine
  0 and methionine. Preferred conservative amino acids substitution groups are: valine-leucine
    isoleucine, phenylalanine-tyrosine, lysine-arginine, alanine-valine, glutamate-aspartate, and
    asparagine-glutamine. Alternatively, a conservative replacement is any change having a
    positive value in the PAM250 log-likelihood matrix disclosed in Gonnet et al. (1992) Science
    256: 1443-45, herein incorporated by reference. A "moderately conservative" replacement is
25  any change having a nonnegative value in the PAM250 log-likelihood matrix.
          Embodiments - The Cell
            In one aspect, the invention provides a cell useful in the production of a protein having
    therapeutic or research utility. In some embodiments, the protein consists of multiple
    subunits, which must be properly folded and assembled to produce sufficient quantities of
30  active protein. Antibodies are an example of multi-subunit proteins having therapeutic or
    research utility. In some embodiments, the cell harbors a recombinant genetic construct
    (i.e., a polynucleotide) that encodes one or more of the individual subunits of the multi
    subunit protein.     In other embodiments, the genetic construct encoding the individual
    polypeptide subunits is naturally occurring, such as for example the nucleic acid sequences
35  encoding the subunits of an antibody in a B cell.
            To facilitate the proper assembly and secretion of the multi-subunit protein, the cell
    contains a recombinant polynucleotide that encodes a stress-induced mannose-binding
                                                        9

        WO 2013/181253                                                          PCT/US2013/043116
    lectin, which in some embodiments is a component of the ERAD. In some embodiments, the
    stress-induced mannose-binding lectin is an endoplasmic reticulum degradation-enhancing
    alpha-mannosidase-like protein 2 (EDEM2).       It is envisioned that any encoded EDEM2 or
    conservatively-substituted variant can be successfully employed in the instant invention.
  5 Table 1 lists some examples of vertebrate EDEM2 proteins. A multiple pairwise comparison
    of those protein sequences, which was performed using the Clustal W program of Thompson
    et al., Nucl. Acids Rev. 22(22): 4673-80, 1994 (see also Yuan et al., Bioinformatics 15(10):
    862-3, 1999), revealed that each of the disclosed EDEM2 polynucleotide sequences is at
    least 69% identical to each other EDEM2 sequence. A Clustal W comparison of the
 .0 disclosed mammalian EDEM2 sequences revealed that each sequence is at least 92%
    identical to the other. Thus, in some embodiments, the cell contains a polynucleotide that
    encodes an EDEM2 polypeptide having a sequence that is at least 92% to any one of a
    mammalian EDEM2. A consensus EDEM2 amino acid sequence was built by aligning a
    mouse, rat, hamster, chimpanzee, and human EDEM2 polypeptide amino acid sequences.
 .5 That consensus sequence is depicted as SEQ ID NO: 8. Thus, in some embodiments, the
    cell contains a polynucleotide that encodes an EDEM2 polypeptide having an amino acid
    sequence of SEQ ID NO: 8.
            In various embodiments, the cell contains a recombinant polynucleotide that encodes
    an EDEM2 polypeptide having an amino acid sequence that is at least 92% identical to the
  0 mouse EDEM2 (mEDEM2) amino acid sequence; and in a particular embodiment, the
    polypeptide is mEDEM2 or a conservatively substituted variant thereof.
         In some embodiments, the multi-subunit protein is an antibody, and the cell contains a
    polynucleotide encoding any one or more of a polypeptide comprising an amino acid
    sequence of SEQ ID NO: 43, SEQ ID NO: 44, SEQ ID NO: 45, and SEQ ID NO: 46. SEQ ID
25  NO: 43 and 44 each represent consensus sequences of the roughly N-terminal and C
    terminal portions, respectively, of particular antibody heavy chains. Thus, the polynucleotide
    encoding a protein subunit in one embodiment encodes a polypeptide comprising both SEQ
    ID NO: 43 and SEQ ID NO: 44. SEQ ID NO: 45 and 46 each represent consensus
    sequences of the roughly N-terminal and C-terminal portions, respectively, of particular
30  antibody light chains. Thus, the polynucleotide encoding a protein subunit in one
    embodiment encodes a polypeptide comprising both SEQ ID NO: 45 and SEQ ID NO: 46. In
    some embodiments, in addition to the recombinant polynucleotide encoding the EDEM2
    protein, the cell contains at least two polynucleotides, each of which encodes a particular
    subunit of the multi-subunit protein. For example, and as exemplified below, the cell
35  contains a polynucleotide encoding an antibody heavy chain comprising an amino acid
    sequence of SEQ ID NO: 43 and SEQ ID NO: 44, and another polynucleotide encoding an
                                                         10

         WO 2013/181253                                                         PCT/US2013/043116
     antibody light chain comprising an amino acid sequence of SEQ ID NO: 45 and SEQ ID NO:
     46.
             In some embodiments, the cell, in addition to containing the stress-response
     polynucleotide and one or more polynucleotides encoding a polypeptide subunit, as
  5  described above, also contains a polynucleotide that encodes an unfolded protein response
     transcription factor that operates upstream of EDEM2. The upstream transcription factor is
     in some cases the spliced form of an XBP1. It is envisioned that any encoded XBP1 can be
     successfully employed in the instant invention. Table 2 lists some examples of sequences of
     vertebrate XBP1 spliced-form polypeptides. A multiple pairwise comparison of those
 .0  polypeptide sequences, which was performed using Clustal W (Thompson 1994; Yuan
     1999), revealed that each of the disclosed spliced XBP1 polynucleotide sequences is at
     least 48% identical to each other XBP1 sequence. A Clustal W comparison of the disclosed
     mammalian XBP1 sequences revealed that each sequence is at least 86% identical to the
     other. Thus, in some embodiments, the cell contains a polynucleotide that encodes a
 .5  spliced-form of an XBP1 polypeptide having a sequence that is at least 86% to any one of a
     mammalian spliced XBP1. A consensus XBP1 amino acid sequence was built by aligning a
     mouse, hamster, and human XBP1 amino acid sequences. That consensus sequence is
     depicted as SEQ ID NO: 13. Thus, in some embodiments, the cell contains a polynucleotide
     that encodes an XBP1 polypeptide having an amino acid sequence of SEQ ID NO: 13.
  O0         In various embodiments, the cell contains a polynucleotide that encodes an XBP1
     polypeptide having an amino acid sequence that is at least 86% identical to the mouse XBP1
     (mXBP1) amino acid sequence (SEQ ID NO: 9); and in a particular embodiment, the
     polypeptide is mXBP1, or a conservatively substituted variant thereof.
         The invention envisions that any cell may be used to harbor the lectin-encoding
25   polypeptide for the production of a properly folded and active multi-subunit protein. Such
     cells include the well-known protein production cells such as the bacterium Escherichia coli
     and similar prokaryotic cells, the yeasts Pichia pastoris and other Pichia and non-pichia
     yeasts, plant cell explants, such as those of Nicotiana, insect cells, such as Schneider 2
     cells, Sf9 and Sf21, and the Trichoplusia ni-derived High Five cells, and the mammalian cells
30   typically used in bioproduction, such as CHO, CHO-K1, COS, HeLa, HEK293, Jurkat, and
     PC12 cells. In some embodiments, the cell is a CHO-K1 or a modified CHO-K1 cell such as
     that which is taught in U.S. Patents No. 7,435,553, 7,514,545, and 7,771,997, as well as
     U.S. Published Patent Application No. US 2010-0304436 Al, each of which is incorporated
     herein by reference in its entirety.
35        In some particular embodiments, the invention provides ex vivo a CHO-K1 cell that
     contains (1) a mEDEM2-encoding polynucleotide comprising a nucleotide sequence of SEQ
     ID NO: 16, (2) an XBP1-encoding polynucleotide comprising a nucleotide sequence of SEQ
                                                       11

        WO 2013/181253                                                         PCT/US2013/043116
    ID NO: 18, (3) an antibody heavy chain-encoding polynucleotide comprising a nucleotide
    sequence that encodes a polypeptide comprising the amino acid sequences of SEQ ID NO:
    43 and 44, and (4) an antibody light chain-encoding polynucleotide comprising a nucleotide
    sequence that encodes a polypeptide comprising the amino acid sequences of SEQ ID NO:
  5 45 and 46.
        In one particular embodiment, the invention provides ex vivo a CHO-K1 cell that contains
    (1) a mEDEM2-encoding polynucleotide comprising a nucleotide sequence of SEQ ID NO:
    16, (2) an XBP1-encoding polynucleotide comprising a nucleotide sequence of SEQ ID
    NO:18, (3) an antibody heavy chain-encoding polynucleotide comprising a nucleotide
 .0 sequence of SEQ ID NO: 23, and (4) an antibody light chain-encoding polynucleotide
    comprising a nucleotide sequence of SEQ ID NO: 25.
        In another particular embodiment, the invention provides ex vivo a CHO-K1 cell that
    contains (1) a mEDEM2-encoding polynucleotide comprising a nucleotide sequence of SEQ
    ID NO: 16, (2) an XBP1-encoding polynucleotide comprising a nucleotide sequence of SEQ
 .5 ID NO: 18, (3) an antibody heavy chain-encoding polynucleotide comprising a nucleotide
    sequence of SEQ ID NO: 31, and (4) an antibody light chain-encoding polynucleotide
    comprising a nucleotide sequence of SEQ ID NO: 33.
        In yet another particular embodiment, the invention provides ex vivo a CHO-K1 cell that
    contains (1) a mEDEM2-encoding polynucleotide comprising a nucleotide sequence of SEQ
 10 ID NO: 16, (2) an XBP1-encoding polynucleotide comprising a nucleotide sequence of SEQ
    ID NO: 18, (3) an antibody heavy chain-encoding polynucleotide comprising a nucleotide
    sequence of SEQ ID NO: 39, and (4) an antibody light chain-encoding polynucleotide
    comprising a nucleotide sequence of SEQ ID NO: 41.
           The Cell Line
25         In another aspect, the invention provides a cell line, which comprises a plurality of cells
    descended by clonal expansion from a cell described above. At least 50%, at least 60%, at
    least 70%, at least 80%, at least 90%, at least 95%, at least 98%, at least 99%, or about
    100% of the constituent cells of the cell line contain a recombinant polynucleotide that
    encodes a stress-induced mannose-binding lectin, which in some embodiments is a
30  component of the ERAD. In some embodiments, the stress-induced mannose-binding lectin
    is an endoplasmic reticulum degradation-enhancing alpha-mannosidase-like protein 2
    (EDEM2). It is envisioned that any encoded EDEM2 or conservatively-substituted variant
    thereof can be successfully employed in the instant invention. Table 1, as discussed in the
    previous section, lists some examples of vertebrate EDEM2 proteins. In some
35  embodiments, the constituent cell contains a polynucleotide that encodes an EDEM2
                                                       12

        WO 2013/181253                                                          PCT/US2013/043116
    polypeptide having a sequence that is at least 92% identical to any mammalian EDEM2. In
    some embodiments, the constituent cell contains a polynucleotide that encodes an EDEM2
    polypeptide having the mammalian consensus amino acid sequence of SEQ ID NO: 8. In
    some embodiments, the constituent cell contains a recombinant polynucleotide of SEQ ID
  5 NO: 1 or a conservatively substituted variant thereof.
        In some embodiments, the multi-subunit protein that is produced by the cell line is an
    antibody, and the constituent cell of the cell line contains a polynucleotide encoding any one
    or more of a polypeptide comprising an amino acid sequence of SEQ ID NO: 43 and SEQ ID
    NO: 44 (which represent consensus sequences of the N-terminal and C-terminal portions,
 .0 respectively, of particular antibody heavy chains), and SEQ ID NO: 45 and SEQ ID NO: 46
    (which represent consensus sequences of the N-terminal and C-terminal portions,
    respectively, of particular antibody light chains). In some embodiments, in addition to the
    recombinant polynucleotide encoding the EDEM2 protein, the constituent cell of the cell line
    contains at least two polynucleotides, each of which encodes a particular subunit of the
 .5 multi-subunit protein. For example, the constituent cell contains a polynucleotide encoding
    an antibody heavy chain comprising an amino acid sequence of SEQ ID NO: 43 and SEQ ID
    NO: 44, and another polynucleotide encoding an antibody light chain comprising an amino
    acid sequence of SEQ ID NO: 45 and SEQ ID NO: 46.
           In some embodiments, the constituent cell, in addition to containing the stress
  0 response polynucleotide and one or more polynucleotides encoding a polypeptide subunit,
    as described above, also contains a polynucleotide that encodes an unfolded protein
    response transcription factor, which operates upstream of EDEM2, such as a spliced form of
    an XBP1. It is envisioned that any encoded XBP1 can be successfully employed in the
    instant invention. Table 2, as discussed in the preceding section, lists some examples of
25  sequences of vertebrate XBP1 spliced-form polypeptides. Clustal W analysis of those
    sequences revealed that each of the disclosed spliced XBP1 polynucleotide sequences is at
    least 48% identical to each other XBP1 sequence; and a comparison of the mammalian
    XBP1 sequences revealed that each sequence is at least 86% identical to the other. Thus,
    in some embodiments, the constituent cell of the cell line contains a polynucleotide that
30  encodes a spliced-form of an XBP1 polypeptide having a sequence that is at least 86% to
    any one of a mammalian spliced XBP1. In some embodiments, the constituent cell contains
    a polynucleotide that encodes an XBP1 polypeptide having a consensus amino acid
    sequence of SEQ ID NO: 13.
           In various embodiments, the cell contains a polynucleotide that encodes an XBP1
35  polypeptide having an amino acid sequence that is at least 86% identical to the mouse XBP1
    (mXBP1) amino acid sequence (SEQ ID NO: 9); and in a particular embodiment, the
    polypeptide is mXBP1 of SEQ ID NO: 9, or a conservatively substituted variant thereof.
                                                        13

        WO 2013/181253                                                           PCT/US2013/043116
        The invention envisions that the cell line comprises constituent cells whose parent is
    selected from a list of well-known protein production cells such as, e.g., the bacterium
    Escherichia coli and similar prokaryotic cells, the yeasts Pichia pastoris and other Pichia and
    non-pichia yeasts, plant cell explants, such as those of Nicotiana, insect cells, such as
  5 Schneider 2 cells, Sf9 and Sf21, and the Trichoplusia ni-derived High Five cells, and the
    mammalian cells typically used in bioporduction, such as CHO, CHO-K1, COS, HeLa,
    HEK293, Jurkat, and PC12 cells. In some embodiments, the cell is a CHO-K1 or a modified
    CHO-K1 cell, such as that which is taught in U.S. Patents No. 7,435,553, 7,514,545, and
    7,771,997, as well as U.S. Published Patent Application No. US 2010-0304436 Al.
 .0      In some embodiments, the cell line, which is cultured in media, is capable of producing
    the multi-subunit protein and secreting the properly assembled multi-subunit protein into the
    media to a titer that is at least 3 g/L, at least 5 g/L, or at least 8 g/L.
         Furthermore, the constituent cells of the cell line are capable proliferating in culture to
    such an extent as to attain an integrated cell density that is about 30% greater than the
 .5 integrated cell density of a cell line that does not contain the recombinant polynucleotide
    encoding the stress-induced mannose-binding lectin. In some cases, the cell line is able to
    attain an integrated cell density that is at least about 50% greater, at least 60% greater, or at
    least 90% greater than the integrated cell density of a cell line that does not contain the
    recombinant polynucleotide that encodes a stress-induced mannose-binding lectin. In some
 10 embodiments, the integrated cell density of the cell line is assessed after about 12 days in
    culture.
         In some particular embodiments, the invention provides a cell-line comprising clonally
    derived constituent cells, wherein the constituent cell is a CHO-K1 cell that contains (1) a
    mEDEM2-encoding polynucleotide comprising a nucleotide sequence of SEQ ID NO: 16, (2)
25  an XBP1-encoding polynucleotide comprising a nucleotide sequence of SEQ ID NO: 18, (3)
    an antibody heavy chain-encoding polynucleotide comprising a nucleotide sequence that
    encodes a polypeptide comprising the amino acid sequences of SEQ ID NO: 43 and 44, and
    (4) an antibody light chain-encoding polynucleotide comprising a nucleotide sequence that
    encodes a polypeptide comprising the amino acid sequences of SEQ ID NO: 45 and 46.
30       In one particular embodiment, the invention provides a cell-line comprising clonally
    derived constituent cells, wherein the constituent cell is a CHO-K1 cell that contains (1) a
    mEDEM2-encoding polynucleotide comprising a nucleotide sequence of SEQ ID NO: 16, (2)
    an XBP1-encoding polynucleotide comprising a nucleotide sequence of SEQ ID NO: 18, (3)
    an antibody heavy chain-encoding polynucleotide comprising a nucleotide sequence of SEQ
35  ID NO: 23, and (4) an antibody light chain-encoding polynucleotide comprising a nucleotide
    sequence of SEQ ID NO: 25.
                                                          14

        WO 2013/181253                                                            PCT/US2013/043116
        In another particular embodiment, the invention provides a cell-line comprising clonally
    derived constituent cells, wherein the constituent cell is a CHO-K1 cell that contains (1) a
    mEDEM2-encoding polynucleotide comprising a nucleotide sequence of SEQ ID NO: 16, (2)
    an XBP1-encoding polynucleotide comprising a nucleotide sequence of SEQ ID NO: 18, (3)
  5 an antibody heavy chain-encoding polynucleotide comprising a nucleotide sequence of SEQ
    ID NO: 31, and (4) an antibody light chain-encoding polynucleotide comprising a nucleotide
    sequence of SEQ ID NO: 33.
        In yet another particular embodiment, the invention provides a cell-line comprising
    clonally-derived constituent cells, wherein the constituent cell is a CHO-K1 cell that contains
 .0 (1) a mEDEM2-encoding polynucleotide comprising a nucleotide sequence of SEQ ID NO:
    16, (2) an XBP1-encoding polynucleotide comprising a nucleotide sequence of SEQ ID NO:
    18, (3) an antibody heavy chain-encoding polynucleotide comprising a nucleotide sequence
    of SEQ ID NO: 39, and (4) an antibody light chain-encoding polynucleotide comprising a
    nucleotide sequence of SEQ ID NO: 41.
 .5         The EDEM2 Polynucleotide
        In another aspect, the invention provides a polynucleotide that encodes an EDEM2
    protein. The EDEM2-encoding polynucleotide is recombinant and can be manufactured,
    stored, used or expressed in vitro, as in a test tube, or an in vitro translation system, or in
    vivo, such as in a cell, which can be ex vivo, as in a cell culture, or in vivo, as in an
  0 organism. In some embodiments, the EDEM2-encoding polynucleotide is within a gene,
    meaning that it is under the control of and down stream of a promoter,and up stream of a
    polyadenylation site. The EDEM2-encoding polynucleotide or gene can be within a plasmid
    or other circular or linear vector. The EDEM2-encoding polynucleotide or gene can be within
    a circular or linear DNA construct, which can be within a cell as an episome or integrated
25  into the cellular genome.
        As described above, the EDEM2-encoding polynucleotide encodes any ortholog,
    homolog or conservatively substituted EDEM2 polypeptide of Table 1, or an EDEM2
    polypeptide having an amino acid sequence that is at least 92% identical to any one of SEQ
    ID NO: 1-5 and 8, including the mammalian consensus sequence of SEQ ID NO: 8.
30      In some cases, the recombinant or isolated EDEM2-encoding polynucleotide is operably
    linked to a mammalian promoter. The promoter can be any promoter, but in some cases it is
    a mammalian promoter, such as for example a ubiquitin C promoter.
        In a particular embodiment, the EDEM2-encoding polynucleotide essentially consists of,
    from 5' to 3', a promoter, such as a ubiquitin C promoter, followed by an optional intron, such
35  as a beta globin intron, followed by an EDEM2 coding sequence, followed by a
                                                       15

        WO 2013/181253                                                            PCT/US2013/043116
    polyadenylation sequence, such as an SV40pA sequence. A specific example, which is also
    a particular embodiment, of such an EDEM2-encoding polynucleotide is described by SEQ
    ID NO: 16. Conserved variants of that sequence are also envisioned to be embodiments of
    the invention.
  5     In some cases, the recombinant EDEM2-encoding polynucleotide is part of a plasmid,
    which can be linear, circular, episomal, integrated, a static DNA construct, or a vector for
    delivering the EDEM2 gene or expressing the EDEM2 protein. In one particular
    embodiment, the plasmid contains (1) an EDEM2 gene, which is under the control of a
    ubiquitin C promoter and terminates with an SV40 polyadenylation signal, and (2) a
 .0 selectable marker, such as a polynucleotide encoding a polypeptide that confers resistance
    to zeocin or a polynucleotide encoding a polypeptide that confers resistance to neomycin,
    under the control of a promoter, such as an SV40 promoter, and terminated with a
    polyadenylation sequence, such as a PGK pA sequence. In one particular embodiment, the
    plasmid comprises, in a circular format running in a 5' to 3' direction, a ubiquitin C promotor,
 .5 a beta globin intron, an EDEM2 coding sequence, an SV40 pA sequence, an SV40
    promoter, a neomycin-resistance coding sequence, and a PGK pA sequence. A specific
    example of this embodiment is exemplified by a plasmid having the sequence of SEQ ID
    NO: 14. In another particular embodiment, the plasmid comprises, in a circular format
    running in a 5' to 3' direction, a ubiquitin C promotor, a beta globin intron, an EDEM2 coding
  0 sequence, an SV40 pA sequence, an SV40 promoter, a zeocin-resistance coding sequence,
    and a PGK pA sequence. A specific example of this embodiment is exemplified by a
    plasmid having the sequence of SEQ ID NO: 15.
        The XBP1 Polynucleotide
        In another aspect, the invention provides a polynucleotide that encodes an XBP1 protein.
25  The XBP1-encoding polynucleotide is recombinant and can be manufactured, stored, used
    or expressed in vitro, as in a test tube, or an in vitro translation system, or in vivo, such as in
    a cell, which can be ex vivo, as in a cell culture, or in vivo, as in an organism. In some
    embodiments, the XBP1-encoding polynucleotide is within a gene, meaning that it is under
    the control of and down stream of a promoter, and up stream of a polyadenylation site. The
30  XBP1-encoding polynucleotide can be within a plasmid or other circular or linear vector. The
    XBP1-encoding polynucleotide or gene can be within a circular or linear DNA construct,
    which can be within a cell as an episome, or integrated into the cellular genome.
        As described above, the XBP1-encoding polynucleotide encodes any ortholog, homolog
    or conservatively substituted XBP1 polypeptide of Table 2, or an XBP1 polypeptide having
                                                        16

        WO 2013/181253                                                          PCT/US2013/043116
    an amino acid sequence that is at least 86% identical to any one of SEQ ID NO: 9, 10, and
    11, including the mammalian consensus sequence of SEQ ID NO: 13.
        In some cases, the recombinant or isolated XBP1-encoding polynucleotide is operably
    linked to a mammalian promoter. The promoter can be any promoter, but in some cases it is
  5 a mammalian promoter, such as for example a ubiquitin C promoter.
        In a particular embodiment, the XBP1-encoding polynucleotide essentially consists of,
    from 5' to 3', a promoter, such as a ubiquitin C promoter, followed by an optional intron, such
    as a beta globin intron, followed by an XBP1 coding sequence, followed by a
    polyadenylation sequence, such as an SV40 pA sequence. SEQ ID NO: 18 describes an
 .0 example of an XBP1-encoding polynucleotide. Conserved variants of that exemplary
    sequence are also envisioned to be embodiments of the invention.
        In some cases, the recombinant XBP1-encoding polynucleotide is part of a plasmid,
    which can be linear, circular, episomal, integrated, a static DNA construct, or a vector for
    delivering the XBP1 gene or expressing the spliced and active XBP1 protein. In one
 .5 particular embodiment, the plasmid contains (1) an XBP1 gene, which is under the control of
    a ubiquitin C promoter and terminates with an SV40 polyadenylation signal, and (2) a
    selectable marker, such as a polynucleotide encoding a polypeptide that confers resistance
    to zeocin or a polynucleotide encoding a polypeptide that confers resistance to neomycin,
    under the control of a promoter, such as an SV40 promoter, and terminated with a
  0 polyadenylation sequence, such as a PGK pA sequence. In one particular embodiment, the
    plasmid comprises, in a circular format running in a 5' to 3' direction, a ubiquitin C promotor,
    a beta globin intron, an XBP1 coding sequence, an SV40 pA sequence, an SV40 promoter,
    a zeocin-resistance coding sequence, and a PGK pA sequence. A specific example of this
    embodiment is exemplified by a circular plasmid having the sequence of SEQ ID NO: 17.
25      The Antibody Heavy and Light Chain-Encoding Polynucleotides
        In another aspect, the invention provides a polynucleotide that encodes an antibody
    heavy chain polypeptide (HC). The HC-encoding polynucleotide is recombinant and can be
    manufactured, stored, used or expressed in vitro, as in a test tube, or an in vitro translation
    system, or in vivo, such as in a cell, which can be ex vivo, as in a cell culture, or in vivo, as in
30  an organism. In some embodiments, the HC-encoding polynucleotide is within a gene,
    meaning that it is under the control of and down stream from a promoter, and up stream of a
    polyadenylation site. The HC-encoding polynucleotide may be within a plasmid or other
    circular or linear vector. The HC-encoding polynucleotide or gene may be within a circular or
    linear DNA construct, which may be within a cell as an episome or integrated into the cellular
35  genome.
                                                      17

        WO 2013/181253                                                          PCT/US2013/043116
         In some cases, the recombinant or isolated HC-encoding polynucleotide is operably
    linked to a mammalian promoter. The promoter can be any promoter, but in some cases it is
    a mammalian promoter, such as for example a ubiquitin C promoter or an hCMV-IE
    promoter.
  5      In a particular embodiment, the HC-encoding polynucleotide is an HC gene, which
    essentially comprises, from 5' to 3', a promoter, for example an hCMV-IE promoter, followed
    by an optional intron, such as a beta globin intron, followed by a heavy chain coding
    sequence, such as for example a sequence encoding an amino acid sequence of SEQ ID
    NO: 43 and 44, SEQ ID NO: 19, SEQ ID NO: 27, or SEQ ID NO: 35, followed by a
 .0 polyadenylation sequence, for example an SV40 pA sequence. A specific example of an HC
    gene is described by SEQ ID NO: 23, SEQ ID NO: 31, or SEQ ID NO: 39. Conserved
    variants of any one of these sequences are also envisioned to be embodiments of the
    invention.
         In some cases, the recombinant HC-encoding polynucleotide is part of a plasmid, which
 .5 can be linear, circular, episomal, integrated, a static DNA construct, or a vector for delivering
    the heavy chain gene or expressing the heavy chain sububunit. In one particular
    embodiment, the plasmid contains (1) an HC gene, which is under the control of an hCMV-IE
    promoter and terminates with an SV40 polyadenylation signal, and (2) a selectable marker,
    such as a polynucleotide encoding a polypeptide that confers resistance to hygromycin,
  0 under the control of a promoter, such as an SV40 promoter, and terminated with a
    polyadenylation sequence, such as a PGK pA sequence. In one particular embodiment, the
    plasmid comprises, in a circular format running in a 5' to 3' direction, an hCMV-IE promoter,
    a beta globin intron, an antibody heavy chain coding sequence (which encodes a HC having
    an amino acid of SEQ ID NO: 43 and 44, SEQ ID NO: 19, SEQ ID NO: 27, or SEQ ID NO:
25  35), an SV40 pA sequence, an SV40 promoter, a hygromycin-resistance coding sequence,
    and a PGK pA sequence. A specific example and particular embodiment of such a plasmid
    containing an HC gene is described by SEQ ID NO: 24, SEQ ID NO: 32, or SEQ ID NO: 40.
    Conserved variants of any one of these sequences are also envisioned to be embodiments
    of the invention.
30       In another aspect, the invention provides a polynucleotide that encodes an antibody light
    chain polypeptide (LC). The LC-encoding polynucleotide is recombinant and can be
    manufactured, stored, used or expressed in vitro, as in a test tube, or an in vitro translation
    system, or in vivo, such as in a cell, which can be ex vivo, as in a cell culture, or in vivo, as in
    an organism. In some embodiments, the LC-encoding polynucleotide is within a gene,
35  meaning that it is under the control of and down stream from a promoter, and up stream of a
    polyadenylation site. The LC-encoding polynucleotide or gene may be within a plasmid or
    other circular or linear vector. The LC-encoding polynucleotide or gene may be within a
                                                       18

        WO 2013/181253                                                             PCT/US2013/043116
    circular or linear DNA construct, which may be within a cell as an episome or integrated into
    the cellular genome.
         In some cases, the recombinant or isolated LC-encoding polynucleotide is operably
    linked to a mammalian promoter. The promoter can be any promoter, but in some cases it is
  5 a mammalian promoter, such as, e.g., a ubiquitin C promoter or an hCMV-IE promoter.
         In a particular embodiment, the LC-encoding polynucleotide is an LC gene, which
    essentially comprises, from 5' to 3', a promoter, for example an hCMV-IE promoter, followed
    by an optional intron, such as a beta globin intron, followed by a light chain coding
    sequence, such as for example a sequence encoding an amino acid sequence of SEQ ID
 .0 NO: 45 and 46, SEQ ID NO: 21, SEQ ID NO: 29, or SEQ ID NO: 37, followed by a
    polyadenylation sequence, such as an SV40 pA sequence. A specific example and particular
    embodiment of such an LC gene is described by SEQ ID NO: 25, SEQ ID NO: 33, or SEQ ID
    NO: 41. Conserved variants of any one of these sequences are also envisioned to be
    embodiments of the invention.
 .5      In some cases, the recombinant LC-encoding polynucleotide is part of a plasmid, which
    may be linear, circular, episomal, integrated, a static DNA construct, or a vector for
    delivering the light chain gene or expressing the light chain sububunit. In one particular
    embodiment, the plasmid contains (1) an LC gene, which is under the control of an hCMV-IE
    promoter and terminates with an SV40 polyadenylation signal, and (2) a selectable marker,
  0 such as a polynucleotide encoding a polypeptide that confers resistance to hygromycin,
    under the control of a promoter, such as an SV40 promoter, and terminated with a
    polyadenylation sequence, such as a PGK pA sequence. In one particular embodiment, the
    plasmid comprises, in a circular format running in a 5' to 3' direction, an hCMV-IE promoter,
    a beta globin intron, an antibody light chain coding sequence (which encodes a LC having
25  an amino acid of SEQ ID NO: 45 and 46, SEQ ID NO: 21, SEQ ID NO: 29, or SEQ ID NO:
    37), an SV40 pA sequence, an SV40 promoter, a hygromycin-resistance coding sequence,
    and a PGK pA sequence. A specific example and particular embodiment of such a plasmid
    containing an LC gene is described by SEQ ID NO: 26, SEQ ID NO: 34, or SEQ ID NO: 42.
    Conserved variants of any one of these sequences are also envisioned to be embodiments
30  of the invention.
             Methods of Manufacturing Multi-subunit Proteins
         In another aspect, the invention provides a method for manufacturing a multi-subunit
    protein by culturing a cell, or a constituent cell of a cell line, which is capable of producing
    and secreting relatively large amounts of a properly assembled multi-subunit protein, in a
35  medium, wherein the multi-subunit component is secreted into the medium at a relatively
                                                         19

        WO 2013/181253                                                                PCT/US2013/043116
    high titer. The cell utilized in this manufacturing process is a cell described in the foregoing
    aspects, which contains an ERAD lectin-encoding polynucleotide described herein.
         Methods of culturing cells, and in particular mammalian cells, for the purpose of
    producing useful recombinant proteins is well-known in the art (e.g., see De Jesus & Wurm,
  5 Eur. J. Pharm. Biopharm. 78:184-188, 2011, and references cited therein). Briefly, cells
    containing the described polynucleotides are cultured in media, which may contain sera or
    hydrolysates, or may be chemically defined and optimized for protein production. The
    cultures may be fed-batch cultures or continuous cultures, as in a chemostat. The cells may
    be cultured in lab bench size flasks (-25 mL), production scale-up bioreactors (1-5 L), or
 .0 industrial scale bioreactors (5,000 - 25,000 L). Production runs may last for several weeks
    to a month, during which time the multi-subunit protein is secreted into the media.
         The subject cell has an enhanced ability to produce and secrete properly assembled
    multi-subunit proteins. In some embodiments, the multi-subunit protein, for example an
    antibody, is secreted into the media at a rate of at least 94 pg/cell/day, at least 37
 .5 pg/cell/day, or at least 39 pg/cell/day. In some embodiments, the multi-subunit protein
    attains a titer of at least at least 3 g/L, at least 5 g/L, at least 6 g/L, or at least 8 g/L after
    about twelve days of culture.
         Furthermore, the subject cell has an enhanced ability to proliferate and attain a relatively
    high cell density, further optimizing productivity. In some embodiments, the cell or cell-line
 10 seed train attains an integrated cell density in culture of at least 5 x 107 cell-day/mL, at least
    1 x 108 cell-day/mL or at least 1.5 x 108 cell-day/mL.
         Optionally, the secreted multi-subunit protein is subsequently purified from the medium
    into which it was secreted. Protein purification methods are well-known in the art (see e.g.,
    Kelley, mAbs 1(5):443-452). In some embodiments, the protein is harvested by
25  centrifugation to remove the cells from the liquid media supernatant, followed by various
    chromatography steps and a filtration step to remove inter alia viruses and other
    contaminants or adulterants. In some embodiments, the chromatography steps include an
    ion exchange step, such as cation-exchange or anion-exchange. Various affinity
    chromatographic media may also be employed, such as protein A chromatography for the
30  purification of antibodies.
         Optionally, the manufacturing method may include the antecedent steps of creating the
    cell. Thus, in some embodiments, the method of manufacturing the multi-subunit protein
    comprises the step of transfecting the cell with the vector that encodes the stress-induced
    mannose-binding lectin, as described above, followed by selecting stable integrants thereof.
35  Non-limiting examples of vectors include those genetic constructs that contain a
    polynucleotide that encodes an EDEM2 having an amino acid sequence of any one of SEQ
                                                           20

         WO 2013/181253                                                          PCT/US2013/043116
     ID NO: 1-8, an amino acid sequence that is at least 92% identical to any one of SEQ ID NO:
     1-8, or any one of a conservatively substituted variant of SEQ ID NO: 1-8. Useful vectors
     also include, for example, a plasmid harboring the gene of SEQ ID NO: 16, the plasmid of
     SEQ ID NO: 15, and the plasmid of SEQ ID NO: 14. One should keep in mind that the
  5  plasmid sequences (e.g., SEQ ID NO: 14, 15, 17, 24, 26, 32, 34, 40, and 42) are circular
     sequences described in a linear manner in the sequence listing. Thus, in those cases, the 3
     prime-most nucleotide of the written sequence may be considered to be immediately 5-prime
     of the 5-prime-most nucleotide of the sequence as written. In the example of the plasmid of
     SEQ ID NO: 14, transformants are selected through resistance to neomycin; for SEQ ID NO:
 .0  15, by selection through ZEOCIN resistance.
          Detailed methods for the construction of polynucleotides and vectors comprising same,
     are described in U.S. Patents No. 7,435,553 and 7,771,997, which are incorporated herein
     by reference, and in, e.g., Zwarthoff et al., J. Gen. Virol. 66(4):685-91, 1985; Mory et al.,
     DNA. 5(3):181-93, 1986; and Pichler et al., Biotechnol. Bioeng. 108(2):386-94, 2011.
 .5       The starting cell, into which the vector that encodes the stress-induced mannose-binding
     lectin is placed, may already contain the constructs or genetic elements encoding or
     regulating the expression of the subunits of the multi-subunit protein, or XBP1 for those
     embodiments utilizing XBP1. Alternatively, the vector that encodes the stress-induced
     mannose-binding lectin may be put inside the cell first, and followed by the other constructs.
  O0          Multi-Subunit Proteins Manufactured by the Process
          In another aspect, the invention provides a multi-subunit protein that is made according
     to the process disclosed herein. Given the inclusion of one or more elements that facilitate
     the proper folding, assembly, and post-translational modification of a multi-subunit protein,
     such as an antibody, one of ordinary skill in the art would reasonably expect such a protein
25   to have distinct structural and functional qualities. For example, an antibody manufactured
     by the disclosed process is reasonably believed to have a particular glycosylation pattern
     and a quantitatively greater proportion of non-aggregated heterotetramers.
     EXAMPLES
          The following examples are presented so as to provide those of ordinary skill in the art
30   with a complete disclosure and description of how to make and use the methods and
     compositions of the invention, and are not intended to limit the scope of what the inventors
     regard as their invention. Efforts have been made to ensure accuracy with respect to
     numbers used (e.g., amounts, temperature, etc.) but some experimental errors and
     deviations should be accounted for. Unless indicated otherwise, parts are parts by mole,
                                                         21

        WO 2013/181253                                                          PCT/US2013/043116
    molecular weight is average molecular weight, percent concentration (%) means the mass of
    the solute in grams divided by the volume of the solution in milliliters times 100% (e.g., 10%
    substance X means 0.1 gram of substance X per milliliter of solution), temperature is in
    degrees Centigrade, and pressure is at or near atmospheric pressure.
  5 EXAMPLE 1: CELL LINES
         CHO-K1 derived host cell line was transfected with two plasmids encoding heavy and
    light chain of a human antibody. Both plasmids contain the hph gene conferring resistance to
    hygromycin B (Asselbergs and Pronk, 1992, Mol. Biol. Rep., 17(1):61-70). Cells were
    transfected using LIPOFECTAMIN reagent (Invitrogen cat.#18324020). Briefly, one day
 .0 before transfection 3.5 million cells were plated on a 10 cm plate in complete F12 (Invitrogen
    cat.#1 1765) containing 10% fetal bovine serum (FBS) (Invitrogen cat.#10100). On the day of
    transfection the cells were washed once and medium was replaced with OPTIMEM from
    (Invitrogen cat.# 31985). DNA/Lipofectamin complexes were prepared in OPTIMEM
    medium and then added to the cells. The medium was changed again to the complete F12
 .5 with 10% FBS 6 hours later. The stable integration of the plasmids was selected using
    hygromycin B selection agent at 400 pig/ml. Clonal antibody expressing cell lines were
    isolated using the FASTR technology (described in the U.S. Pat. No. 6,919,183, which is
    herein incorporated by reference).
        The antibody expressing lines were then re-transfected with the EDEM2 encoding
 10 plasmid. EDEM2 plasmids contained either neomycin phosphotransferase (plasmid
    construct designated "p3") or sh ble (plasmid "p7") genes to confer resistance to either G418
    or zeocin respectively. The same transfection method was used. Depending on the
    selectable marker, cells were selected with either G418 or zeocin at 400 pig/ml or 250 pig/ml,
    respectively. The clonal cell lines were then isolated using FASTR technology.
25
        Table 3: Cell Lines
    Name        Enhancers             Constructs                                           Protein
    C1            EDEM2 + XBP1        HC/LC = pl/p2
    C2                 XBP1           EDEM2 = p3                                           aAng2
                                      XBP1 = p4
    C3            EDEM2 + XBP1        HC/LC = p5/p6
    C4                 XBP1           EDEM2= p7                                            aGDF8
    C5                EDEM2           XBP1= p4
    C6            EDEM2 + XBP1        HC/LC = p8/p9
    C7                 XBP1           EDEM2 = p3                                          aAngPtl4
                                      XBP1 = p4
                                                       22

        WO 2013/181253                                                           PCT/US2013/043116
    EXAMPLE 2:
         The antibody production was evaluated in a scaled-down 12-day fed batch process using
    shaker flasks. In this method the cells were seeded in a shaker flask at the density of 0.8
    million cells per mL in the production medium (defined media with high amino acid). The
  5 culture was maintained for about 12 days, and was supplemented with three feeds as well
    as glucose. The viable cell density, and antibody titer were monitored throughout the batch.
         To determine the effect of mEDEM2 on enhanced protein production, the production of
    proteins by CHO cell lines containing mEDEM2 and mXBP1 were compared to production
    by control cells that contained mXBP1, but not mEDEM2. Protein titers were higher in those
 .0 cell lines expressing mEDEM2 versus those cell lines that did not express mEDEM2.
    TABLE 4: TITERS
    Cell Line                  Enhancers              Production rate             Titre g/L
                                                        (pg/cell/day)           (% increase)
    C1                       EDEM2 + XBP1                    39                    8.1 (93)
    C2                           XBP1                        39                       4.2
    C3                       EDEM2 + XBP1                    37                    5.9 (55)
    C8                           XBP1                        32                       3.8
    C6                       EDEM2 + XBP1                    94                   5.3 (152)
    C7                           XBP1                        52                       2.1
    C5                          EDEM2                        29                   3.1 (343)
    C9                             ---                        9                       0.7
    EXAMPLE 3: INTEGRATED CELL DAYS
         Integrated Cell Days ("ICD") is a phrase used to describe the growth of the culture
    throughout the fed batch process. In the course of the 12-day production assay, we
15  monitored viable cell density on days 0, 3, 5, 7, 10, and 12. This data was then plotted
    against time. ICD is the integral of viable cell density, calculated as the area under the cell
    density curve. EDEM2 transfected lines have higher ICD in a 12-day fed batch process (see
    Table 5).
    TABLE 5: INTEGRATED CELL DENSITIES
    Cell Line                  Enhancers              ICD 10' cell-day/mL
                                                          (% increase)
    C1                       EDEM2 + XBP1                   205 (93)
    C2                            XBP1                         106
                                                       23

       WO 2013/181253                                                             PCT/US2013/043116
   C3                       EDEM2 + XBP1                    157(34)
   C4                             XBP1                        117
   C6                       EDEM2 + XBP1                    56(51)
   C7                             XBP1                        37
   C5                            EDEM2                      116(59)
   C9                               ---                       73
   EXAMPLE 4: ANTI-GDF8 ANTIBODY PRODUCTION
        The effect of ectopic expression of EDEM2, XBP1, or both on the production of an anti
   GDF8 antibody having a heavy chain sequence of SEQ ID NO: 19 and a light chain
   sequence of SEQ ID NO: 21 was examined. Individual cell-lines were examined for titer and
 5 integrated cell density and placed into "bins", or ranges of values. Ectopic expression of
   EDEM2 significantly increased the number of cell lines that express antibody in the 5-6 g/L
   titer range. The combination of XBP1 and EDEM2 showed more than an additive effect
   toward the increase in high titer cell lines. The expression of EDEM2 in the antibody
   secreting cells also significantly increased the number of cell lines that attain a high ICD (see
.0 Table 6).
   TABLE 6:
                                 Titre Bins (g/L)                     ICD Bins (10' cell-day/mL)
     construct      <1           1-3          3-5       5-6         30-50      50-100      100-200
        E+X         0%         33.3%        44.4%     22.2%        11.1%        50%         38.9%
         X          0%         37.5%         54%       8.3%        14.3%       85.7%          0%
         E          0%          33%          60%        7%           0%         27%          73%
          -        82%          18%           0%        0%           13%        67%          21%
                                                      24

   The claims defining the invention are as follows:
   1.      An isolated polynucleotide comprising a nucleotide sequence encoding:
           an endoplasmic reticulum degradation-enhancing alpha-mannosidase-like protein 2
 5 (EDEM2) polypeptide, wherein the EDEM2 comprises an amino acid sequence that is at least
   92% identical to SEQ ID NO:1;
           a promoter; and
           a multi-subunit protein.
10 2.      The isolated polynucleotide of claim 1, wherein the promoter is selected from the
   group consisting of ubiquitin C, CMV-IE and SV40.
   3.      The isolated polynucleotide of claims 1 or 2, wherein the EDEM2 polypeptide
   comprises the amino acid sequence of SEQ ID NO: 8.
15
   4.      The isolated polynucleotide of any one of claims 1 to 3, wherein the EDEM2
   polypeptide consists essentially of the amino acid sequence of SEQ ID NO: 8.
   5.      The isolated polynucleotide of any one of claims 1 to 4, wherein the EDEM2
20 polypeptide comprises the amino acid sequence selected from the group consisting of SEQ
   ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5 and SEQ ID NO: 6.
   6.      The isolated polynucleotide of any one of claims 1-3 and 5, wherein the EDEM2
   polypeptide consists essentially of the amino acid sequence of SEQ ID NO: 1.
25
   7.      The isolated polynucleotide of any one of claims 1 to 6, wherein the nucleotide
   sequence encoding a multi-subunit protein encodes at least one antibody heavy chain or at
   least one antibody light chain.
30 8.      The isolated polynucleotide of claim 7, wherein the nucleotide sequence encoding an
   antibody heavy chain comprising amino acid sequences SEQ ID NO: 43 and SEQ ID NO: 44.
   9.      The isolated polynucleotide of claims 7 or 8, wherein the nucleotide sequence
   encoding a multi-subunit protein further encodes an antibody light chain comprising amino
35 acid sequences SEQ ID NO: 45 and SEQ ID NO: 46.
                                                 25

   10.     The isolated polynucleotide of claim 7, 8 or 9, wherein the nucleotide sequence
   encoding a multi-subunit protein encodes an antibody heavy chain comprising amino acid
   sequences SEQ ID NO: 43 and SEQ ID NO: 44 and an antibody light chain comprising amino
   acid sequences SEQ ID NO: 45 and SEQ ID NO: 46.
 5
   11.     The isolated polynucleotide of claim 7, wherein the nucleotide sequence encoding a
   multi-subunit protein encodes an anti-GDF8 antibody heavy chain operably linked to a
   mammalian ubiquitin C promoter or a human CMV-IE promoter.
10 12.     The isolated polynucleotide of claim 11, wherein the anti-GDF8 antibody heavy chain
   comprises the amino acid sequence of SEQ ID NO: 19.
   13.     The isolated polynucleotide of claim 11, wherein the anti-GDF8 antibody heavy chain
   comprises the amino acid sequence of SEQ ID NO: 20.
15
   14.     The isolated polynucleotide of claim 11, wherein the nucleotide sequence encoding a
   multi-subunit protein encodes an anti-GDF8 antibody heavy chain comprises SEQ ID NO: 23.
   15.     The isolated polynucleotide of claim 11, wherein the nucleotide sequence encoding a
20 multi-subunit protein encodes an anti-GDF8 antibody heavy chain comprises SEQ ID NO: 24.
   16.     The isolated polynucleotide of any one of claims 7-15, wherein the nucleotide
   sequence encodes an anti-GDF8 antibody light chain, operably linked to a mammalian
   ubiquitin C promoter or a human CMV-IE promoter.
25
   17.     The isolated polynucleotide of claim 16, wherein the nucleotide sequence encoding a
   multi-subunit protein encodes an anti-GDF8 antibody light chain comprising the amino acid
   sequence of SEQ ID NO: 22.
30 18.     The isolated polynucleotide of claim 16, wherein the nucleotide sequence encoding a
   multi-subunit protein encodes an anti-GDF8 antibody light chain comprising the amino acid
   sequence of SEQ ID NO: 21.
   19.     The isolated polynucleotide of claim 16, wherein the nucleotide sequence encoding a
35 multi-subunit protein encodes an anti-GDF8 antibody light chain comprising the nucleotide
   sequence of SEQ ID NO: 25.
                                                 26

   20.     The isolated polynucleotide claim 16, wherein the nucleotide sequence encoding a
   multi-subunit protein encodes an anti-GDF8 antibody light chain comprising the nucleotide
   sequence of SEQ ID NO: 26.
 5 21.     The isolated polynucleotide of claim 7, 8, 9 or 10, wherein the nucleotide sequence
   encoding a multi-subunit protein encodes an anti-ANG2 antibody heavy chain operably linked
   to a mammalian ubiquitin C promoter or a human CMV-IE promoter.
   22.     The isolated polynucleotide of claim 21, wherein the anti-ANG2 antibody heavy chain
10 comprises the amino acid sequence of SEQ ID NO: 28.
   23.     The isolated polynucleotide of claim 21, wherein the anti-ANG2 antibody heavy chain
   comprises the amino acid sequence of SEQ ID NO: 27.
15 24.     The isolated polynucleotide of claim 21, wherein the nucleotide sequence encoding a
   multi-subunit protein comprises the nucleotide sequence of SEQ ID NO: 31.
   25.     The isolated polynucleotide of claim 21, wherein the nucleotide sequence encoding a
   multi-subunit protein comprises the nucleotide sequence of SEQ ID NO: 32.
20
   26.     The isolated polynucleotide of any one of claims 21-25, wherein the nucleotide
   sequence encoding a multi-subunit protein encodes an anti-ANG2 antibody light chain,
   operably linked to a mammalian promoter.
25 27.     The isolated polynucleotide of claim 26, wherein the anti-ANG2 antibody light chain
   comprises the amino acid sequence of SEQ ID NO: 30.
   28.     The isolated polynucleotide of claim 26, wherein the anti-ANG2 antibody light chain
   comprises the amino acid sequence of SEQ ID NO: 29.
30
   29.     The isolated polynucleotide of claim 26, wherein the nucleotide sequence encoding a
   multi-subunit protein comprises the nucleotide sequence of SEQ ID NO: 33.
   30.     The isolated polynucleotide of claim 26, wherein the nucleotide sequence encoding a
35 multi-subunit protein comprises the nucleotide sequence of SEQ ID NO: 34.
                                                 27

   31.     The isolated polynucleotide of any one of claims 7-10, encoding a multi-subunit
   protein encodes an anti-AngPtl4 antibody heavy chain, operably linked to a mammalian
   ubiquitin C promoter or a human CMV-IE promoter.
 5 32.     The isolated polynucleotide of claim 31, wherein the anti-AngPtl4 antibody heavy
   chain comprises the amino acid sequence of SEQ ID NO: 36.
   33.     The isolated polynucleotide of claim 31, wherein the anti-AngPtl4 antibody heavy
   chain comprises the amino acid sequence of SEQ ID NO: 35.
10
   34.     The isolated polynucleotide of claim 31, wherein the nucleotide sequence encoding a
   multi-subunit protein comprises the nucleotide sequence of SEQ ID NO: 39.
   35.     The isolated polynucleotide of claim 31, wherein the nucleotide sequence encoding a
15 multi-subunit protein comprises the nucleotide sequence of SEQ ID NO: 40.
   36.     The isolated polynucleotide of claim 31, wherein the nucleotide sequence encodes an
   anti-AngPtl4 antibody light chain operably linked to a mammalian ubiquitin C promoter or a
   human CMV-IE promoter.
20
   37.     The isolated polynucleotide of claim 36, wherein the anti-AngPtl4 antibody light chain
   comprises the amino acid sequence of SEQ ID NO: 38.
   38.     The isolated polynucleotide of claim 36, wherein the anti-AngPtl4 antibody light chain
25 comprises the amino acid sequence of SEQ ID NO: 37.
   39.     The isolated polynucleotide of claim 36, wherein the nucleotide sequence encoding a
   multi-subunit protein comprises the nucleotide sequence of SEQ ID NO: 41.
30 40.     The isolated polynucleotide of claim 36, wherein the nucleotide sequence encoding a
   multi-subunit protein comprises the nucleotide sequence of SEQ ID NO: 42.
   41.     The isolated polynucleotide of any one of claims 1-40, further comprising a nucleotide
   sequence encoding a spliced form of an X-box binding protein 1 (XBP1).
35
   42.     The isolated polynucleotide of claim 41, wherein the XBP1 comprises an amino acid
   sequence of SEQ ID NO: 13.
                                                 28

  43.    The isolated polynucleotide of claim 41, wherein the XBP1 comprises an amino acid
  sequence that is at least 86% identical to SEQ ID NO: 9.
5 44.    The isolated polypeptide of any one of claims 41-43, wherein the nucleotide sequence
  that encodes the spliced form of XBP1 comprises the nucleotide sequence of SEQ ID NO: 17
  or 18.
                                                29

                                        SEQUENCE LISTING
<removed-date>
              <110>   Regeneron Pharmaceuticals, Inc.
              <120>   Production Cell Line Enhancers
              <130>   8150A
              <150>   US 61/652,549
              <151>   2012-05-29
<removed-apn>
              <160>   46
              <170>   PatentIn version 3.5
              <210>   1
              <211>   577
              <212>   PRT
              <213>   Mus musculus
              <400>   1
              Met Pro Phe Arg Leu Leu Ile Pro Leu Gly Leu Val Cys Val Leu Leu
              1               5                   10                  15
              Pro Leu His His Gly Ala Pro Gly Pro Asp Gly Thr Ala Pro Asp Pro
                          20                  25                  30
              Ala His Tyr Arg Glu Arg Val Lys Ala Met Phe Tyr His Ala Tyr Asp
                      35                  40                  45
              Ser Tyr Leu Glu Asn Ala Phe Pro Tyr Asp Glu Leu Arg Pro Leu Thr
                  50                  55                  60
              Cys Asp Gly His Asp Thr Trp Gly Ser Phe Ser Leu Thr Leu Ile Asp
              65                  70                  75                  80
              Ala Leu Asp Thr Leu Leu Ile Leu Gly Asn Thr Ser Glu Phe Gln Arg
                              85                  90                  95
              Val Val Glu Val Leu Gln Asp Asn Val Asp Phe Asp Ile Asp Val Asn
                          100                 105                 110
              Ala Ser Val Phe Glu Thr Asn Ile Arg Val Val Gly Gly Leu Leu Ser
                      115                 120                 125
              Ala His Leu Leu Ser Lys Lys Ala Gly Val Glu Val Glu Ala Gly Trp
                  130                 135                 140
                                                       1

              Pro Cys Ser Gly Pro Leu Leu Arg Met Ala Glu Glu Ala Ala Arg Lys
<removed-date>
              145                 150                 155                 160
              Leu Leu Pro Ala Phe Gln Thr Pro Thr Gly Met Pro Tyr Gly Thr Val
                              165                 170                 175
              Asn Leu Leu His Gly Val Asn Pro Gly Glu Thr Pro Val Thr Cys Thr
                          180                 185                 190
<removed-apn>
              Ala Gly Ile Gly Thr Phe Ile Val Glu Phe Ala Thr Leu Ser Ser Leu
                      195                 200                 205
              Thr Gly Asp Pro Val Phe Glu Asp Val Ala Arg Val Ala Leu Met Arg
                  210                 215                 220
              Leu Trp Glu Ser Arg Ser Asp Ile Gly Leu Val Gly Asn His Ile Asp
              225                 230                 235                 240
              Val Leu Thr Gly Lys Trp Val Ala Gln Asp Ala Gly Ile Gly Ala Gly
                              245                 250                 255
              Val Asp Ser Tyr Phe Glu Tyr Leu Val Lys Gly Ala Ile Leu Leu Gln
                          260                 265                 270
              Asp Lys Lys Leu Met Ala Met Phe Leu Glu Tyr Asn Lys Ala Ile Arg
                      275                 280                 285
              Asn Tyr Thr His Phe Asp Asp Trp Tyr Leu Trp Val Gln Met Tyr Lys
                  290                 295                 300
              Gly Thr Val Ser Met Pro Val Phe Gln Ser Leu Glu Ala Tyr Trp Pro
              305                 310                 315                 320
              Gly Leu Gln Ser Leu Ile Gly Asp Ile Asp Asn Ala Met Arg Thr Phe
                              325                 330                 335
              Leu Asn Tyr Tyr Thr Val Trp Lys Gln Phe Gly Gly Leu Pro Glu Phe
                          340                 345                 350
              Tyr Asn Ile Pro Gln Gly Tyr Thr Val Glu Lys Arg Glu Gly Tyr Pro
                      355                 360                 365
              Leu Arg Pro Glu Leu Ile Glu Ser Ala Met Tyr Leu Tyr Arg Ala Thr
                  370                 375                 380
                                                   2

<removed-date>
              Gly Asp Pro Thr Leu Leu Glu Leu Gly Arg Asp Ala Val Glu Ser Ile
              385                 390                 395                 400
              Glu Lys Ile Ser Lys Val Glu Cys Gly Phe Ala Thr Ile Lys Asp Leu
                              405                 410                 415
              Arg Asp His Lys Leu Asp Asn Arg Met Glu Ser Phe Phe Leu Ala Glu
<removed-apn>
                          420                 425                 430
              Thr Val Lys Tyr Leu Tyr Leu Leu Phe His Pro Asn Asn Phe Ile His
                      435                 440                 445
              Asn Asn Gly Ser Thr Phe Asp Ser Val Met Thr Pro His Gly Glu Cys
                  450                 455                 460
              Ile Leu Gly Ala Gly Gly Tyr Ile Phe Asn Thr Glu Ala His Pro Ile
              465                 470                 475                 480
              Asp Pro Ala Ala Leu His Cys Cys Arg Arg Leu Lys Glu Glu Gln Trp
                              485                 490                 495
              Glu Val Glu Asp Leu Ile Lys Glu Phe Tyr Ser Leu Lys Gln Ser Arg
                          500                 505                 510
              Pro Lys Arg Ala Gln Arg Lys Thr Val Arg Ser Gly Pro Trp Glu Pro
                      515                 520                 525
              Gln Ser Gly Pro Ala Thr Leu Ser Ser Pro Ala Asn Gln Pro Arg Glu
                  530                 535                 540
              Lys Gln Pro Ala Gln Gln Arg Thr Pro Leu Leu Ser Cys Pro Ser Gln
              545                 550                 555                 560
              Pro Phe Thr Ser Lys Leu Ala Leu Leu Gly Gln Val Phe Leu Asp Ser
                              565                 570                 575
              Ser
              <210>   2
              <211>   576
              <212>   PRT
              <213>   Rattus norvegicus
                                                   3

<removed-date>
              <400>   2
              Met Pro Phe Arg Leu Leu Ile Pro Leu Gly Leu Val Cys Val Leu Leu
              1               5                   10                  15
              Pro Leu His His Gly Ala Pro Gly Pro Glu Gly Thr Ala Pro Asp Pro
                          20                  25                  30
<removed-apn>
              Ala His Tyr Arg Glu Arg Val Lys Ala Met Phe Tyr His Ala Tyr Asp
                      35                  40                  45
              Ser Tyr Leu Glu Asn Ala Phe Pro Tyr Asp Glu Leu Arg Pro Leu Thr
                  50                  55                  60
              Cys Asp Gly His Asp Thr Trp Gly Ser Phe Ser Leu Thr Leu Ile Asp
              65                  70                  75                  80
              Ala Leu Asp Thr Leu Leu Ile Leu Gly Asn Thr Ser Glu Phe Gln Arg
                              85                  90                  95
              Val Val Glu Val Leu Gln Asp Asn Val Asp Phe Asp Ile Asp Val Asn
                          100                 105                 110
              Ala Ser Val Phe Glu Thr Asn Ile Arg Val Val Gly Gly Leu Leu Ser
                      115                 120                 125
              Ala His Leu Leu Ser Lys Lys Ala Gly Val Glu Val Glu Ala Gly Trp
                  130                 135                 140
              Pro Cys Ser Gly Pro Leu Leu Arg Met Ala Glu Glu Ala Ala Arg Lys
              145                 150                 155                 160
              Leu Leu Pro Ala Phe Gln Thr Pro Thr Gly Met Pro Tyr Gly Thr Val
                              165                 170                 175
              Asn Leu Leu His Gly Val Asn Pro Gly Glu Thr Pro Val Thr Cys Thr
                          180                 185                 190
              Ala Gly Ile Gly Thr Phe Ile Val Glu Phe Ala Thr Leu Ser Ser Leu
                      195                 200                 205
              Thr Gly Asp Pro Val Phe Glu Asp Val Ala Arg Val Ala Leu Met Arg
                  210                 215                 220
                                                   4

<removed-date>
              Leu Trp Glu Ser Arg Ser Asp Ile Gly Leu Val Gly Asn His Ile Asp
              225                 230                 235                 240
              Val Leu Thr Gly Lys Trp Val Ala Gln Asp Ala Gly Ile Gly Ala Gly
                              245                 250                 255
              Val Asp Ser Tyr Phe Glu Tyr Leu Val Lys Gly Ala Ile Leu Leu Gln
                          260                 265                 270
<removed-apn>
              Asp Lys Lys Leu Met Ala Met Phe Leu Glu Tyr Asn Lys Ala Ile Arg
                      275                 280                 285
              Asn Tyr Thr His Phe Asp Asp Trp Tyr Leu Trp Val Gln Met Tyr Lys
                  290                 295                 300
              Gly Thr Val Ser Met Pro Val Phe Gln Ser Leu Glu Ala Tyr Trp Pro
              305                 310                 315                 320
              Gly Leu Gln Ser Leu Ile Gly Asp Ile Asp Asn Ala Met Arg Thr Phe
                              325                 330                 335
              Leu Asn Tyr Tyr Thr Val Trp Lys Gln Phe Gly Gly Leu Pro Glu Phe
                          340                 345                 350
              Tyr Asn Ile Pro Gln Gly Tyr Thr Val Glu Lys Arg Glu Gly Tyr Pro
                      355                 360                 365
              Leu Arg Pro Glu Leu Ile Glu Ser Ala Met Tyr Leu Tyr Arg Ala Thr
                  370                 375                 380
              Gly Asp Pro Thr Leu Leu Glu Leu Gly Arg Asp Ala Val Glu Ser Ile
              385                 390                 395                 400
              Glu Lys Ile Ser Lys Val Glu Cys Gly Phe Ala Thr Ile Lys Asp Leu
                              405                 410                 415
              Arg Asp His Lys Leu Asp Asn Arg Met Glu Ser Phe Phe Leu Ala Glu
                          420                 425                 430
              Thr Val Lys Tyr Leu Tyr Leu Leu Phe His Pro Asn Asn Phe Ile His
                      435                 440                 445
              Asn Asn Gly Ser Thr Phe Asp Ser Val Met Thr Pro His Gly Glu Cys
                                                   5

                  450                 455                 460
<removed-date>
              Ile Leu Gly Ala Gly Gly Tyr Ile Phe Asn Thr Glu Ala His Pro Ile
              465                 470                 475                 480
              Asp Pro Ala Ala Leu His Cys Cys Arg Arg Leu Lys Glu Glu Gln Trp
                              485                 490                 495
<removed-apn>
              Glu Val Glu Asp Leu Ile Lys Glu Phe Tyr Ser Leu Arg Gln Ser Arg
                          500                 505                 510
              Ser Arg Ala Gln Arg Lys Thr Val Ser Ser Gly Pro Trp Glu Pro Pro
                      515                 520                 525
              Ala Gly Pro Gly Thr Leu Ser Ser Pro Glu Asn Gln Pro Arg Glu Lys
                  530                 535                 540
              Gln Pro Ala Arg Gln Arg Ala Pro Leu Leu Ser Cys Pro Ser Gln Pro
              545                 550                 555                 560
              Phe Thr Ser Lys Leu Ala Leu Leu Gly Gln Val Phe Leu Asp Ser Ser
                              565                 570                 575
              <210>   3
              <211>   578
              <212>   PRT
              <213>   Cricetulus griseus
              <400>   3
              Met Pro Phe Arg Leu Leu Ile Pro Leu Gly Leu Val Cys Val Phe Leu
              1               5                   10                  15
              Pro Leu His His Gly Ala Pro Gly Pro Asp Gly Thr Ala Pro Asp Pro
                          20                  25                  30
              Ala His Tyr Arg Glu Arg Val Lys Ala Met Phe Tyr His Ala Tyr Asp
                      35                  40                  45
              Ser Tyr Leu Glu Asn Ala Phe Pro Tyr Asp Glu Leu Arg Pro Leu Thr
                  50                  55                  60
              Cys Asp Gly His Asp Thr Trp Gly Ser Phe Ser Leu Thr Leu Ile Asp
              65                  70                  75                  80
                                                   6

              Ala Leu Asp Thr Leu Leu Ile Leu Gly Asn Thr Ser Glu Phe Gln Arg
<removed-date>
                              85                  90                  95
              Val Val Glu Val Leu Gln Asp Asn Val Asp Phe Asp Ile Asp Val Asn
                          100                 105                 110
              Ala Ser Val Phe Glu Thr Asn Ile Arg Val Val Gly Gly Leu Leu Ser
                      115                 120                 125
<removed-apn>
              Ala His Leu Leu Ser Lys Lys Ala Gly Val Glu Val Glu Ala Gly Trp
                  130                 135                 140
              Pro Cys Ser Gly Pro Leu Leu Arg Met Ala Glu Glu Ala Ala Arg Lys
              145                 150                 155                 160
              Leu Leu Pro Ala Phe Gln Thr Pro Thr Gly Met Pro Tyr Gly Thr Val
                              165                 170                 175
              Asn Leu Leu His Gly Val Asn Pro Gly Glu Thr Pro Val Thr Cys Thr
                          180                 185                 190
              Ala Gly Ile Gly Thr Phe Ile Val Glu Phe Ala Thr Leu Ser Ser Leu
                      195                 200                 205
              Thr Gly Asp Pro Val Phe Glu Asp Val Ala Arg Leu Ala Leu Met Arg
                  210                 215                 220
              Leu Trp Glu Ser Arg Ser Asp Ile Gly Leu Val Gly Asn His Ile Asp
              225                 230                 235                 240
              Val Leu Thr Gly Lys Trp Val Ala Gln Asp Ala Gly Ile Gly Ala Gly
                              245                 250                 255
              Val Asp Ser Tyr Phe Glu Tyr Leu Val Lys Gly Ala Ile Leu Leu Gln
                          260                 265                 270
              Asp Lys Lys Leu Met Ala Met Phe Leu Glu Tyr Asn Arg Ala Ile Arg
                      275                 280                 285
              Asn Tyr Thr His Phe Asp Asp Trp Tyr Leu Trp Val Gln Met Tyr Lys
                  290                 295                 300
              Gly Thr Val Ser Met Pro Val Phe Gln Ser Leu Glu Ala Tyr Trp Pro
              305                 310                 315                 320
                                                   7

<removed-date>
              Gly Leu Gln Ser Leu Ile Gly Asp Ile Asp Asn Ala Met Arg Thr Phe
                              325                 330                 335
              Leu Asn Tyr Tyr Thr Val Trp Lys Gln Phe Gly Gly Leu Pro Glu Phe
                          340                 345                 350
              Tyr Asn Ile Ala Gln Gly Tyr Thr Val Glu Lys Arg Glu Gly Tyr Pro
<removed-apn>
                      355                 360                 365
              Leu Arg Pro Glu Leu Ile Glu Ser Ala Met Tyr Leu Tyr Arg Ala Thr
                  370                 375                 380
              Gly Asp Pro Thr Leu Leu Glu Leu Gly Arg Asp Ala Val Glu Ser Ile
              385                 390                 395                 400
              Glu Lys Ile Ser Lys Val Glu Cys Gly Phe Ala Thr Ile Lys Asp Leu
                              405                 410                 415
              Arg Asp His Lys Leu Asp Asn Arg Met Glu Ser Phe Phe Leu Ala Glu
                          420                 425                 430
              Thr Val Lys Tyr Leu Tyr Leu Leu Phe His Pro Asn Asn Phe Ile His
                      435                 440                 445
              Asn Asn Gly Ser Thr Phe Asp Ser Val Met Thr Pro His Gly Glu Cys
                  450                 455                 460
              Ile Leu Gly Ala Gly Gly Tyr Ile Phe Asn Thr Glu Ala His Pro Ile
              465                 470                 475                 480
              Asp Pro Ala Ala Leu His Cys Cys Arg Arg Leu Lys Glu Glu Gln Trp
                              485                 490                 495
              Glu Val Glu Asp Leu Met Arg Glu Leu His Ser Leu Lys Gln Ser Arg
                          500                 505                 510
              Ser Arg Ala Gln Arg Lys Thr Thr Ser Ser Gly Pro Trp Glu Pro Pro
                      515                 520                 525
              Ala Gly Pro Gly Ser Pro Ser Ala Pro Gly Lys Gln Asp Gln Pro Arg
                  530                 535                 540
                                                   8

              Glu Lys Gln Pro Ala Lys Gln Arg Thr Pro Leu Leu Ser Cys Pro Ser
<removed-date>
              545                 550                 555                 560
              Gln Pro Phe Thr Ser Lys Leu Ala Leu Leu Gly Gln Val Phe Leu Asp
                              565                 570                 575
              Ser Ser
<removed-apn>
              <210>   4
              <211>   578
              <212>   PRT
              <213>   Homo sapiens
              <400>   4
              Met Pro Phe Arg Leu Leu Ile Pro Leu Gly Leu Leu Cys Ala Leu Leu
              1               5                   10                  15
              Pro Gln His His Gly Ala Pro Gly Pro Asp Gly Ser Ala Pro Asp Pro
                          20                  25                  30
              Ala His Tyr Arg Glu Arg Val Lys Ala Met Phe Tyr His Ala Tyr Asp
                      35                  40                  45
              Ser Tyr Leu Glu Asn Ala Phe Pro Phe Asp Glu Leu Arg Pro Leu Thr
                  50                  55                  60
              Cys Asp Gly His Asp Thr Trp Gly Ser Phe Ser Leu Thr Leu Ile Asp
              65                  70                  75                  80
              Ala Leu Asp Thr Leu Leu Ile Leu Gly Asn Val Ser Glu Phe Gln Arg
                              85                  90                  95
              Val Val Glu Val Leu Gln Asp Ser Val Asp Phe Asp Ile Asp Val Asn
                          100                 105                 110
              Ala Ser Val Phe Glu Thr Asn Ile Arg Val Val Gly Gly Leu Leu Ser
                      115                 120                 125
              Ala His Leu Leu Ser Lys Lys Ala Gly Val Glu Val Glu Ala Gly Trp
                  130                 135                 140
              Pro Cys Ser Gly Pro Leu Leu Arg Met Ala Glu Glu Ala Ala Arg Lys
              145                 150                 155                 160
                                                   9

<removed-date>
              Leu Leu Pro Ala Phe Gln Thr Pro Thr Gly Met Pro Tyr Gly Thr Val
                              165                 170                 175
              Asn Leu Leu His Gly Val Asn Pro Gly Glu Thr Pro Val Thr Cys Thr
                          180                 185                 190
              Ala Gly Ile Gly Thr Phe Ile Val Glu Phe Ala Thr Leu Ser Ser Leu
                      195                 200                 205
<removed-apn>
              Thr Gly Asp Pro Val Phe Glu Asp Val Ala Arg Val Ala Leu Met Arg
                  210                 215                 220
              Leu Trp Glu Ser Arg Ser Asp Ile Gly Leu Val Gly Asn His Ile Asp
              225                 230                 235                 240
              Val Leu Thr Gly Lys Trp Val Ala Gln Asp Ala Gly Ile Gly Ala Gly
                              245                 250                 255
              Val Asp Ser Tyr Phe Glu Tyr Leu Val Lys Gly Ala Ile Leu Leu Gln
                          260                 265                 270
              Asp Lys Lys Leu Met Ala Met Phe Leu Glu Tyr Asn Lys Ala Ile Arg
                      275                 280                 285
              Asn Tyr Thr Arg Phe Asp Asp Trp Tyr Leu Trp Val Gln Met Tyr Lys
                  290                 295                 300
              Gly Thr Val Ser Met Pro Val Phe Gln Ser Leu Glu Ala Tyr Trp Pro
              305                 310                 315                 320
              Gly Leu Gln Ser Leu Ile Gly Asp Ile Asp Asn Ala Met Arg Thr Phe
                              325                 330                 335
              Leu Asn Tyr Tyr Thr Val Trp Lys Gln Phe Gly Gly Leu Pro Glu Phe
                          340                 345                 350
              Tyr Asn Ile Pro Gln Gly Tyr Thr Val Glu Lys Arg Glu Gly Tyr Pro
                      355                 360                 365
              Leu Arg Pro Glu Leu Ile Glu Ser Ala Met Tyr Leu Tyr Arg Ala Thr
                  370                 375                 380
              Gly Asp Pro Thr Leu Leu Glu Leu Gly Arg Asp Ala Val Glu Ser Ile
                                                  10

              385                 390                  395               400
<removed-date>
              Glu Lys Ile Ser Lys Val Glu Cys Gly Phe Ala Thr Ile Lys Asp Leu
                              405                 410                 415
              Arg Asp His Lys Leu Asp Asn Arg Met Glu Ser Phe Phe Leu Ala Glu
                          420                 425                 430
<removed-apn>
              Thr Val Lys Tyr Leu Tyr Leu Leu Phe Asp Pro Thr Asn Phe Ile His
                      435                 440                 445
              Asn Asn Gly Ser Thr Phe Asp Thr Val Ile Thr Pro Tyr Gly Glu Cys
                  450                 455                 460
              Ile Leu Gly Ala Gly Gly Tyr Ile Phe Asn Thr Glu Ala His Pro Ile
              465                 470                 475                 480
              Asp Pro Ala Ala Leu His Cys Cys Gln Arg Leu Lys Glu Glu Gln Trp
                              485                 490                 495
              Glu Val Glu Asp Leu Met Arg Glu Phe Tyr Ser Leu Lys Arg Ser Arg
                          500                 505                 510
              Ser Lys Phe Gln Lys Asn Thr Val Ser Ser Gly Pro Trp Glu Pro Pro
                      515                 520                 525
              Ala Arg Pro Gly Thr Leu Phe Ser Pro Glu Asn His Asp Gln Ala Arg
                  530                 535                 540
              Glu Arg Lys Pro Ala Lys Gln Lys Val Pro Leu Leu Ser Cys Pro Ser
              545                 550                 555                 560
              Gln Pro Phe Thr Ser Lys Leu Ala Leu Leu Gly Gln Val Phe Leu Asp
                              565                 570                 575
              Ser Ser
              <210>   5
              <211>   578
              <212>   PRT
              <213>   Pan troglodytes
              <400>   5
                                                  11

              Met Pro Phe Arg Leu Leu Ile Pro Leu Gly Leu Leu Cys Ala Leu Leu
<removed-date>
              1               5                   10                  15
              Pro Leu His His Gly Ala Pro Gly Pro Asp Gly Ser Ala Pro Asp Pro
                          20                  25                  30
              Ala His Tyr Arg Glu Arg Val Lys Ala Met Phe Tyr His Ala Tyr Asp
                      35                  40                  45
<removed-apn>
              Ser Tyr Leu Glu Asn Ala Phe Pro Phe Asp Glu Leu Arg Pro Leu Thr
                  50                  55                  60
              Cys Asp Gly His Asp Thr Trp Gly Ser Phe Ser Leu Thr Leu Ile Asp
              65                  70                  75                  80
              Ala Leu Asp Thr Leu Leu Ile Leu Gly Asn Val Ser Glu Phe Gln Arg
                              85                  90                  95
              Val Val Glu Val Leu Gln Asp Ser Val Asp Phe Asp Ile Asp Val Asn
                          100                 105                 110
              Ala Ser Val Phe Glu Thr Asn Ile Arg Val Val Gly Gly Leu Leu Ser
                      115                 120                 125
              Ala His Leu Leu Ser Lys Lys Ala Gly Val Glu Val Glu Ala Gly Trp
                  130                 135                 140
              Pro Cys Ser Gly Pro Leu Leu Arg Met Ala Glu Glu Ala Ala Arg Lys
              145                 150                 155                 160
              Leu Leu Pro Ala Phe Gln Thr Pro Thr Gly Met Pro Tyr Gly Thr Val
                              165                 170                 175
              Asn Leu Leu His Gly Val Asn Pro Gly Glu Thr Pro Val Thr Cys Thr
                          180                 185                 190
              Ala Gly Ile Gly Thr Phe Ile Val Glu Phe Ala Thr Leu Ser Ser Leu
                      195                 200                 205
              Thr Gly Asp Pro Val Phe Glu Asp Val Ala Arg Val Ala Leu Met Arg
                  210                 215                 220
              Leu Trp Glu Ser Arg Ser Asp Ile Gly Leu Val Gly Asn His Ile Asp
              225                 230                 235                 240
                                                  12

<removed-date>
              Val Leu Thr Gly Lys Trp Val Ala Gln Asp Ala Gly Ile Gly Ala Gly
                              245                 250                 255
              Val Asp Ser Tyr Phe Glu Tyr Leu Val Lys Gly Ala Ile Leu Leu Gln
                          260                 265                 270
              Asp Lys Lys Leu Met Ala Met Phe Leu Glu Tyr Asn Lys Ala Ile Arg
<removed-apn>
                      275                 280                 285
              Asn Tyr Thr Arg Phe Asp Asp Trp Tyr Leu Trp Val Gln Met Tyr Lys
                  290                 295                 300
              Gly Thr Val Ser Met Pro Val Phe Gln Ser Leu Glu Ala Tyr Trp Pro
              305                 310                 315                 320
              Gly Leu Gln Ser Leu Ile Gly Asp Ile Asp Asn Ala Met Arg Thr Phe
                              325                 330                 335
              Leu Asn Tyr Tyr Thr Val Trp Lys Gln Phe Gly Gly Leu Pro Glu Phe
                          340                 345                 350
              Tyr Asn Ile Pro Gln Gly Tyr Thr Val Glu Lys Arg Glu Gly Tyr Pro
                      355                 360                 365
              Leu Arg Pro Glu Leu Ile Glu Ser Ala Met Tyr Leu Tyr Arg Ala Thr
                  370                 375                 380
              Gly Asp Pro Thr Leu Leu Glu Leu Gly Arg Asp Ala Val Glu Ser Ile
              385                 390                 395                 400
              Glu Lys Ile Ser Lys Val Glu Cys Gly Phe Ala Thr Ile Lys Asp Leu
                              405                 410                 415
              Arg Asp His Lys Leu Asp Asn Arg Met Glu Ser Phe Phe Leu Ala Glu
                          420                 425                 430
              Thr Val Lys Tyr Leu Tyr Leu Leu Phe Asp Pro Thr Asn Phe Ile His
                      435                 440                 445
              Asn Asn Gly Ser Thr Phe Asp Ala Val Ile Thr Pro Tyr Gly Glu Cys
                  450                 455                 460
                                                  13

              Ile Leu Gly Ala Gly Gly Tyr Ile Phe Asn Thr Glu Ala His Pro Ile
<removed-date>
              465                 470                 475                 480
              Asp Pro Ala Ala Leu His Cys Cys Gln Arg Leu Lys Glu Glu Gln Trp
                              485                 490                 495
              Glu Val Glu Asp Leu Met Arg Glu Phe Tyr Ser Leu Lys Arg Ser Arg
                          500                 505                 510
<removed-apn>
              Ser Lys Phe Gln Lys Lys Thr Val Ser Ser Gly Pro Trp Glu Pro Pro
                      515                 520                 525
              Ala Arg Pro Gly Thr Leu Phe Ser Pro Glu Asn His Asp Gln Ala Arg
                  530                 535                 540
              Glu Arg Lys Pro Ala Lys Gln Lys Val Pro Leu Leu Ser Cys Pro Ser
              545                 550                 555                 560
              Gln Pro Phe Thr Ser Lys Leu Ala Leu Leu Gly Gln Val Phe Leu Asp
                              565                 570                 575
              Ser Ser
              <210>   6
              <211>   513
              <212>   PRT
              <213>   Pongo pygmaeus
              <400>   6
              Met Asn Thr Leu Ser Cys Ser Leu Phe Ser Leu Thr Leu Ile Asp Ala
              1               5                   10                  15
              Leu Asp Thr Leu Leu Ile Leu Gly Asn Val Ser Glu Phe Gln Arg Val
                          20                  25                  30
              Val Glu Val Leu Gln Asp Asn Val Asp Phe Asp Ile Asp Val Asn Ala
                      35                  40                  45
              Ser Val Phe Glu Thr Asn Ile Arg Val Val Gly Gly Leu Leu Ser Ala
                  50                  55                  60
              His Leu Leu Ser Lys Lys Ala Gly Val Glu Val Glu Ala Gly Trp Pro
              65                  70                  75                  80
                                                  14

<removed-date>
              Cys Ser Gly Pro Leu Leu Arg Met Ala Glu Glu Ala Ala Arg Lys Leu
                              85                  90                  95
              Leu Pro Ala Phe Gln Thr Pro Thr Gly Met Pro Tyr Gly Thr Val Asn
                          100                 105                 110
              Leu Leu His Gly Val Asn Pro Gly Glu Thr Pro Val Thr Cys Thr Ala
                      115                 120                 125
<removed-apn>
              Gly Ile Gly Thr Phe Ile Val Glu Phe Ala Thr Leu Ser Ser Leu Thr
                  130                 135                 140
              Gly Asp Pro Val Phe Glu Asp Val Ala Arg Val Ala Leu Met Arg Leu
              145                 150                 155                 160
              Trp Glu Ser Arg Ser Asp Ile Gly Leu Val Gly Asn His Ile Asp Val
                              165                 170                 175
              Leu Thr Gly Lys Trp Val Ala Gln Asp Ala Gly Ile Gly Ala Gly Val
                          180                 185                 190
              Asp Ser Tyr Phe Glu Tyr Leu Val Lys Gly Ala Ile Leu Leu Gln Asp
                      195                 200                 205
              Lys Lys Leu Met Ala Met Phe Leu Glu Tyr Asn Lys Ala Ile Arg Asn
                  210                 215                 220
              Tyr Thr Arg Phe Asp Asp Trp Tyr Leu Trp Val Gln Met Tyr Lys Gly
              225                 230                 235                 240
              Thr Val Ser Met Pro Val Phe Gln Ser Leu Glu Ala Tyr Trp Pro Gly
                              245                 250                 255
              Leu Gln Ser Leu Ile Gly Asp Ile Asp Asn Ala Met Arg Thr Phe Leu
                          260                 265                 270
              Asn Tyr Tyr Thr Val Trp Lys Gln Phe Gly Gly Leu Pro Glu Phe Tyr
                      275                 280                 285
              Asn Ile Pro Gln Gly Tyr Thr Val Glu Lys Arg Glu Gly Tyr Pro Leu
                  290                 295                 300
              Arg Pro Glu Leu Ile Glu Ser Ala Met Tyr Leu Tyr Arg Ala Thr Gly
                                                  15

              305                 310                  315               320
<removed-date>
              Asp Pro Thr Leu Leu Glu Leu Gly Arg Asp Ala Val Glu Ser Ile Glu
                              325                 330                 335
              Lys Ile Ser Lys Val Glu Cys Gly Phe Ala Thr Ile Lys Asp Leu Arg
                          340                 345                 350
<removed-apn>
              Asp His Lys Leu Asp Asn Arg Met Glu Ser Phe Phe Leu Ala Glu Thr
                      355                 360                 365
              Val Lys Tyr Leu Tyr Leu Leu Phe Asp Pro Thr Asn Phe Ile His Asn
                  370                 375                 380
              Asn Gly Ser Thr Phe Asp Ala Val Ile Thr Pro Tyr Gly Glu Cys Ile
              385                 390                 395                 400
              Leu Gly Ala Gly Gly Tyr Ile Phe Asn Thr Glu Ala His Pro Ile Asp
                              405                 410                 415
              Pro Ala Ala Leu His Cys Cys Gln Arg Leu Lys Glu Glu Gln Trp Glu
                          420                 425                 430
              Val Glu Asp Leu Met Arg Glu Phe Tyr Ser Leu Lys Arg Asn Arg Ser
                      435                 440                 445
              Lys Phe Gln Lys Lys Thr Val Ser Ser Gly Pro Trp Glu Pro Pro Ala
                  450                 455                 460
              Arg Pro Gly Thr Leu Phe Ser Pro Glu Asn His Asp Gln Ala Arg Gly
              465                 470                 475                 480
              Arg Lys Pro Ala Lys Gln Lys Val Pro Leu Leu Ser Cys Pro Ser Gln
                              485                 490                 495
              Pro Phe Thr Ser Lys Leu Ala Leu Leu Gly Gln Val Phe Leu Asp Ser
                          500                 505                 510
              Ser
              <210>   7
              <211>   572
              <212>   PRT
                                                  16

              <213>   Danio rerio
<removed-date>
              <400>   7
              Leu Tyr Tyr Leu Pro Leu Phe Thr Ser Arg Tyr Phe Met Leu Thr Phe
              1               5                   10                  15
              Leu Phe Ser Ala Ile Phe Cys Ala Ala Tyr Leu Ser Pro Ile Ile Ser
                          20                  25                  30
<removed-apn>
              His Val Lys Gly Arg Asp Phe Thr Glu Gln Glu Met Ser His Tyr Arg
                      35                  40                  45
              Asp Arg Val Lys Ser Met Phe Tyr His Ala Tyr Asn Ser Tyr Leu Asp
                  50                  55                  60
              Asn Ala Tyr Pro Tyr Asp Glu Leu Arg Pro Leu Thr Cys Asp Gly Gln
              65                  70                  75                  80
              Asp Thr Trp Gly Ser Phe Ser Leu Thr Leu Ile Asp Ala Leu Asp Thr
                              85                  90                  95
              Leu Leu Ile Leu Gly Asn His Thr Glu Phe Gln Arg Val Ala Thr Leu
                          100                 105                 110
              Leu Gln Asp Thr Val Asp Phe Asp Ile Asp Val Asn Ala Ser Val Phe
                      115                 120                 125
              Glu Thr Asn Ile Arg Val Val Gly Gly Leu Leu Ser Ala His Leu Leu
                  130                 135                 140
              Ser Lys Arg Ala Gly Met Lys Val Glu Glu Gly Trp Pro Cys Ser Gly
              145                 150                 155                 160
              Pro Leu Leu Arg Met Ala Glu Asp Ala Ala Arg Lys Leu Leu Pro Ala
                              165                 170                 175
              Phe Gln Thr Pro Thr Gly Met Pro Tyr Gly Thr Val Asn Leu Leu Arg
                          180                 185                 190
              Gly Val Asn Pro Gly Glu Thr Pro Val Thr Cys Thr Ala Gly Val Gly
                      195                 200                 205
              Thr Phe Ile Leu Glu Phe Ser Thr Leu Ser Arg Leu Thr Gly Asp Pro
                  210                 215                 220
                                                  17

<removed-date>
              Val Phe Glu Asn Val Ala Arg Lys Ala Leu Arg Ala Leu Trp Arg Thr
              225                 230                 235                 240
              Arg Ser Asp Ile Gly Leu Val Gly Asn His Ile Asp Val Ile Thr Ser
                              245                 250                 255
              Lys Trp Val Ala Gln Asp Ala Gly Ile Gly Ala Gly Val Asp Ser Tyr
<removed-apn>
                          260                 265                 270
              Phe Glu Tyr Leu Val Arg Gly Ala Ile Met Leu Gln Asp Glu Glu Leu
                      275                 280                 285
              Leu Thr Met Phe Tyr Glu Phe Asp Lys Ser Ile Lys Asn Tyr Thr Lys
                  290                 295                 300
              Phe Asp Asp Trp Tyr Leu Trp Val Gln Met His Lys Gly Thr Val Ser
              305                 310                 315                 320
              Met Pro Val Phe Gln Ser Leu Glu Ala Phe Trp Pro Gly Met Gln Ser
                              325                 330                 335
              Leu Ile Gly Asp Ile Ser Ser Ala Thr Lys Ser Phe His Asn Tyr Tyr
                          340                 345                 350
              Ser Val Trp Arg Gln Phe Gly Gly Leu Pro Glu Phe Tyr Ser Ile Pro
                      355                 360                 365
              Gln Gly Tyr Thr Val Asp Lys Arg Glu Gly Tyr Pro Leu Arg Pro Glu
                  370                 375                 380
              Leu Ile Glu Ser Ala Met Tyr Leu Tyr Lys Ala Thr Gly Asp Pro Ser
              385                 390                 395                 400
              Phe Ile Gln Leu Gly Arg Asp Ala Val Glu Ser Ile Asp Arg Ile Ser
                              405                 410                 415
              Arg Val Asn Cys Gly Phe Ala Thr Val Lys Asp Val Arg Asp His Lys
                          420                 425                 430
              Leu Asp Asn Arg Met Glu Ser Phe Phe Leu Ala Glu Thr Ile Lys Tyr
                      435                 440                 445
                                                  18

              Leu Tyr Leu Leu Phe Asp Pro Asp Asn Phe Leu His Asn Thr Gly Thr
<removed-date>
                  450                 455                 460
              Glu Phe Glu Leu Gly Gly Leu Arg Gly Asp Cys Ile Leu Ser Ala Gly
              465                 470                 475                 480
              Gly Tyr Val Phe Asn Thr Glu Ala His Pro Leu Asp Pro Ala Ala Leu
                              485                 490                 495
<removed-apn>
              His Cys Cys Ser Arg Glu Gln Gln Asp Arg Arg Glu Ile Gln Asp Ile
                          500                 505                 510
              Leu Leu Ser Phe Ser Gln Pro His Thr Glu Glu Pro Ser Arg Asp Gln
                      515                 520                 525
              Ser Ala Gly Gly Ser Pro Glu Ser Ile Ala Leu Lys Pro Gly Glu Gln
                  530                 535                 540
              Arg Lys Ala Pro Val Leu Ser Cys Pro Thr Gln Pro Phe Ser Ala Lys
              545                 550                 555                 560
              Leu Ala Val Met Gly Gln Val Phe Ser Asp Asn Ser
                              565                 570
              <210>   8
              <211>   577
              <212>   PRT
              <213>   Artificial
              <220>
              <223>   Consensus sequence
              <220>
              <221>   MISC_FEATURE
              <222>   (12)..(12)
              <223>   V or L
              <220>
              <221>   MISC_FEATURE
              <222>   (14)..(14)
              <223>   V or A
              <220>
              <221>   MISC_FEATURE
              <222>   (15)..(15)
              <223>   L or F
              <220>
              <221>   MISC_FEATURE
                                                  19

              <222>   (26)..(26)
<removed-date>
              <223>   D or E
              <220>
              <221>   MISC_FEATURE
              <222>   (28)..(28)
              <223>   T or S
              <220>
              <221>   MISC_FEATURE
              <222>   (57)..(57)
<removed-apn>
              <223>   Y or F
              <220>
              <221>   MISC_FEATURE
              <222>   (91)..(91)
              <223>   T or V
              <220>
              <221>   MISC_FEATURE
              <222>   (104)..(104)
              <223>   N or S
              <220>
              <221>   MISC_FEATURE
              <222>   (220)..(220)
              <223>   V or L
              <220>
              <221>   MISC_FEATURE
              <222>   (285)..(285)
              <223>   K or R
              <220>
              <221>   MISC_FEATURE
              <222>   (292)..(292)
              <223>   H or R
              <220>
              <221>   MISC_FEATURE
              <222>   (356)..(356)
              <223>   P or A
              <220>
              <221>   MISC_FEATURE
              <222>   (442)..(442)
              <223>   H or D
              <220>
              <221>   MISC_FEATURE
              <222>   (444)..(444)
              <223>   N or T
              <220>
              <221>   MISC_FEATURE
              <222>   (456)..(456)
              <223>   S, T, or A
                                     20

              <220>
<removed-date>
              <221>   MISC_FEATURE
              <222>   (458)..(458)
              <223>   M or I
              <220>
              <221>   MISC_FEATURE
              <222>   (461)..(461)
              <223>   H or Y
              <220>
<removed-apn>
              <221>   MISC_FEATURE
              <222>   (489)..(489)
              <223>   R or Q
              <220>
              <221>   MISC_FEATURE
              <222>   (502)..(502)
              <223>   I or M
              <220>
              <221>   MISC_FEATURE
              <222>   (503)..(503)
              <223>   K or R
              <220>
              <221>   MISC_FEATURE
              <222>   (505)..(505)
              <223>   F or L
              <220>
              <221>   MISC_FEATURE
              <222>   (506)..(506)
              <223>   Y or H
              <220>
              <221>   MISC_FEATURE
              <222>   (509)..(509)
              <223>   K or R
              <220>
              <221>   MISC_FEATURE
              <222>   (510)..(510)
              <223>   Q or R
              <220>
              <221>   MISC_FEATURE
              <222>   (513)..(513)
              <223>   P or S
              <220>
              <221>   MISC_FEATURE
              <222>   (514)..(516)
              <223>   KRA, RA, or KF
              <220>
              <221>   MISC_FEATURE
              <222>   (518)..(518)
                                       21

              <223>   R or K
<removed-date>
              <220>
              <221>   MISC_FEATURE
              <222>   (519)..(519)
              <223>   K or N
              <220>
              <221>   MISC_FEATURE
              <222>   (522)..(522)
              <223>   R or S
<removed-apn>
              <220>
              <221>   MISC_FEATURE
              <222>   (529)..(529)
              <223>   Q or P
              <220>
              <221>   MISC_FEATURE
              <222>   (530)..(530)
              <223>   S or A
              <220>
              <221>   MISC_FEATURE
              <222>   (531)..(531)
              <223>   G or R
              <220>
              <221>   MISC_FEATURE
              <222>   (533)..(533)
              <223>   A or G
              <220>
              <221>   MISC_FEATURE
              <222>   (534)..(534)
              <223>   T or S
              <220>
              <221>   MISC_FEATURE
              <222>   (535)..(535)
              <223>   L or P
              <220>
              <221>   MISC_FEATURE
              <222>   (536)..(536)
              <223>   S or F
              <220>
              <221>   MISC_FEATURE
              <222>   (537)..(537)
              <223>   S or A
              <220>
              <221>   MISC_FEATURE
              <222>   (539)..(540)
              <223>   AN, EN, GKQD, or ENHD
              <220>
                                              22

              <221>   MISC_FEATURE
<removed-date>
              <222>   (542)..(542)
              <223>   P or A
              <220>
              <221>   MISC_FEATURE
              <222>   (545)..(545)
              <223>   K or R
              <220>
              <221>   MISC_FEATURE
<removed-apn>
              <222>   (546)..(546)
              <223>   Q or K
              <220>
              <221>   MISC_FEATURE
              <222>   (549)..(549)
              <223>   Q, R, or K
              <220>
              <221>   MISC_FEATURE
              <222>   (551)..(551)
              <223>   R or K
              <220>
              <221>   MISC_FEATURE
              <222>   (552)..(552)
              <223>   T, A, or V
              <400>   8
              Met Pro Phe Arg Leu Leu Ile Pro Leu Gly Leu Xaa Cys Xaa Xaa Leu
              1               5                   10                  15
              Pro Leu His His Gly Ala Pro Gly Pro Xaa Gly Xaa Ala Pro Asp Pro
                          20                  25                  30
              Ala His Tyr Arg Glu Arg Val Lys Ala Met Phe Tyr His Ala Tyr Asp
                      35                  40                  45
              Ser Tyr Leu Glu Asn Ala Phe Pro Xaa Asp Glu Leu Arg Pro Leu Thr
                  50                  55                  60
              Cys Asp Gly His Asp Thr Trp Gly Ser Phe Ser Leu Thr Leu Ile Asp
              65                  70                  75                  80
              Ala Leu Asp Thr Leu Leu Ile Leu Gly Asn Xaa Ser Glu Phe Gln Arg
                              85                  90                  95
              Val Val Glu Val Leu Gln Asp Xaa Val Asp Phe Asp Ile Asp Val Asn
                          100                 105                 110
                                                  23

<removed-date>
              Ala Ser Val Phe Glu Thr Asn Ile Arg Val Val Gly Gly Leu Leu Ser
                      115                 120                 125
              Ala His Leu Leu Ser Lys Lys Ala Gly Val Glu Val Glu Ala Gly Trp
                  130                 135                 140
              Pro Cys Ser Gly Pro Leu Leu Arg Met Ala Glu Glu Ala Ala Arg Lys
              145                 150                 155                 160
<removed-apn>
              Leu Leu Pro Ala Phe Gln Thr Pro Thr Gly Met Pro Tyr Gly Thr Val
                              165                 170                 175
              Asn Leu Leu His Gly Val Asn Pro Gly Glu Thr Pro Val Thr Cys Thr
                          180                 185                 190
              Ala Gly Ile Gly Thr Phe Ile Val Glu Phe Ala Thr Leu Ser Ser Leu
                      195                 200                 205
              Thr Gly Asp Pro Val Phe Glu Asp Val Ala Arg Xaa Ala Leu Met Arg
                  210                 215                 220
              Leu Trp Glu Ser Arg Ser Asp Ile Gly Leu Val Gly Asn His Ile Asp
              225                 230                 235                 240
              Val Leu Thr Gly Lys Trp Val Ala Gln Asp Ala Gly Ile Gly Ala Gly
                              245                 250                 255
              Val Asp Ser Tyr Phe Glu Tyr Leu Val Lys Gly Ala Ile Leu Leu Gln
                          260                 265                 270
              Asp Lys Lys Leu Met Ala Met Phe Leu Glu Tyr Asn Xaa Ala Ile Arg
                      275                 280                 285
              Asn Tyr Thr Xaa Phe Asp Asp Trp Tyr Leu Trp Val Gln Met Tyr Lys
                  290                 295                 300
              Gly Thr Val Ser Met Pro Val Phe Gln Ser Leu Glu Ala Tyr Trp Pro
              305                 310                 315                 320
              Gly Leu Gln Ser Leu Ile Gly Asp Ile Asp Asn Ala Met Arg Thr Phe
                              325                 330                 335
              Leu Asn Tyr Tyr Thr Val Trp Lys Gln Phe Gly Gly Leu Pro Glu Phe
                                                  24

                          340                345                  350
<removed-date>
              Tyr Asn Ile Xaa Gln Gly Tyr Thr Val Glu Lys Arg Glu Gly Tyr Pro
                      355                 360                 365
              Leu Arg Pro Glu Leu Ile Glu Ser Ala Met Tyr Leu Tyr Arg Ala Thr
                  370                 375                 380
<removed-apn>
              Gly Asp Pro Thr Leu Leu Glu Leu Gly Arg Asp Ala Val Glu Ser Ile
              385                 390                 395                 400
              Glu Lys Ile Ser Lys Val Glu Cys Gly Phe Ala Thr Ile Lys Asp Leu
                              405                 410                 415
              Arg Asp His Lys Leu Asp Asn Arg Met Glu Ser Phe Phe Leu Ala Glu
                          420                 425                 430
              Thr Val Lys Tyr Leu Tyr Leu Leu Phe Xaa Pro Xaa Asn Phe Ile His
                      435                 440                 445
              Asn Asn Gly Ser Thr Phe Asp Xaa Val Xaa Thr Pro Xaa Gly Glu Cys
                  450                 455                 460
              Ile Leu Gly Ala Gly Gly Tyr Ile Phe Asn Thr Glu Ala His Pro Ile
              465                 470                 475                 480
              Asp Pro Ala Ala Leu His Cys Cys Xaa Arg Leu Lys Glu Glu Gln Trp
                              485                 490                 495
              Glu Val Glu Asp Leu Xaa Xaa Glu Xaa Xaa Ser Leu Xaa Xaa Ser Arg
                          500                 505                 510
              Xaa Xaa Xaa Xaa Gln Xaa Xaa Thr Val Xaa Ser Gly Pro Trp Glu Pro
                      515                 520                 525
              Xaa Xaa Xaa Pro Xaa Xaa Xaa Xaa Xaa Pro Xaa Xaa Gln Xaa Arg Glu
                  530                 535                 540
              Xaa Xaa Pro Ala Xaa Gln Xaa Xaa Pro Leu Leu Ser Cys Pro Ser Gln
              545                 550                 555                 560
              Pro Phe Thr Ser Lys Leu Ala Leu Leu Gly Gln Val Phe Leu Asp Ser
                              565                 570                 575
                                                   25

<removed-date>
              Ser
              <210>   9
              <211>   371
              <212>   PRT
              <213>   Mus musculus
              <400>   9
<removed-apn>
              Met Val Val Val Ala Ala Ala Pro Ser Ala Ala Thr Ala Ala Pro Lys
              1               5                   10                  15
              Val Leu Leu Leu Ser Gly Gln Pro Ala Ser Gly Gly Arg Ala Leu Pro
                          20                  25                  30
              Leu Met Val Pro Gly Pro Arg Ala Ala Gly Ser Glu Ala Ser Gly Thr
                      35                  40                  45
              Pro Gln Ala Arg Lys Arg Gln Arg Leu Thr His Leu Ser Pro Glu Glu
                  50                  55                  60
              Lys Ala Leu Arg Arg Lys Leu Lys Asn Arg Val Ala Ala Gln Thr Ala
              65                  70                  75                  80
              Arg Asp Arg Lys Lys Ala Arg Met Ser Glu Leu Glu Gln Gln Val Val
                              85                  90                  95
              Asp Leu Glu Glu Glu Asn His Lys Leu Gln Leu Glu Asn Gln Leu Leu
                          100                 105                 110
              Arg Glu Lys Thr His Gly Leu Val Val Glu Asn Gln Glu Leu Arg Thr
                      115                 120                 125
              Arg Leu Gly Met Asp Thr Leu Asp Pro Asp Glu Val Pro Glu Val Glu
                  130                 135                 140
              Ala Lys Gly Ser Gly Val Arg Leu Val Ala Gly Ser Ala Glu Ser Ala
              145                 150                 155                 160
              Ala Gly Ala Gly Pro Val Val Thr Ser Pro Glu His Leu Pro Met Asp
                              165                 170                 175
              Ser Asp Thr Val Ala Ser Ser Asp Ser Glu Ser Asp Ile Leu Leu Gly
                          180                 185                 190
                                                  26

<removed-date>
              Ile Leu Asp Lys Leu Asp Pro Val Met Phe Phe Lys Cys Pro Ser Pro
                      195                 200                 205
              Glu Ser Ala Ser Leu Glu Glu Leu Pro Glu Val Tyr Pro Glu Gly Pro
                  210                 215                 220
              Ser Ser Leu Pro Ala Ser Leu Ser Leu Ser Val Gly Thr Ser Ser Ala
<removed-apn>
              225                 230                 235                 240
              Lys Leu Glu Ala Ile Asn Glu Leu Ile Arg Phe Asp His Val Tyr Thr
                              245                 250                 255
              Lys Pro Leu Val Leu Glu Ile Pro Ser Glu Thr Glu Ser Gln Thr Asn
                          260                 265                 270
              Val Val Val Lys Ile Glu Glu Ala Pro Leu Ser Ser Ser Glu Glu Asp
                      275                 280                 285
              His Pro Glu Phe Ile Val Ser Val Lys Lys Glu Pro Leu Glu Asp Asp
                  290                 295                 300
              Phe Ile Pro Glu Leu Gly Ile Ser Asn Leu Leu Ser Ser Ser His Cys
              305                 310                 315                 320
              Leu Arg Pro Pro Ser Cys Leu Leu Asp Ala His Ser Asp Cys Gly Tyr
                              325                 330                 335
              Glu Gly Ser Pro Ser Pro Phe Ser Asp Met Ser Ser Pro Leu Gly Thr
                          340                 345                 350
              Asp His Ser Trp Glu Asp Thr Phe Ala Asn Glu Leu Phe Pro Gln Leu
                      355                 360                 365
              Ile Ser Val
                  370
              <210>   10
              <211>   369
              <212>   PRT
              <213>   Cricetulus griseus
              <400>   10
              Met Val Val Val Ala Ala Ser Pro Ser Ala Ala Thr Ala Ala Pro Lys
                                                  27

              1               5                  10                  15
<removed-date>
              Val Leu Leu Leu Ser Gly Gln Pro Ala Ala Asp Gly Arg Ala Leu Pro
                          20                  25                  30
              Leu Met Val Pro Gly Ser Arg Ala Ala Gly Ser Glu Ala Asn Gly Ala
                      35                  40                  45
<removed-apn>
              Pro Gln Ala Arg Lys Arg Gln Arg Leu Thr His Leu Ser Pro Glu Glu
                  50                  55                  60
              Lys Ala Leu Arg Arg Lys Leu Lys Asn Arg Val Ala Ala Gln Thr Ala
              65                  70                  75                  80
              Arg Asp Arg Lys Lys Ala Arg Met Ser Glu Leu Glu Gln Gln Val Val
                              85                  90                  95
              Asp Leu Glu Glu Glu Asn Gln Lys Leu Leu Leu Glu Asn Gln Leu Leu
                          100                 105                 110
              Arg Glu Lys Thr His Gly Leu Val Ile Glu Asn Gln Glu Leu Arg Thr
                      115                 120                 125
              Arg Leu Gly Met Asp Val Leu Thr Thr Glu Glu Ala Pro Glu Thr Glu
                  130                 135                 140
              Ser Lys Gly Asn Gly Val Arg Pro Val Ala Gly Ser Ala Glu Ser Ala
              145                 150                 155                 160
              Ala Gly Ala Gly Pro Val Val Thr Ser Pro Glu His Leu Pro Met Asp
                              165                 170                 175
              Ser Asp Thr Val Asp Ser Ser Asp Ser Glu Ser Asp Ile Leu Leu Gly
                          180                 185                 190
              Ile Leu Asp Lys Leu Asp Pro Val Met Phe Phe Lys Cys Pro Ser Pro
                      195                 200                 205
              Glu Ser Ala Asn Leu Glu Glu Leu Pro Glu Val Tyr Pro Gly Pro Ser
                  210                 215                 220
              Ser Leu Pro Ala Ser Leu Ser Leu Ser Val Gly Thr Ser Ser Ala Lys
              225                 230                 235                 240
                                                  28

<removed-date>
              Leu Glu Ala Ile Asn Glu Leu Ile Arg Phe Asp His Val Tyr Thr Lys
                              245                 250                 255
              Pro Leu Val Leu Glu Ile Pro Ser Glu Thr Glu Ser Gln Thr Asn Val
                          260                 265                 270
              Val Val Lys Ile Glu Glu Ala Pro Leu Ser Ser Ser Glu Glu Asp His
                      275                 280                 285
<removed-apn>
              Pro Glu Phe Ile Val Ser Val Lys Lys Glu Pro Glu Glu Asp Phe Ile
                  290                 295                 300
              Pro Glu Pro Gly Ile Ser Asn Leu Leu Ser Ser Ser His Cys Leu Lys
              305                 310                 315                 320
              Pro Ser Ser Cys Leu Leu Asp Ala Tyr Ser Asp Cys Gly Tyr Glu Gly
                              325                 330                 335
              Ser Pro Ser Pro Phe Ser Asp Met Ser Ser Pro Leu Gly Ile Asp His
                          340                 345                 350
              Ser Trp Glu Asp Thr Phe Ala Asn Glu Leu Phe Pro Gln Leu Ile Ser
                      355                 360                 365
              Val
              <210>   11
              <211>   376
              <212>   PRT
              <213>   Homo sapiens
              <400>   11
              Met Val Val Val Ala Ala Ala Pro Asn Pro Ala Asp Gly Thr Pro Lys
              1               5                   10                  15
              Val Leu Leu Leu Ser Gly Gln Pro Ala Ser Ala Ala Gly Ala Pro Ala
                          20                  25                  30
              Gly Gln Ala Leu Pro Leu Met Val Pro Ala Gln Arg Gly Ala Ser Pro
                      35                  40                  45
              Glu Ala Ala Ser Gly Gly Leu Pro Gln Ala Arg Lys Arg Gln Arg Leu
                  50                  55                  60
                                                  29

<removed-date>
              Thr His Leu Ser Pro Glu Glu Lys Ala Leu Arg Arg Lys Leu Lys Asn
              65                  70                  75                  80
              Arg Val Ala Ala Gln Thr Ala Arg Asp Arg Lys Lys Ala Arg Met Ser
                              85                  90                  95
              Glu Leu Glu Gln Gln Val Val Asp Leu Glu Glu Glu Asn Gln Lys Leu
<removed-apn>
                          100                 105                 110
              Leu Leu Glu Asn Gln Leu Leu Arg Glu Lys Thr His Gly Leu Val Val
                      115                 120                 125
              Glu Asn Gln Glu Leu Arg Gln Arg Leu Gly Met Asp Ala Leu Val Ala
                  130                 135                 140
              Glu Glu Glu Ala Glu Ala Lys Gly Asn Glu Val Arg Pro Val Ala Gly
              145                 150                 155                 160
              Ser Ala Glu Ser Ala Ala Gly Ala Gly Pro Val Val Thr Pro Pro Glu
                              165                 170                 175
              His Leu Pro Met Asp Ser Gly Gly Ile Asp Ser Ser Asp Ser Glu Ser
                          180                 185                 190
              Asp Ile Leu Leu Gly Ile Leu Asp Asn Leu Asp Pro Val Met Phe Phe
                      195                 200                 205
              Lys Cys Pro Ser Pro Glu Pro Ala Ser Leu Glu Glu Leu Pro Glu Val
                  210                 215                 220
              Tyr Pro Glu Gly Pro Ser Ser Leu Pro Ala Ser Leu Ser Leu Ser Val
              225                 230                 235                 240
              Gly Thr Ser Ser Ala Lys Leu Glu Ala Ile Asn Glu Leu Ile Arg Phe
                              245                 250                 255
              Asp His Ile Tyr Thr Lys Pro Leu Val Leu Glu Ile Pro Ser Glu Thr
                          260                 265                 270
              Glu Ser Gln Ala Asn Val Val Val Lys Ile Glu Glu Ala Pro Leu Ser
                      275                 280                 285
                                                  30

              Pro Ser Glu Asn Asp His Pro Glu Phe Ile Val Ser Val Lys Glu Glu
<removed-date>
                  290                 295                 300
              Pro Val Glu Asp Asp Leu Val Pro Glu Leu Gly Ile Ser Asn Leu Leu
              305                 310                 315                 320
              Ser Ser Ser His Cys Pro Lys Pro Ser Ser Cys Leu Leu Asp Ala Tyr
                              325                 330                 335
<removed-apn>
              Ser Asp Cys Gly Tyr Gly Gly Ser Leu Ser Pro Phe Ser Asp Met Ser
                          340                 345                 350
              Ser Leu Leu Gly Val Asn His Ser Trp Glu Asp Thr Phe Ala Asn Glu
                      355                 360                 365
              Leu Phe Pro Gln Leu Ile Ser Val
                  370                 375
              <210>   12
              <211>   383
              <212>   PRT
              <213>   Danio rerio
              <400>   12
              Met Val Val Val Thr Ala Gly Thr Gly Gly Ala His Lys Val Leu Leu
              1               5                   10                  15
              Ile Ser Gly Lys Gln Ser Ala Ser Thr Gly Ala Thr Gln Gly Gly Tyr
                          20                  25                  30
              Ser Arg Ser Ile Ser Val Met Ile Pro Asn Gln Ala Ser Ser Asp Ser
                      35                  40                  45
              Asp Ser Thr Thr Ser Gly Pro Pro Leu Arg Lys Arg Gln Arg Leu Thr
                  50                  55                  60
              His Leu Ser Pro Glu Glu Lys Ala Leu Arg Arg Lys Leu Lys Asn Arg
              65                  70                  75                  80
              Val Ala Ala Gln Thr Ala Arg Asp Arg Lys Lys Ala Lys Met Gly Glu
                              85                  90                  95
              Leu Glu Gln Gln Val Leu Glu Leu Glu Leu Glu Asn Gln Lys Leu His
                          100                 105                 110
                                                  31

<removed-date>
              Val Glu Asn Arg Leu Leu Arg Asp Lys Thr Ser Asp Leu Leu Ser Glu
                      115                 120                 125
              Asn Glu Glu Leu Arg Gln Arg Leu Gly Leu Asp Thr Leu Glu Thr Lys
                  130                 135                 140
              Glu Gln Val Gln Val Leu Glu Ser Ala Val Ser Asp Leu Gly Leu Val
              145                 150                 155                 160
<removed-apn>
              Thr Gly Ser Ser Glu Ser Ala Ala Gly Ala Gly Pro Ala Val Pro Lys
                              165                 170                 175
              Ser Glu Asp Phe Thr Met Asp Thr His Ser Pro Gly Pro Ala Asp Ser
                          180                 185                 190
              Glu Ser Asp Leu Leu Leu Gly Ile Leu Asp Ile Leu Asp Pro Glu Leu
                      195                 200                 205
              Phe Leu Lys Thr Asp Leu Pro Glu Ala Gln Glu Pro Gln Gln Glu Leu
                  210                 215                 220
              Val Leu Val Gly Gly Ala Gly Glu Gln Val Pro Ser Ser Ala Pro Ala
              225                 230                 235                 240
              Ala Leu Gly Pro Ala Pro Val Lys Leu Glu Ala Leu Asn Glu Leu Ile
                              245                 250                 255
              His Phe Asp His Ile Tyr Thr Lys Pro Ala Glu Val Leu Val Ser Glu
                          260                 265                 270
              Glu Ser Ile Cys Glu Val Lys Ala Glu Asp Ser Val Ala Phe Ser Glu
                      275                 280                 285
              Thr Glu Glu Glu Ile Gln Val Glu Asp Gln Thr Val Ser Val Lys Asp
                  290                 295                 300
              Glu Pro Glu Glu Val Val Ile Pro Ala Glu Asn Gln Asn Pro Asp Ala
              305                 310                 315                 320
              Ala Asp Asp Phe Leu Ser Asp Thr Ser Phe Gly Gly Tyr Glu Lys Ala
                              325                 330                 335
              Ser Tyr Leu Thr Asp Ala Tyr Ser Asp Ser Gly Tyr Glu Arg Ser Pro
                                                  32

                           340               345                  350
<removed-date>
              Ser Pro Phe Ser Asn Ile Ser Ser Pro Leu Cys Ser Glu Gly Ser Trp
                      355                 360                 365
              Asp Asp Met Phe Ala Ser Glu Leu Phe Pro Gln Leu Ile Ser Val
                  370                 375                 380
<removed-apn>
              <210>   13
              <211>   371
              <212>   PRT
              <213>   Artificial
              <220>
              <223>   consensus sequence
              <220>
              <221>   MISC_FEATURE
              <222>   (7)..(7)
              <223>   A or S
              <220>
              <221>   MISC_FEATURE
              <222>   (9)..(9)
              <223>   S or N
              <220>
              <221>   MISC_FEATURE
              <222>   (10)..(10)
              <223>   A or P
              <220>
              <221>   MISC_FEATURE
              <222>   (12)..(12)
              <223>   T or D
              <220>
              <221>   MISC_FEATURE
              <222>   (13)..(13)
              <223>   A or G
              <220>
              <221>   MISC_FEATURE
              <222>   (14)..(14)
              <223>   A or T
              <220>
              <221>   MISC_FEATURE
              <222>   (26)..(26)
              <223>   S or A
              <220>
              <221>   misc_feature
              <222>   (27)..(27)
                                                   33

              <223>   Xaa can be any naturally occurring amino acid
<removed-date>
              <220>
              <221>   MISC_FEATURE
              <222>   (29)..(29)
              <223>   R or Q
              <220>
              <221>   MISC_FEATURE
              <222>   (37)..(37)
              <223>   G or A
<removed-apn>
              <220>
              <221>   misc_feature
              <222>   (38)..(38)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (40)..(40)
              <223>   A or G
              <220>
              <221>   MISC_FEATURE
              <222>   (46)..(46)
              <223>   S or N, or ASG
              <220>
              <221>   MISC_FEATURE
              <222>   (48)..(48)
              <223>   T, A, or L
              <220>
              <221>   MISC_FEATURE
              <222>   (103)..(103)
              <223>   H or Q
              <220>
              <221>   MISC_FEATURE
              <222>   (106)..(106)
              <223>   Q or L
              <220>
              <221>   MISC_FEATURE
              <222>   (121)..(121)
              <223>   V or I
              <220>
              <221>   MISC_FEATURE
              <222>   (128)..(128)
              <223>   T or Q
              <220>
              <221>   MISC_FEATURE
              <222>   (134)..(134)
              <223>   T, V, or A
              <220>
                                                   34

              <221>   MISC_FEATURE
<removed-date>
              <222>   (136)..(136)
              <223>   D, T, or V
              <220>
              <221>   MISC_FEATURE
              <222>   (137)..(137)
              <223>   P, T, or A
              <220>
              <221>   MISC_FEATURE
<removed-apn>
              <222>   (138)..(138)
              <223>   D or E
              <220>
              <221>   MISC_FEATURE
              <222>   (140)..(140)
              <223>   V, A, or none
              <220>
              <221>   MISC_FEATURE
              <222>   (141)..(141)
              <223>   P or none
              <220>
              <221>   MISC_FEATURE
              <222>   (143)..(143)
              <223>   V, T, or A
              <220>
              <221>   MISC_FEATURE
              <222>   (145)..(145)
              <223>   A or S
              <220>
              <221>   MISC_FEATURE
              <222>   (148)..(148)
              <223>   S or N
              <220>
              <221>   MISC_FEATURE
              <222>   (149)..(149)
              <223>   G or E
              <220>
              <221>   MISC_FEATURE
              <222>   (152)..(152)
              <223>   L or P
              <220>
              <221>   MISC_FEATURE
              <222>   (169)..(169)
              <223>   S or P
              <220>
              <221>   MISC_FEATURE
              <222>   (178)..(178)
              <223>   D or G
                                      35

<removed-date>
              <220>
              <221>   MISC_FEATURE
              <222>   (179)..(179)
              <223>   T or G
              <220>
              <221>   MISC_FEATURE
              <222>   (180)..(180)
              <223>   V or I
<removed-apn>
              <220>
              <221>   MISC_FEATURE
              <222>   (181)..(181)
              <223>   A or D
              <220>
              <221>   MISC_FEATURE
              <222>   (196)..(196)
              <223>   K or N
              <220>
              <221>   MISC_FEATURE
              <222>   (210)..(210)
              <223>   S or P
              <220>
              <221>   MISC_FEATURE
              <222>   (212)..(212)
              <223>   S or N
              <220>
              <221>   MISC_FEATURE
              <222>   (222)..(222)
              <223>   E or none
              <220>
              <221>   MISC_FEATURE
              <222>   (254)..(254)
              <223>   V or I
              <220>
              <221>   MISC_FEATURE
              <222>   (271)..(271)
              <223>   T or A
              <220>
              <221>   MISC_FEATURE
              <222>   (284)..(284)
              <223>   S or P
              <220>
              <221>   MISC_FEATURE
              <222>   (287)..(287)
              <223>   E or N
              <220>
              <221>   MISC_FEATURE
                                     36

              <222>   (298)..(298)
<removed-date>
              <223>   K or E
              <220>
              <221>   MISC_FEATURE
              <222>   (301)..(301)
              <223>   L, V, or none
              <220>
              <221>   MISC_FEATURE
              <222>   (303)..(303)
<removed-apn>
              <223>   D or E
              <220>
              <221>   MISC_FEATURE
              <222>   (305)..(305)
              <223>   F or L
              <220>
              <221>   MISC_FEATURE
              <222>   (306)..(306)
              <223>   I or V
              <220>
              <221>   MISC_FEATURE
              <222>   (309)..(309)
              <223>   L or P
              <220>
              <221>   MISC_FEATURE
              <222>   (321)..(321)
              <223>   L or P
              <220>
              <221>   MISC_FEATURE
              <222>   (322)..(322)
              <223>   R or K
              <220>
              <221>   MISC_FEATURE
              <222>   (324)..(324)
              <223>   P or S
              <220>
              <221>   MISC_FEATURE
              <222>   (331)..(331)
              <223>   H or Y
              <220>
              <221>   MISC_FEATURE
              <222>   (337)..(337)
              <223>   E or G
              <220>
              <221>   MISC_FEATURE
              <222>   (340)..(340)
              <223>   P or L
                                      37

              <220>
<removed-date>
              <221>   MISC_FEATURE
              <222>   (349)..(349)
              <223>   P or L
              <220>
              <221>   MISC_FEATURE
              <222>   (352)..(352)
              <223>   T, I, or V
              <220>
<removed-apn>
              <221>   MISC_FEATURE
              <222>   (353)..(353)
              <223>   D or N
              <400>   13
              Met Val Val Val Ala Ala Xaa Pro Xaa Xaa Ala Xaa Xaa Xaa Pro Lys
              1               5                   10                  15
              Val Leu Leu Leu Ser Gly Gln Pro Ala Xaa Xaa Gly Arg Ala Leu Pro
                          20                  25                  30
              Leu Met Val Pro Xaa Xaa Arg Xaa Ala Gly Ser Glu Ala Xaa Gly Xaa
                      35                  40                  45
              Pro Gln Ala Arg Lys Arg Gln Arg Leu Thr His Leu Ser Pro Glu Glu
                  50                  55                  60
              Lys Ala Leu Arg Arg Lys Leu Lys Asn Arg Val Ala Ala Gln Thr Ala
              65                  70                  75                  80
              Arg Asp Arg Lys Lys Ala Arg Met Ser Glu Leu Glu Gln Gln Val Val
                              85                  90                  95
              Asp Leu Glu Glu Glu Asn Xaa Lys Leu Xaa Leu Glu Asn Gln Leu Leu
                          100                 105                 110
              Arg Glu Lys Thr His Gly Leu Val Xaa Glu Asn Gln Glu Leu Arg Xaa
                      115                 120                 125
              Arg Leu Gly Met Asp Xaa Leu Asp Xaa Xaa Glu Xaa Xaa Glu Xaa Glu
                  130                 135                 140
              Xaa Lys Gly Xaa Xaa Val Arg Xaa Val Ala Gly Ser Ala Glu Ser Ala
              145                 150                 155                 160
              Ala Gly Ala Gly Pro Val Val Thr Xaa Pro Glu His Leu Pro Met Asp
                                                  38

                              165                170                 175
<removed-date>
              Ser Xaa Xaa Xaa Xaa Ser Ser Asp Ser Glu Ser Asp Ile Leu Leu Gly
                          180                 185                 190
              Ile Leu Asp Xaa Leu Asp Pro Val Met Phe Phe Lys Cys Pro Ser Pro
                      195                 200                 205
<removed-apn>
              Glu Xaa Ala Xaa Leu Glu Glu Leu Pro Glu Val Tyr Pro Xaa Gly Pro
                  210                 215                 220
              Ser Ser Leu Pro Ala Ser Leu Ser Leu Ser Val Gly Thr Ser Ser Ala
              225                 230                 235                 240
              Lys Leu Glu Ala Ile Asn Glu Leu Ile Arg Phe Asp His Xaa Tyr Thr
                              245                 250                 255
              Lys Pro Leu Val Leu Glu Ile Pro Ser Glu Thr Glu Ser Gln Xaa Asn
                          260                 265                 270
              Val Val Val Lys Ile Glu Glu Ala Pro Leu Ser Xaa Ser Glu Xaa Asp
                      275                 280                 285
              His Pro Glu Phe Ile Val Ser Val Lys Xaa Glu Pro Xaa Glu Xaa Asp
                  290                 295                 300
              Xaa Xaa Pro Glu Xaa Gly Ile Ser Asn Leu Leu Ser Ser Ser His Cys
              305                 310                 315                 320
              Xaa Xaa Pro Xaa Ser Cys Leu Leu Asp Ala Xaa Ser Asp Cys Gly Tyr
                              325                 330                 335
              Xaa Gly Ser Xaa Ser Pro Phe Ser Asp Met Ser Ser Xaa Leu Gly Xaa
                          340                 345                 350
              Xaa His Ser Trp Glu Asp Thr Phe Ala Asn Glu Leu Phe Pro Gln Leu
                      355                 360                 365
              Ile Ser Val
                  370
              <210>   14
              <211>   7686
              <212>   DNA
                                                  39

              <213>   Artificial
<removed-date>
              <220>
              <223>   Synthetic plasmid
              <400> 14
              aagcttatac tcgagctcta gattgggaac ccgggtctct cgaattcgat gccttttaga    60
              ctcctgatac cattgggtct tgtttgcgtt ctcctccctc tccatcacgg cgccccaggt    120
              ccagacggta ccgcacctga tcctgcccat taccgcgaac gcgttaaagc catgttctac    180
<removed-apn>
              cacgcctatg actcctatct ggaaaatgca ttcccctatg atgagctccg accccttacc    240
              tgcgatggtc atgatacttg gggctctttt tcccttaccc ttattgacgc tctggacaca    300
              ctccttatcc tcggaaacac cagcgaattt caaagagtag ttgaagtact tcaggacaat    360
              gtcgactttg acatcgatgt gaacgcatca gttttcgaaa caaatataag agtcgttgga    420
              ggtctgctct ccgcccacct tctctctaaa aaagccggag tagaagttga agctggctgg    480
              ccctgctccg gacccctcct tcgtatggct gaagaagctg cccgcaaact ccttcccgct    540
              tttcagaccc caaccggtat gccctatggt actgttaacc tcctgcacgg agtaaatccc    600
              ggcgaaaccc ccgtcacatg tacagccgga attggaacct ttattgtgga atttgcaacc    660
              cttagcagcc tgaccggaga tcctgtattc gaagacgtgg ctcgggttgc cctgatgcga    720
              ctgtgggaat ccaggtctga tatcggtctg gtcggtaacc atatagacgt actcactggt    780
              aaatgggttg cacaagacgc tggaattggg gcaggcgtgg attcttattt tgaatatctc    840
              gtaaaagggg ccatactctt gcaggacaaa aaacttatgg ctatgttcct ggaatataac    900
              aaagctatta ggaactacac acacttcgat gattggtatt tgtgggtcca aatgtataaa    960
              ggaaccgttt ctatgcctgt ctttcagtca ctggaggctt attggcctgg tctgcaatcc   1020
              ctgatcggag acattgacaa tgcaatgagg acattcctta attattacac tgtttggaag   1080
              cagttcggcg gattgcccga attttacaac attcctcaag gctatacagt tgaaaaaaga   1140
              gaaggatatc ccctgcgccc cgagcttatt gaaagcgcta tgtatctgta tcgtgcaaca   1200
              ggtgatccaa ccctgcttga actgggacga gacgccgtcg aatcaatcga gaaaatttca   1260
              aaagtggaat gcggctttgc aacaattaaa gatcttagag accacaaact ggataatcgc   1320
              atggagtcat tctttttggc tgagaccgtc aagtatctgt atctgctttt tcatcccaac   1380
              aacttcatcc ataataacgg gtccaccttc gattcagtca tgacccctca cggtgaatgc   1440
              atactcggag ctggaggcta tatttttaac actgaagctc acccaattga cccagctgcc   1500
              cttcattgtt gtcgacgtct gaaagaagaa caatgggagg ttgaagattt gatcaaagaa   1560
                                                  40

              ttttactcac ttaaacaaag tcgacctaaa cgcgcacaga gaaaaactgt aagatctggt   1620
<removed-date>
              ccttgggaac ctcagtccgg cccagcaact ctttcatccc ccgccaacca accacgagaa   1680
              aaacaaccag cccaacagag aacccccctg ctcagctgcc cctctcagcc cttcacttca   1740
              aaactcgccc tgcttggaca ggtgtttctg gactcctctt gatttaaaca cgcggccgct   1800
              aatcagccat accacatttg tagaggtttt acttgcttta aaaaacctcc cacacctccc   1860
              cctgaacctg aaacataaaa tgaatgcaat tgttgttgtt aacttgttta ttgcagctta   1920
<removed-apn>
              taatggttac aaataaagca atagcatcac aaatttcaca aataaagcat ttttttcact   1980
              gcattctagt tgtggtttgt ccaaactcat caatgtatct tatcatgtct accggtaggg   2040
              cccctctctt catgtgagca aaaggccagc aaaaggccag gaaccgtaaa aaggccgcgt   2100
              tgctggcgtt tttccatagg ctccgccccc ctgacgagca tcacaaaaat cgacgctcaa   2160
              gtcagaggtg gcgaaacccg acaggactat aaagatacca ggcgtttccc cctggaagct   2220
              ccctcgtgcg ctctcctgtt ccgaccctgc cgcttaccgg atacctgtcc gcctttctcc   2280
              cttcgggaag cgtggcgctt tctcaatgct cacgctgtag gtatctcagt tcggtgtagg   2340
              tcgttcgctc caagctgggc tgtgtgcacg aaccccccgt tcagcccgac cgctgcgcct   2400
              tatccggtaa ctatcgtctt gagtccaacc cggtaagaca cgacttatcg ccactggcag   2460
              cagccactgg taacaggatt agcagagcga ggtatgtagg cggtgctaca gagttcttga   2520
              agtggtggcc taactacggc tacactagaa ggacagtatt tggtatctgc gctctgctga   2580
              agccagttac cttcggaaaa agagttggta gctcttgatc cggcaaacaa accaccgctg   2640
              gtagcggtgg tttttttgtt tgcaagcagc agattacgcg cagaaaaaaa ggatctcaag   2700
              aagatccttt gatcttttct acggggtctg acgctcagtg gaacgaaaac tcacgttaag   2760
              ggattttggt catgggcgcg cctcatactc ctgcaggcat gagattatca aaaaggatct   2820
              tcacctagat ccttttaaat taaaaatgaa gttttaaatc aatctaaagt atatatgagt   2880
              aaacttggtc tgacagttac caatgcttaa tcagtgaggc acctatctca gcgatctgtc   2940
              tatttcgttc atccatagtt gcctgactcc ccgtcgtgta gataactacg atacgggagg   3000
              gcttaccatc tggccccagt gctgcaatga taccgcgaga cccacgctca ccggctccag   3060
              atttatcagc aataaaccag ccagccggaa gggccgagcg cagaagtggt cctgcaactt   3120
              tatccgcctc catccagtct attaattgtt gccgggaagc tagagtaagt agttcgccag   3180
              ttaatagttt gcgcaacgtt gttgccattg ctacaggcat cgtggtgtca cgctcgtcgt   3240
              ttggtatggc ttcattcagc tccggttccc aacgatcaag gcgagttaca tgatccccca   3300
                                                  41

              tgttgtgcaa aaaagcggtt agctccttcg gtcctccgat cgttgtcaga agtaagttgg   3360
<removed-date>
              ccgcagtgtt atcactcatg gttatggcag cactgcataa ttctcttact gtcatgccat   3420
              ccgtaagatg cttttctgtg actggtgagt actcaaccaa gtcattctga gaatagtgta   3480
              tgcggcgacc gagttgctct tgcccggcgt caatacggga taataccgcg ccacatagca   3540
              gaactttaaa agtgctcatc attggaaaac gttcttcggg gcgaaaactc tcaaggatct   3600
              taccgctgtt gagatccagt tcgatgtaac ccactcgtgc acccaactga tcttcagcat   3660
<removed-apn>
              cttttacttt caccagcgtt tctgggtgag caaaaacagg aaggcaaaat gccgcaaaaa   3720
              agggaataag ggcgacacgg aaatgttgaa tactcatact cttccttttt caatattatt   3780
              gaagcattta tcagggttat tgtctcatga gcggatacat atttgaatgt atttagaaaa   3840
              ataaacaaat aggggttccg cgcacatttc cccgaaaagt gccacctgac gtcaggtacc   3900
              aagcctaggc ctccaaaaaa gcctcctcac tacttctgga atagctcaga ggcagaggcg   3960
              gcctcggcct ctgcataaat aaaaaaaatt agtcagccat ggggcggaga atgggcggaa   4020
              ctgggcggag ttaggggcgg gatgggcgga gttaggggcg ggactatggt tgctgactaa   4080
              ttgagatgca tgctttgcat acttctgcct gctggggagc ctggggactt tccacacctg   4140
              gttgctgact aattgagatg catgctttgc atacttctgc ctgctgggga gcctggggac   4200
              tttccacacc ggatccacca tgggatcggc cattgaacaa gatggattgc acgcaggttc   4260
              tccggccgct tgggtggaga ggctattcgg ctatgactgg gcacaacaga caatcggctg   4320
              ctctgatgcc gccgtgttcc ggctgtcagc gcaggggcgc ccggttcttt ttgtcaagac   4380
              cgacctgtcc ggtgccctga atgaactgca ggacgaggca gcgcggctat cgtggctggc   4440
              cacgacgggc gttccttgcg cagctgtgct cgacgttgtc actgaagcgg gaagggactg   4500
              gctgctattg ggcgaagtgc cggggcagga tctcctgtca tctcaccttg ctcctgccga   4560
              gaaagtatcc atcatggctg atgcaatgcg gcggctgcat acgcttgatc cggctacctg   4620
              cccattcgac caccaagcga aacatcgcat cgagcgagca cgtactcgga tggaagccgg   4680
              tcttgtcgat caggatgatc tggacgaaga gcatcagggg ctcgcgccag ccgaactgtt   4740
              cgccaggctc aaggcgcgca tgcccgacgg cgatgatctc gtcgtgaccc atggcgatgc   4800
              ctgcttgccg aatatcatgg tggaaaatgg ccgcttttct ggattcatcg actgtggccg   4860
              gctgggtgtg gcggaccgct atcaggacat agcgttggct acccgtgata ttgctgaaga   4920
              gcttggcggc gaatgggctg accgcttcct cgtgctttac ggtatcgccg ctcccgattc   4980
              gcagcgcatc gccttctatc gccttcttga cgagttcttc tgaacgcgtg ctgtaagtct   5040
                                                  42

              gcagaaattg atgatctatt aaacaataaa gatgtccact aaaatggaag tttttcctgt   5100
<removed-date>
              catactttgt taagaagggt gagaacagag tacctacatt ttgaatggaa ggattggagc   5160
              tacgggggtg ggggtggggt gggattagat aaatgcctgc tctttactga aggctcttta   5220
              ctattgcttt atgataatgt ttcatagttg gatatcataa tttaaacaag caaaaccaaa   5280
              ttaagggcca gctcattcct cccactcatg atctatggat ctatagatct ctcgtgcagc   5340
              tggggctcta gggggtatcc ccacgcgccc tgtagcggcg cattaagcgc ggcgggtgtg   5400
<removed-apn>
              gtggttacgc gcagcgtgac cgctacactt gccagcgccc tagcgcccgc tcctttcgct   5460
              ttcttccctt cctttctcgc cacgttcgcc ggctttcccc gtcaagctct aaatcggggg   5520
              ctccctttag ggttccgatt tagtgcttta cggcacctcg accccaaaaa acttgattag   5580
              ggtgatggtt cacgtagtgg gccatcgccc tgatagacgg tttttcgccc tttgacgttg   5640
              gagtccacgt tctttaatag tggactcttg ttccaaactg gaacaacact caaccctatc   5700
              tcggtctatt cttttgattt ataagggatt ttgccgattt cggcctattg gttaaaaaat   5760
              gagctgattt aacaaaaatt taacgcgaat taattctgtg gaatgtgtgt cagttagtcg   5820
              cgaggcctcc gcgccgggtt ttggcgcctc ccgcgggcgc ccccctcctc acggcgagcg   5880
              ctgccacgtc agacgaaggg cgcagcgagc gtcctgatcc ttccgcccgg acgctcagga   5940
              cagcggcccg ctgctcataa gactcggcct tagaacccca gtatcagcag aaggacattt   6000
              taggacggga cttgggtgac tctagggcac tggttttctt tccagagagc ggaacaggcg   6060
              aggaaaagta gtcccttctc ggcgattctg cggagggatc tccgtggggc ggtgaacgcc   6120
              gatgattata taaggacgcg ccgggtgtgg cacagctagt tccgtcgcag ccgggatttg   6180
              ggtcgcggtt cttgtttgtg gatcgctgtg atcgtcactt ggtgagtagc gggctgctgg   6240
              gctggccggg gctttcgtgg ccgccgggcc gctcggtggg acggaagcgt gtggagagac   6300
              cgccaagggc tgtagtctgg gtccgcgagc aaggttgccc tgaactgggg gttgggggga   6360
              gcgcagcaaa atggcggctg ttcccgagtc ttgaatggaa gacgcttgtg aggcgggctg   6420
              tgaggtcgtt gaaacaaggt ggggggcatg gtgggcggca agaacccaag gtcttgaggc   6480
              cttcgctaat gcgggaaagc tcttattcgg gtgagatggg ctggggcacc atctggggac   6540
              cctgacgtga agtttgtcac tgactggaga actcggtttg tcgtctgttg cgggggcggc   6600
              agttatggcg gtgccgttgg gcagtgcacc cgtacctttg ggagcgcgcg ccctcgtcgt   6660
              gtcgtgacgt cacccgttct gttggcttat aatgcagggt ggggccacct gccggtaggt   6720
              gtgcggtagg cttttctccg tcgcaggacg cagggttcgg gcctagggta ggctctcctg   6780
                                                  43

              aatcgacagg cgccggacct ctggtgaggg gagggataag tgaggcgtca gtttctttgg   6840
<removed-date>
              tcggttttat gtacctatct tcttaagtag ctgaagctcc ggttttgaac tatgcgctcg   6900
              gggttggcga gtgtgttttg tgaagttttt taggcacctt ttgaaatgta atcatttggg   6960
              tcaatatgta attttcagtg ttagactagt aaattgtccg ctaaattctg gccgtttttg   7020
              gcttttttgt tagacgtcga ccgatcctga gaacttcagg gtgagtttgg ggacccttga   7080
              ttgttctttc tttttcgcta ttgtaaaatt catgttatat ggagggggca aagttttcag   7140
<removed-apn>
              ggtgttgttt agaatgggaa gatgtccctt gtatcaccat ggaccctcat gataattttg   7200
              tttctttcac tttctactct gttgacaacc attgtctcct cttattttct tttcattttc   7260
              tgtaactttt tcgttaaact ttagcttgca tttgtaacga atttttaaat tcacttttgt   7320
              ttatttgtca gattgtaagt actttctcta atcacttttt tttcaaggca atcagggtat   7380
              attatattgt acttcagcac agttttagag aacaattgtt ataattaaat gataaggtag   7440
              aatatttctg catataaatt ctggctggcg tggaaatatt cttattggta gaaacaacta   7500
              caccctggtc atcatcctgc ctttctcttt atggttacaa tgatatacac tgtttgagat   7560
              gaggataaaa tactctgagt ccaaaccggg cccctctgct aaccatgttc atgccttctt   7620
              ctctttccta cagctcctgg gcaacgtgct ggttgttgtg ctgtctcatc attttggcaa   7680
              agaatt                                                              7686
              <210>    15
              <211>    7257
              <212>    DNA
              <213>    Artificial
              <220>
              <223>    Synthetic plasmid
              <400> 15
              aagcttatac tcgagctcta gattgggaac ccgggtctct cgaattcgat gccttttaga    60
              ctcctgatac cattgggtct tgtttgcgtt ctcctccctc tccatcacgg cgccccaggt    120
              ccagacggta ccgcacctga tcctgcccat taccgcgaac gcgttaaagc catgttctac    180
              cacgcctatg actcctatct ggaaaatgca ttcccctatg atgagctccg accccttacc    240
              tgcgatggtc atgatacttg gggctctttt tcccttaccc ttattgacgc tctggacaca    300
              ctccttatcc tcggaaacac cagcgaattt caaagagtag ttgaagtact tcaggacaat    360
              gtcgactttg acatcgatgt gaacgcatca gttttcgaaa caaatataag agtcgttgga    420
              ggtctgctct ccgcccacct tctctctaaa aaagccggag tagaagttga agctggctgg    480
                                                  44

              ccctgctccg gacccctcct tcgtatggct gaagaagctg cccgcaaact ccttcccgct    540
<removed-date>
              tttcagaccc caaccggtat gccctatggt actgttaacc tcctgcacgg agtaaatccc    600
              ggcgaaaccc ccgtcacatg tacagccgga attggaacct ttattgtgga atttgcaacc    660
              cttagcagcc tgaccggaga tcctgtattc gaagacgtgg ctcgggttgc cctgatgcga    720
              ctgtgggaat ccaggtctga tatcggtctg gtcggtaacc atatagacgt actcactggt    780
              aaatgggttg cacaagacgc tggaattggg gcaggcgtgg attcttattt tgaatatctc    840
<removed-apn>
              gtaaaagggg ccatactctt gcaggacaaa aaacttatgg ctatgttcct ggaatataac    900
              aaagctatta ggaactacac acacttcgat gattggtatt tgtgggtcca aatgtataaa    960
              ggaaccgttt ctatgcctgt ctttcagtca ctggaggctt attggcctgg tctgcaatcc   1020
              ctgatcggag acattgacaa tgcaatgagg acattcctta attattacac tgtttggaag   1080
              cagttcggcg gattgcccga attttacaac attcctcaag gctatacagt tgaaaaaaga   1140
              gaaggatatc ccctgcgccc cgagcttatt gaaagcgcta tgtatctgta tcgtgcaaca   1200
              ggtgatccaa ccctgcttga actgggacga gacgccgtcg aatcaatcga gaaaatttca   1260
              aaagtggaat gcggctttgc aacaattaaa gatcttagag accacaaact ggataatcgc   1320
              atggagtcat tctttttggc tgagaccgtc aagtatctgt atctgctttt tcatcccaac   1380
              aacttcatcc ataataacgg gtccaccttc gattcagtca tgacccctca cggtgaatgc   1440
              atactcggag ctggaggcta tatttttaac actgaagctc acccaattga cccagctgcc   1500
              cttcattgtt gtcgacgtct gaaagaagaa caatgggagg ttgaagattt gatcaaagaa   1560
              ttttactcac ttaaacaaag tcgacctaaa cgcgcacaga gaaaaactgt aagatctggt   1620
              ccttgggaac ctcagtccgg cccagcaact ctttcatccc ccgccaacca accacgagaa   1680
              aaacaaccag cccaacagag aacccccctg ctcagctgcc cctctcagcc cttcacttca   1740
              aaactcgccc tgcttggaca ggtgtttctg gactcctctt gatttaaaca cgcggccgct   1800
              aatcagccat accacatttg tagaggtttt acttgcttta aaaaacctcc cacacctccc   1860
              cctgaacctg aaacataaaa tgaatgcaat tgttgttgtt aacttgttta ttgcagctta   1920
              taatggttac aaataaagca atagcatcac aaatttcaca aataaagcat ttttttcact   1980
              gcattctagt tgtggtttgt ccaaactcat caatgtatct tatcatgtct accggtaggg   2040
              cccctctctt catgtgagca aaaggccagc aaaaggccag gaaccgtaaa aaggccgcgt   2100
              tgctggcgtt tttccatagg ctccgccccc ctgacgagca tcacaaaaat cgacgctcaa   2160
              gtcagaggtg gcgaaacccg acaggactat aaagatacca ggcgtttccc cctggaagct   2220
                                                  45

              ccctcgtgcg ctctcctgtt ccgaccctgc cgcttaccgg atacctgtcc gcctttctcc   2280
<removed-date>
              cttcgggaag cgtggcgctt tctcatagct cacgctgtag gtatctcagt tcggtgtagg   2340
              tcgttcgctc caagctgggc tgtgtgcacg aaccccccgt tcagcccgac cgctgcgcct   2400
              tatccggtaa ctatcgtctt gagtccaacc cggtaagaca cgacttatcg ccactggcag   2460
              cagccactgg taacaggatt agcagagcga ggtatgtagg cggtgctaca gagttcttga   2520
              agtggtggcc taactacggc tacactagaa ggacagtatt tggtatctgc gctctgctga   2580
<removed-apn>
              agccagttac cttcggaaaa agagttggta gctcttgatc cggcaaacaa accaccgctg   2640
              gtagcggtgg tttttttgtt tgcaagcagc agattacgcg cagaaaaaaa ggatctcaag   2700
              aagatccttt gatcttttct acggggtctg acgctcagtg gaacgaaaac tcacgttaag   2760
              ggattttggt catgggcgcg cctcatactc ctgcaggcat gagattatca aaaaggatct   2820
              tcacctagat ccttttaaat taaaaatgaa gttttaaatc aatctaaagt atatatgagt   2880
              aaacttggtc tgacagttac caatgcttaa tcagtgaggc acctatctca gcgatctgtc   2940
              tatttcgttc atccatagtt gcctgactcc ccgtcgtgta gataactacg atacgggagg   3000
              gcttaccatc tggccccagt gctgcaatga taccgcgaga cccacgctca ccggctccag   3060
              atttatcagc aataaaccag ccagccggaa gggccgagcg cagaagtggt cctgcaactt   3120
              tatccgcctc catccagtct attaattgtt gccgggaagc tagagtaagt agttcgccag   3180
              ttaatagttt gcgcaacgtt gttgccattg ctacaggcat cgtggtgtca cgctcgtcgt   3240
              ttggtatggc ttcattcagc tccggttccc aacgatcaag gcgagttaca tgatccccca   3300
              tgttgtgcaa aaaagcggtt agctccttcg gtcctccgat cgttgtcaga agtaagttgg   3360
              ccgcagtgtt atcactcatg gttatggcag cactgcataa ttctcttact gtcatgccat   3420
              ccgtaagatg cttttctgtg actggtgagt actcaaccaa gtcattctga gaatagtgta   3480
              tgcggcgacc gagttgctct tgcccggcgt caatacggga taataccgcg ccacatagca   3540
              gaactttaaa agtgctcatc attggaaaac gttcttcggg gcgaaaactc tcaaggatct   3600
              taccgctgtt gagatccagt tcgatgtaac ccactcgtgc acccaactga tcttcagcat   3660
              cttttacttt caccagcgtt tctgggtgag caaaaacagg aaggcaaaat gccgcaaaaa   3720
              agggaataag ggcgacacgg aaatgttgaa tactcatact cttccttttt caatattatt   3780
              gaagcattta tcagggttat tgtctcatga gcggatacat atttgaatgt atttagaaaa   3840
              ataaacaaat aggggttccg cgcacatttc cccgaaaagt gccacctgac gtcaggtacc   3900
              aagcctaggc ctccaaaaaa gcctcctcac tacttctgga atagctcaga ggcagaggcg   3960
                                                  46

              gcctcggcct ctgcataaat aaaaaaaatt agtcagccat ggggcggaga atgggcggaa   4020
<removed-date>
              ctgggcggag ttaggggcgg gatgggcgga gttaggggcg ggactatggt tgctgactaa   4080
              ttgagatgca tgctttgcat acttctgcct gctggggagc ctggggactt tccacacctg   4140
              gttgctgact aattgagatg catgctttgc atacttctgc ctgctgggga gcctggggac   4200
              tttccacacc ggatccacca tggccaagtt gaccagtgcc gttccggtgc tcaccgcgcg   4260
              cgacgtcgcc ggagcggtcg agttctggac cgaccggctc gggttctccc gggacttcgt   4320
<removed-apn>
              ggaggacgac ttcgccggtg tggtccggga cgacgtgacc ctgttcatca gcgcggtcca   4380
              ggaccaggtg gtgccggaca acaccctggc ctgggtgtgg gtgcgcggcc tggacgagct   4440
              gtacgccgag tggtcggagg tcgtgtccac gaacttccgg gacgcctccg ggccggccat   4500
              gaccgagatc ggcgagcagc cgtgggggcg ggagttcgcc ctgcgcgacc cggccggcaa   4560
              ctgcgtgcac ttcgtggccg aggagcagga ctgaacgcgt gctgtaagtc tgcagaaatt   4620
              gatgatctat taaacaataa agatgtccac taaaatggaa gtttttcctg tcatactttg   4680
              ttaagaaggg tgagaacaga gtacctacat tttgaatgga aggattggag ctacgggggt   4740
              gggggtgggg tgggattaga taaatgcctg ctctttactg aaggctcttt actattgctt   4800
              tatgataatg tttcatagtt ggatatcata atttaaacaa gcaaaaccaa attaagggcc   4860
              agctcattcc tcccactcat gatctatgga tctatagatc tctcgtgcag ctggggctct   4920
              agggggtatc cccacgcgcc ctgtagcggc gcattaagcg cggcgggtgt ggtggttacg   4980
              cgcagcgtga ccgctacact tgccagcgcc ctagcgcccg ctcctttcgc tttcttccct   5040
              tcctttctcg ccacgttcgc cggctttccc cgtcaagctc taaatcgggg gctcccttta   5100
              gggttccgat ttagtgcttt acggcacctc gaccccaaaa aacttgatta gggtgatggt   5160
              tcacgtagtg ggccatcgcc ctgatagacg gtttttcgcc ctttgacgtt ggagtccacg   5220
              ttctttaata gtggactctt gttccaaact ggaacaacac tcaaccctat ctcggtctat   5280
              tcttttgatt tataagggat tttgccgatt tcggcctatt ggttaaaaaa tgagctgatt   5340
              taacaaaaat ttaacgcgaa ttaattctgt ggaatgtgtg tcagttagtc gcgaggcctc   5400
              cgcgccgggt tttggcgcct cccgcgggcg cccccctcct cacggcgagc gctgccacgt   5460
              cagacgaagg gcgcagcgag cgtcctgatc cttccgcccg gacgctcagg acagcggccc   5520
              gctgctcata agactcggcc ttagaacccc agtatcagca gaaggacatt ttaggacggg   5580
              acttgggtga ctctagggca ctggttttct ttccagagag cggaacaggc gaggaaaagt   5640
              agtcccttct cggcgattct gcggagggat ctccgtgggg cggtgaacgc cgatgattat   5700
                                                  47

              ataaggacgc gccgggtgtg gcacagctag ttccgtcgca gccgggattt gggtcgcggt   5760
<removed-date>
              tcttgtttgt ggatcgctgt gatcgtcact tggtgagtag cgggctgctg ggctggccgg   5820
              ggctttcgtg gccgccgggc cgctcggtgg gacggaagcg tgtggagaga ccgccaaggg   5880
              ctgtagtctg ggtccgcgag caaggttgcc ctgaactggg ggttgggggg agcgcagcaa   5940
              aatggcggct gttcccgagt cttgaatgga agacgcttgt gaggcgggct gtgaggtcgt   6000
              tgaaacaagg tggggggcat ggtgggcggc aagaacccaa ggtcttgagg ccttcgctaa   6060
<removed-apn>
              tgcgggaaag ctcttattcg ggtgagatgg gctggggcac catctgggga ccctgacgtg   6120
              aagtttgtca ctgactggag aactcggttt gtcgtctgtt gcgggggcgg cagttatggc   6180
              ggtgccgttg ggcagtgcac ccgtaccttt gggagcgcgc gccctcgtcg tgtcgtgacg   6240
              tcacccgttc tgttggctta taatgcaggg tggggccacc tgccggtagg tgtgcggtag   6300
              gcttttctcc gtcgcaggac gcagggttcg ggcctagggt aggctctcct gaatcgacag   6360
              gcgccggacc tctggtgagg ggagggataa gtgaggcgtc agtttctttg gtcggtttta   6420
              tgtacctatc ttcttaagta gctgaagctc cggttttgaa ctatgcgctc ggggttggcg   6480
              agtgtgtttt gtgaagtttt ttaggcacct tttgaaatgt aatcatttgg gtcaatatgt   6540
              aattttcagt gttagactag taaattgtcc gctaaattct ggccgttttt ggcttttttg   6600
              ttagacgtcg accgatcctg agaacttcag ggtgagtttg gggacccttg attgttcttt   6660
              ctttttcgct attgtaaaat tcatgttata tggagggggc aaagttttca gggtgttgtt   6720
              tagaatggga agatgtccct tgtatcacca tggaccctca tgataatttt gtttctttca   6780
              ctttctactc tgttgacaac cattgtctcc tcttattttc ttttcatttt ctgtaacttt   6840
              ttcgttaaac tttagcttgc atttgtaacg aatttttaaa ttcacttttg tttatttgtc   6900
              agattgtaag tactttctct aatcactttt ttttcaaggc aatcagggta tattatattg   6960
              tacttcagca cagttttaga gaacaattgt tataattaaa tgataaggta gaatatttct   7020
              gcatataaat tctggctggc gtggaaatat tcttattggt agaaacaact acaccctggt   7080
              catcatcctg cctttctctt tatggttaca atgatataca ctgtttgaga tgaggataaa   7140
              atactctgag tccaaaccgg gcccctctgc taaccatgtt catgccttct tctctttcct   7200
              acagctcctg ggcaacgtgc tggttgttgt gctgtctcat cattttggca aagaatt      7257
              <210>   16
              <211>   3892
              <212>   DNA
              <213>   Artificial
                                                  48

              <220>
<removed-date>
              <223>   Synthetic construct
              <400> 16
              aggcctccgc gccgggtttt ggcgcctccc gcgggcgccc ccctcctcac ggcgagcgct     60
              gccacgtcag acgaagggcg cagcgagcgt cctgatcctt ccgcccggac gctcaggaca    120
              gcggcccgct gctcataaga ctcggcctta gaaccccagt atcagcagaa ggacatttta    180
              ggacgggact tgggtgactc tagggcactg gttttctttc cagagagcgg aacaggcgag    240
<removed-apn>
              gaaaagtagt cccttctcgg cgattctgcg gagggatctc cgtggggcgg tgaacgccga    300
              tgattatata aggacgcgcc gggtgtggca cagctagttc cgtcgcagcc gggatttggg    360
              tcgcggttct tgtttgtgga tcgctgtgat cgtcacttgg tgagtagcgg gctgctgggc    420
              tggccggggc tttcgtggcc gccgggccgc tcggtgggac ggaagcgtgt ggagagaccg    480
              ccaagggctg tagtctgggt ccgcgagcaa ggttgccctg aactgggggt tggggggagc    540
              gcagcaaaat ggcggctgtt cccgagtctt gaatggaaga cgcttgtgag gcgggctgtg    600
              aggtcgttga aacaaggtgg ggggcatggt gggcggcaag aacccaaggt cttgaggcct    660
              tcgctaatgc gggaaagctc ttattcgggt gagatgggct ggggcaccat ctggggaccc    720
              tgacgtgaag tttgtcactg actggagaac tcggtttgtc gtctgttgcg ggggcggcag    780
              ttatggcggt gccgttgggc agtgcacccg tacctttggg agcgcgcgcc ctcgtcgtgt    840
              cgtgacgtca cccgttctgt tggcttataa tgcagggtgg ggccacctgc cggtaggtgt    900
              gcggtaggct tttctccgtc gcaggacgca gggttcgggc ctagggtagg ctctcctgaa    960
              tcgacaggcg ccggacctct ggtgagggga gggataagtg aggcgtcagt ttctttggtc   1020
              ggttttatgt acctatcttc ttaagtagct gaagctccgg ttttgaacta tgcgctcggg   1080
              gttggcgagt gtgttttgtg aagtttttta ggcacctttt gaaatgtaat catttgggtc   1140
              aatatgtaat tttcagtgtt agactagtaa attgtccgct aaattctggc cgtttttggc   1200
              ttttttgtta gacgtcgacc gatcctgaga acttcagggt gagtttgggg acccttgatt   1260
              gttctttctt tttcgctatt gtaaaattca tgttatatgg agggggcaaa gttttcaggg   1320
              tgttgtttag aatgggaaga tgtcccttgt atcaccatgg accctcatga taattttgtt   1380
              tctttcactt tctactctgt tgacaaccat tgtctcctct tattttcttt tcattttctg   1440
              taactttttc gttaaacttt agcttgcatt tgtaacgaat ttttaaattc acttttgttt   1500
              atttgtcaga ttgtaagtac tttctctaat cacttttttt tcaaggcaat cagggtatat   1560
              tatattgtac ttcagcacag ttttagagaa caattgttat aattaaatga taaggtagaa   1620
                                                  49

              tatttctgca tataaattct ggctggcgtg gaaatattct tattggtaga aacaactaca   1680
<removed-date>
              ccctggtcat catcctgcct ttctctttat ggttacaatg atatacactg tttgagatga   1740
              ggataaaata ctctgagtcc aaaccgggcc cctctgctaa ccatgttcat gccttcttct   1800
              ctttcctaca gctcctgggc aacgtgctgg ttgttgtgct gtctcatcat tttggcaaag   1860
              aattaagctt atactcgagc tctagattgg gaacccgggt ctctcgaatt cgatgccttt   1920
              tagactcctg ataccattgg gtcttgtttg cgttctcctc cctctccatc acggcgcccc   1980
<removed-apn>
              aggtccagac ggtaccgcac ctgatcctgc ccattaccgc gaacgcgtta aagccatgtt   2040
              ctaccacgcc tatgactcct atctggaaaa tgcattcccc tatgatgagc tccgacccct   2100
              tacctgcgat ggtcatgata cttggggctc tttttccctt acccttattg acgctctgga   2160
              cacactcctt atcctcggaa acaccagcga atttcaaaga gtagttgaag tacttcagga   2220
              caatgtcgac tttgacatcg atgtgaacgc atcagttttc gaaacaaata taagagtcgt   2280
              tggaggtctg ctctccgccc accttctctc taaaaaagcc ggagtagaag ttgaagctgg   2340
              ctggccctgc tccggacccc tccttcgtat ggctgaagaa gctgcccgca aactccttcc   2400
              cgcttttcag accccaaccg gtatgcccta tggtactgtt aacctcctgc acggagtaaa   2460
              tcccggcgaa acccccgtca catgtacagc cggaattgga acctttattg tggaatttgc   2520
              aacccttagc agcctgaccg gagatcctgt attcgaagac gtggctcggg ttgccctgat   2580
              gcgactgtgg gaatccaggt ctgatatcgg tctggtcggt aaccatatag acgtactcac   2640
              tggtaaatgg gttgcacaag acgctggaat tggggcaggc gtggattctt attttgaata   2700
              tctcgtaaaa ggggccatac tcttgcagga caaaaaactt atggctatgt tcctggaata   2760
              taacaaagct attaggaact acacacactt cgatgattgg tatttgtggg tccaaatgta   2820
              taaaggaacc gtttctatgc ctgtctttca gtcactggag gcttattggc ctggtctgca   2880
              atccctgatc ggagacattg acaatgcaat gaggacattc cttaattatt acactgtttg   2940
              gaagcagttc ggcggattgc ccgaatttta caacattcct caaggctata cagttgaaaa   3000
              aagagaagga tatcccctgc gccccgagct tattgaaagc gctatgtatc tgtatcgtgc   3060
              aacaggtgat ccaaccctgc ttgaactggg acgagacgcc gtcgaatcaa tcgagaaaat   3120
              ttcaaaagtg gaatgcggct ttgcaacaat taaagatctt agagaccaca aactggataa   3180
              tcgcatggag tcattctttt tggctgagac cgtcaagtat ctgtatctgc tttttcatcc   3240
              caacaacttc atccataata acgggtccac cttcgattca gtcatgaccc ctcacggtga   3300
              atgcatactc ggagctggag gctatatttt taacactgaa gctcacccaa ttgacccagc   3360
                                                  50

              tgcccttcat tgttgtcgac gtctgaaaga agaacaatgg gaggttgaag atttgatcaa   3420
<removed-date>
              agaattttac tcacttaaac aaagtcgacc taaacgcgca cagagaaaaa ctgtaagatc   3480
              tggtccttgg gaacctcagt ccggcccagc aactctttca tcccccgcca accaaccacg   3540
              agaaaaacaa ccagcccaac agagaacccc cctgctcagc tgcccctctc agcccttcac   3600
              ttcaaaactc gccctgcttg gacaggtgtt tctggactcc tcttgattta aacacgcggc   3660
              cgctaatcag ccataccaca tttgtagagg ttttacttgc tttaaaaaac ctcccacacc   3720
<removed-apn>
              tccccctgaa cctgaaacat aaaatgaatg caattgttgt tgttaacttg tttattgcag   3780
              cttataatgg ttacaaataa agcaatagca tcacaaattt cacaaataaa gcattttttt   3840
              cactgcattc tagttgtggt ttgtccaaac tcatcaatgt atcttatcat gt           3892
              <210>   17
              <211>   6629
              <212>   DNA
              <213>   Artificial
              <220>
              <223>   Synthetic plasmid
              <400> 17
              aagcttatac tcgagctcta gattgggaac ccgggtctct cgaattcatg gtggtggtgg    60
              ctgctgctcc ttctgctgct acagctgctc ctaaggtgct gctgctgtct ggacagcctg    120
              cttctggagg aagagctctg cctctgatgg tgcctggacc tagagctgct ggatctgagg    180
              cttctggaac acctcaggct agaaagagac agagactgac acatctgtct cctgaagaaa    240
              aggctctgag aagaaagctg aagaatagag tggctgctca gacagctaga gatagaaaga    300
              aggctagaat gtctgaactg gaacagcagg tggtggatct ggaagaagaa aatcataagc    360
              tgcagctgga aaatcagctg ctgagagaaa agacacatgg actggtggtg gaaaatcagg    420
              aactgagaac aagactggga atggatacac tggatcctga tgaagtgcct gaagtggaag    480
              ctaagggatc tggagtgaga ctggtggctg gatctgctga atctgctgct ggagctggac    540
              ctgtggtgac atctcctgaa catctgccta tggattctga tacagtggct tcttctgatt    600
              ctgaatctga tatcctgctg ggaatcctgg ataagctgga tcctgtgatg ttttttaagt    660
              gtccttctcc tgaatctgct tctctggaag aactgcctga agtgtatcct gaaggacctt    720
              cttctctgcc tgcttctctg tctctgtctg tgggaacatc ttctgctaag ctggaagcta    780
              tcaatgaact gatcagattt gatcatgtgt atacaaagcc tctggtgctg gaaatccctt    840
              ctgaaacaga atctcagaca aatgtggtgg tgaagatcga agaagctcct ctgtcttctt    900
                                                  51

              ctgaagaaga tcatcctgaa tttatcgtgt ctgtgaagaa ggaacctctg gaagatgatt    960
<removed-date>
              ttatccctga actgggaatc tctaatctgc tgtcttcttc tcattgtctg agacctcctt   1020
              cttgtctgct ggatgctcat tctgattgtg gatatgaagg atctccttct cctttttctg   1080
              atatgtcttc tcctctggga acagatcatt cttgggaaga tacatttgct aatgaactgt   1140
              ttcctcagct gatctctgtg tgagcggccg ctaatcagcc ataccacatt tgtagaggtt   1200
              ttacttgctt taaaaaacct cccacacctc cccctgaacc tgaaacataa aatgaatgca   1260
<removed-apn>
              attgttgttg ttaacttgtt tattgcagct tataatggtt acaaataaag caatagcatc   1320
              acaaatttca caaataaagc atttttttca ctgcattcta gttgtggttt gtccaaactc   1380
              atcaatgtat cttatcatgt ctaccggtag ggcccctctc ttcatgtgag caaaaggcca   1440
              gcaaaaggcc aggaaccgta aaaaggccgc gttgctggcg tttttccata ggctccgccc   1500
              ccctgacgag catcacaaaa atcgacgctc aagtcagagg tggcgaaacc cgacaggact   1560
              ataaagatac caggcgtttc cccctggaag ctccctcgtg cgctctcctg ttccgaccct   1620
              gccgcttacc ggatacctgt ccgcctttct cccttcggga agcgtggcgc tttctcatag   1680
              ctcacgctgt aggtatctca gttcggtgta ggtcgttcgc tccaagctgg gctgtgtgca   1740
              cgaacccccc gttcagcccg accgctgcgc cttatccggt aactatcgtc ttgagtccaa   1800
              cccggtaaga cacgacttat cgccactggc agcagccact ggtaacagga ttagcagagc   1860
              gaggtatgta ggcggtgcta cagagttctt gaagtggtgg cctaactacg gctacactag   1920
              aaggacagta tttggtatct gcgctctgct gaagccagtt accttcggaa aaagagttgg   1980
              tagctcttga tccggcaaac aaaccaccgc tggtagcggt ggtttttttg tttgcaagca   2040
              gcagattacg cgcagaaaaa aaggatctca agaagatcct ttgatctttt ctacggggtc   2100
              tgacgctcag tggaacgaaa actcacgtta agggattttg gtcatgggcg cgcctcatac   2160
              tcctgcaggc atgagattat caaaaaggat cttcacctag atccttttaa attaaaaatg   2220
              aagttttaaa tcaatctaaa gtatatatga gtaaacttgg tctgacagtt accaatgctt   2280
              aatcagtgag gcacctatct cagcgatctg tctatttcgt tcatccatag ttgcctgact   2340
              ccccgtcgtg tagataacta cgatacggga gggcttacca tctggcccca gtgctgcaat   2400
              gataccgcga gacccacgct caccggctcc agatttatca gcaataaacc agccagccgg   2460
              aagggccgag cgcagaagtg gtcctgcaac tttatccgcc tccatccagt ctattaattg   2520
              ttgccgggaa gctagagtaa gtagttcgcc agttaatagt ttgcgcaacg ttgttgccat   2580
              tgctacaggc atcgtggtgt cacgctcgtc gtttggtatg gcttcattca gctccggttc   2640
                                                  52

              ccaacgatca aggcgagtta catgatcccc catgttgtgc aaaaaagcgg ttagctcctt   2700
<removed-date>
              cggtcctccg atcgttgtca gaagtaagtt ggccgcagtg ttatcactca tggttatggc   2760
              agcactgcat aattctctta ctgtcatgcc atccgtaaga tgcttttctg tgactggtga   2820
              gtactcaacc aagtcattct gagaatagtg tatgcggcga ccgagttgct cttgcccggc   2880
              gtcaatacgg gataataccg cgccacatag cagaacttta aaagtgctca tcattggaaa   2940
              acgttcttcg gggcgaaaac tctcaaggat cttaccgctg ttgagatcca gttcgatgta   3000
<removed-apn>
              acccactcgt gcacccaact gatcttcagc atcttttact ttcaccagcg tttctgggtg   3060
              agcaaaaaca ggaaggcaaa atgccgcaaa aaagggaata agggcgacac ggaaatgttg   3120
              aatactcata ctcttccttt ttcaatatta ttgaagcatt tatcagggtt attgtctcat   3180
              gagcggatac atatttgaat gtatttagaa aaataaacaa ataggggttc cgcgcacatt   3240
              tccccgaaaa gtgccacctg acgtcaggta ccaagcctag gcctccaaaa aagcctcctc   3300
              actacttctg gaatagctca gaggcagagg cggcctcggc ctctgcataa ataaaaaaaa   3360
              ttagtcagcc atggggcgga gaatgggcgg aactgggcgg agttaggggc gggatgggcg   3420
              gagttagggg cgggactatg gttgctgact aattgagatg catgctttgc atacttctgc   3480
              ctgctgggga gcctggggac tttccacacc tggttgctga ctaattgaga tgcatgcttt   3540
              gcatacttct gcctgctggg gagcctgggg actttccaca ccggatccac catggccaag   3600
              ttgaccagtg ccgttccggt gctcaccgcg cgcgacgtcg ccggagcggt cgagttctgg   3660
              accgaccggc tcgggttctc ccgggacttc gtggaggacg acttcgccgg tgtggtccgg   3720
              gacgacgtga ccctgttcat cagcgcggtc caggaccagg tggtgccgga caacaccctg   3780
              gcctgggtgt gggtgcgcgg cctggacgag ctgtacgccg agtggtcgga ggtcgtgtcc   3840
              acgaacttcc gggacgcctc cgggccggcc atgaccgaga tcggcgagca gccgtggggg   3900
              cgggagttcg ccctgcgcga cccggccggc aactgcgtgc acttcgtggc cgaggagcag   3960
              gactgaacgc gtgctgtaag tctgcagaaa ttgatgatct attaaacaat aaagatgtcc   4020
              actaaaatgg aagtttttcc tgtcatactt tgttaagaag ggtgagaaca gagtacctac   4080
              attttgaatg gaaggattgg agctacgggg gtgggggtgg ggtgggatta gataaatgcc   4140
              tgctctttac tgaaggctct ttactattgc tttatgataa tgtttcatag ttggatatca   4200
              taatttaaac aagcaaaacc aaattaaggg ccagctcatt cctcccactc atgatctatg   4260
              gatctataga tctctcgtgc agctggggct ctagggggta tccccacgcg ccctgtagcg   4320
              gcgcattaag cgcggcgggt gtggtggtta cgcgcagcgt gaccgctaca cttgccagcg   4380
                                                  53

              ccctagcgcc cgctcctttc gctttcttcc cttcctttct cgccacgttc gccggctttc   4440
<removed-date>
              cccgtcaagc tctaaatcgg gggctccctt tagggttccg atttagtgct ttacggcacc   4500
              tcgaccccaa aaaacttgat tagggtgatg gttcacgtag tgggccatcg ccctgataga   4560
              cggtttttcg ccctttgacg ttggagtcca cgttctttaa tagtggactc ttgttccaaa   4620
              ctggaacaac actcaaccct atctcggtct attcttttga tttataaggg attttgccga   4680
              tttcggccta ttggttaaaa aatgagctga tttaacaaaa atttaacgcg aattaattct   4740
<removed-apn>
              gtggaatgtg tgtcagttag tcgcgaggcc tccgcgccgg gttttggcgc ctcccgcggg   4800
              cgcccccctc ctcacggcga gcgctgccac gtcagacgaa gggcgcagcg agcgtcctga   4860
              tccttccgcc cggacgctca ggacagcggc ccgctgctca taagactcgg ccttagaacc   4920
              ccagtatcag cagaaggaca ttttaggacg ggacttgggt gactctaggg cactggtttt   4980
              ctttccagag agcggaacag gcgaggaaaa gtagtccctt ctcggcgatt ctgcggaggg   5040
              atctccgtgg ggcggtgaac gccgatgatt atataaggac gcgccgggtg tggcacagct   5100
              agttccgtcg cagccgggat ttgggtcgcg gttcttgttt gtggatcgct gtgatcgtca   5160
              cttggtgagt agcgggctgc tgggctggcc ggggctttcg tggccgccgg gccgctcggt   5220
              gggacggaag cgtgtggaga gaccgccaag ggctgtagtc tgggtccgcg agcaaggttg   5280
              ccctgaactg ggggttgggg ggagcgcagc aaaatggcgg ctgttcccga gtcttgaatg   5340
              gaagacgctt gtgaggcggg ctgtgaggtc gttgaaacaa ggtggggggc atggtgggcg   5400
              gcaagaaccc aaggtcttga ggccttcgct aatgcgggaa agctcttatt cgggtgagat   5460
              gggctggggc accatctggg gaccctgacg tgaagtttgt cactgactgg agaactcggt   5520
              ttgtcgtctg ttgcgggggc ggcagttatg gcggtgccgt tgggcagtgc acccgtacct   5580
              ttgggagcgc gcgccctcgt cgtgtcgtga cgtcacccgt tctgttggct tataatgcag   5640
              ggtggggcca cctgccggta ggtgtgcggt aggcttttct ccgtcgcagg acgcagggtt   5700
              cgggcctagg gtaggctctc ctgaatcgac aggcgccgga cctctggtga ggggagggat   5760
              aagtgaggcg tcagtttctt tggtcggttt tatgtaccta tcttcttaag tagctgaagc   5820
              tccggttttg aactatgcgc tcggggttgg cgagtgtgtt ttgtgaagtt ttttaggcac   5880
              cttttgaaat gtaatcattt gggtcaatat gtaattttca gtgttagact agtaaattgt   5940
              ccgctaaatt ctggccgttt ttggcttttt tgttagacgt cgaccgatcc tgagaacttc   6000
              agggtgagtt tggggaccct tgattgttct ttctttttcg ctattgtaaa attcatgtta   6060
              tatggagggg gcaaagtttt cagggtgttg tttagaatgg gaagatgtcc cttgtatcac   6120
                                                  54

              catggaccct catgataatt ttgtttcttt cactttctac tctgttgaca accattgtct   6180
<removed-date>
              cctcttattt tcttttcatt ttctgtaact ttttcgttaa actttagctt gcatttgtaa   6240
              cgaattttta aattcacttt tgtttatttg tcagattgta agtactttct ctaatcactt   6300
              ttttttcaag gcaatcaggg tatattatat tgtacttcag cacagtttta gagaacaatt   6360
              gttataatta aatgataagg tagaatattt ctgcatataa attctggctg gcgtggaaat   6420
              attcttattg gtagaaacaa ctacaccctg gtcatcatcc tgcctttctc tttatggtta   6480
<removed-apn>
              caatgatata cactgtttga gatgaggata aaatactctg agtccaaacc gggcccctct   6540
              gctaaccatg ttcatgcctt cttctctttc ctacagctcc tgggcaacgt gctggttgtt   6600
              gtgctgtctc atcattttgg caaagaatt                                     6629
              <210>   18
              <211>   3264
              <212>   DNA
              <213>   Artificial
              <220>
              <223>   Synthetic construct
              <400> 18
              ggcctccgcg ccgggttttg gcgcctcccg cgggcgcccc cctcctcacg gcgagcgctg    60
              ccacgtcaga cgaagggcgc agcgagcgtc ctgatccttc cgcccggacg ctcaggacag    120
              cggcccgctg ctcataagac tcggccttag aaccccagta tcagcagaag gacattttag    180
              gacgggactt gggtgactct agggcactgg ttttctttcc agagagcgga acaggcgagg    240
              aaaagtagtc ccttctcggc gattctgcgg agggatctcc gtggggcggt gaacgccgat    300
              gattatataa ggacgcgccg ggtgtggcac agctagttcc gtcgcagccg ggatttgggt    360
              cgcggttctt gtttgtggat cgctgtgatc gtcacttggt gagtagcggg ctgctgggct    420
              ggccggggct ttcgtggccg ccgggccgct cggtgggacg gaagcgtgtg gagagaccgc    480
              caagggctgt agtctgggtc cgcgagcaag gttgccctga actgggggtt ggggggagcg    540
              cagcaaaatg gcggctgttc ccgagtcttg aatggaagac gcttgtgagg cgggctgtga    600
              ggtcgttgaa acaaggtggg gggcatggtg ggcggcaaga acccaaggtc ttgaggcctt    660
              cgctaatgcg ggaaagctct tattcgggtg agatgggctg gggcaccatc tggggaccct    720
              gacgtgaagt ttgtcactga ctggagaact cggtttgtcg tctgttgcgg gggcggcagt    780
              tatggcggtg ccgttgggca gtgcacccgt acctttggga gcgcgcgccc tcgtcgtgtc    840
              gtgacgtcac ccgttctgtt ggcttataat gcagggtggg gccacctgcc ggtaggtgtg    900
                                                  55

              cggtaggctt ttctccgtcg caggacgcag ggttcgggcc tagggtaggc tctcctgaat    960
<removed-date>
              cgacaggcgc cggacctctg gtgaggggag ggataagtga ggcgtcagtt tctttggtcg   1020
              gttttatgta cctatcttct taagtagctg aagctccggt tttgaactat gcgctcgggg   1080
              ttggcgagtg tgttttgtga agttttttag gcaccttttg aaatgtaatc atttgggtca   1140
              atatgtaatt ttcagtgtta gactagtaaa ttgtccgcta aattctggcc gtttttggct   1200
              tttttgttag acgtcgaccg atcctgagaa cttcagggtg agtttgggga cccttgattg   1260
<removed-apn>
              ttctttcttt ttcgctattg taaaattcat gttatatgga gggggcaaag ttttcagggt   1320
              gttgtttaga atgggaagat gtcccttgta tcaccatgga ccctcatgat aattttgttt   1380
              ctttcacttt ctactctgtt gacaaccatt gtctcctctt attttctttt cattttctgt   1440
              aactttttcg ttaaacttta gcttgcattt gtaacgaatt tttaaattca cttttgttta   1500
              tttgtcagat tgtaagtact ttctctaatc actttttttt caaggcaatc agggtatatt   1560
              atattgtact tcagcacagt tttagagaac aattgttata attaaatgat aaggtagaat   1620
              atttctgcat ataaattctg gctggcgtgg aaatattctt attggtagaa acaactacac   1680
              cctggtcatc atcctgcctt tctctttatg gttacaatga tatacactgt ttgagatgag   1740
              gataaaatac tctgagtcca aaccgggccc ctctgctaac catgttcatg ccttcttctc   1800
              tttcctacag ctcctgggca acgtgctggt tgttgtgctg tctcatcatt ttggcaaaga   1860
              attaagctta tactcgagct ctagattggg aacccgggtc tctcgaattc atggtggtgg   1920
              tggctgctgc tccttctgct gctacagctg ctcctaaggt gctgctgctg tctggacagc   1980
              ctgcttctgg aggaagagct ctgcctctga tggtgcctgg acctagagct gctggatctg   2040
              aggcttctgg aacacctcag gctagaaaga gacagagact gacacatctg tctcctgaag   2100
              aaaaggctct gagaagaaag ctgaagaata gagtggctgc tcagacagct agagatagaa   2160
              agaaggctag aatgtctgaa ctggaacagc aggtggtgga tctggaagaa gaaaatcata   2220
              agctgcagct ggaaaatcag ctgctgagag aaaagacaca tggactggtg gtggaaaatc   2280
              aggaactgag aacaagactg ggaatggata cactggatcc tgatgaagtg cctgaagtgg   2340
              aagctaaggg atctggagtg agactggtgg ctggatctgc tgaatctgct gctggagctg   2400
              gacctgtggt gacatctcct gaacatctgc ctatggattc tgatacagtg gcttcttctg   2460
              attctgaatc tgatatcctg ctgggaatcc tggataagct ggatcctgtg atgtttttta   2520
              agtgtccttc tcctgaatct gcttctctgg aagaactgcc tgaagtgtat cctgaaggac   2580
              cttcttctct gcctgcttct ctgtctctgt ctgtgggaac atcttctgct aagctggaag   2640
                                                  56

              ctatcaatga actgatcaga tttgatcatg tgtatacaaa gcctctggtg ctggaaatcc   2700
<removed-date>
              cttctgaaac agaatctcag acaaatgtgg tggtgaagat cgaagaagct cctctgtctt   2760
              cttctgaaga agatcatcct gaatttatcg tgtctgtgaa gaaggaacct ctggaagatg   2820
              attttatccc tgaactggga atctctaatc tgctgtcttc ttctcattgt ctgagacctc   2880
              cttcttgtct gctggatgct cattctgatt gtggatatga aggatctcct tctccttttt   2940
              ctgatatgtc ttctcctctg ggaacagatc attcttggga agatacattt gctaatgaac   3000
<removed-apn>
              tgtttcctca gctgatctct gtgtgagcgg ccgctaatca gccataccac atttgtagag   3060
              gttttacttg ctttaaaaaa cctcccacac ctccccctga acctgaaaca taaaatgaat   3120
              gcaattgttg ttgttaactt gtttattgca gcttataatg gttacaaata aagcaatagc   3180
              atcacaaatt tcacaaataa agcatttttt tcactgcatt ctagttgtgg tttgtccaaa   3240
              ctcatcaatg tatcttatca tgtc                                          3264
              <210>   19
              <211>   447
              <212>   PRT
              <213>   Homo sapiens
              <400>   19
              Glu Val Gln Val Leu Glu Ser Gly Gly Asp Leu Val Gln Pro Gly Gly
              1               5                   10                  15
              Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ala Tyr
                          20                  25                  30
              Ala Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
                      35                  40                  45
              Ser Ala Ile Ser Gly Ser Gly Gly Ser Ala Tyr Tyr Ala Asp Ser Val
                  50                  55                  60
              Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Val Tyr
              65                  70                  75                  80
              Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                              85                  90                  95
              Ala Lys Asp Gly Ala Trp Lys Met Ser Gly Leu Asp Val Trp Gly Gln
                          100                 105                 110
                                                  57

              Gly Thr Thr Val Ile Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
<removed-date>
                      115                 120                 125
              Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser Thr Ala Ala
                  130                 135                 140
              Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
              145                 150                 155                 160
<removed-apn>
              Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
                              165                 170                 175
              Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
                          180                 185                 190
              Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val Asp His Lys
                      195                 200                 205
              Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys Tyr Gly Pro
                  210                 215                 220
              Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly Pro Ser Val
              225                 230                 235                 240
              Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
                              245                 250                 255
              Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asp Pro Glu
                          260                 265                 270
              Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys
                      275                 280                 285
              Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser
                  290                 295                 300
              Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys
              305                 310                 315                 320
              Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu Lys Thr Ile
                              325                 330                 335
              Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro
                          340                 345                 350
                                                  58

<removed-date>
              Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu
                      355                 360                 365
              Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn
                  370                 375                 380
              Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser
<removed-apn>
              385                 390                 395                 400
              Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp Lys Ser Arg
                              405                 410                 415
              Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu
                          420                 425                 430
              His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu Gly Lys
                      435                 440                 445
              <210>   20
              <211>   110
              <212>   PRT
              <213>   Homo sapiens
              <400>   20
              Glu Ser Gly Gly Asp Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser
              1               5                   10                  15
              Cys Ala Ala Ser Gly Phe Thr Phe Ser Ala Tyr Ala Met Thr Trp Val
                          20                  25                  30
              Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser Ala Ile Ser Gly
                      35                  40                  45
              Ser Gly Gly Ser Ala Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr
                  50                  55                  60
              Ile Ser Arg Asp Asn Ser Lys Asn Thr Val Tyr Leu Gln Met Asn Ser
              65                  70                  75                  80
              Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Lys Asp Gly Ala
                              85                  90                  95
              Trp Lys Met Ser Gly Leu Asp Val Trp Gly Gln Gly Thr Thr
                                                  59

                           100               105                  110
<removed-date>
              <210>   21
              <211>   214
              <212>   PRT
              <213>   Homo sapiens
              <400>   21
              Asp Ile Gln Met Thr Gln Ser Pro Ala Ser Leu Ser Ala Ser Val Gly
<removed-apn>
              1               5                   10                  15
              Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Ile Ser Asp Tyr
                          20                  25                  30
              Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ile Pro Arg Leu Leu Ile
                      35                  40                  45
              Tyr Thr Thr Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Arg Gly
                  50                  55                  60
              Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
              65                  70                  75                  80
              Glu Asp Val Ala Thr Tyr Tyr Cys Gln Lys Tyr Asp Ser Ala Pro Leu
                              85                  90                  95
              Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
                          100                 105                 110
              Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
                      115                 120                 125
              Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
                  130                 135                 140
              Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
              145                 150                 155                 160
              Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
                              165                 170                 175
              Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
                          180                 185                 190
                                                   60

              Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
<removed-date>
                      195                 200                 205
              Phe Asn Arg Gly Glu Cys
                  210
              <210>   22
              <211>   100
              <212>   PRT
<removed-apn>
              <213>   Homo sapiens
              <400>   22
              Gln Ser Pro Ala Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile
              1               5                   10                  15
              Thr Cys Arg Ala Ser Gln Asp Ile Ser Asp Tyr Leu Ala Trp Tyr Gln
                          20                  25                  30
              Gln Lys Pro Gly Lys Ile Pro Arg Leu Leu Ile Tyr Thr Thr Ser Thr
                      35                  40                  45
              Leu Gln Ser Gly Val Pro Ser Arg Phe Arg Gly Ser Gly Ser Gly Thr
                  50                  55                  60
              Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Val Ala Thr
              65                  70                  75                  80
              Tyr Tyr Cys Gln Lys Tyr Asp Ser Ala Pro Leu Thr Phe Gly Gly Gly
                              85                  90                  95
              Thr Lys Val Glu
                          100
              <210>   23
              <211>   2971
              <212>   DNA
              <213>   Artificial
              <220>
              <223>   Synthetic construct
              <400> 23
              tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata tggagttccg   60
              cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc cccgcccatt   120
              gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc attgacgtca   180
                                                  61

              atgggtggag tatttacggt aaactgccca cttggcagta catcaagtgt atcatatgcc    240
<removed-date>
              aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt atgcccagta    300
              catgacctta tgggactttc ctacttggca gtacatctac gtattagtca tcgctattac    360
              catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg actcacgggg    420
              atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc aaaatcaacg    480
              ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg gtaggcgtgt    540
<removed-apn>
              acggtgggag gtctatataa gcagagctca tgatagaagc actctactat tcgtcgaccg    600
              atcctgagaa cttcagggtg agtttgggga cccttgattg ttctttcttt ttcgctattg    660
              taaaattcat gttatatgga gggggcaaag ttttcagggt gttgtttaga atgggaagat    720
              gtcccttgta tcaccatgga ccctcatgat aattttgttt ctttcacttt ctactctgtt    780
              gacaaccatt gtctcctctt attttctttt cattttctgt aactttttcg ttaaacttta    840
              gcttgcattt gtaacgaatt tttaaattca cttttgttta tttgtcagat tgtaagtact    900
              ttctctaatc actttttttt caaggcaatc agggtatatt atattgtact tcagcacagt    960
              tttagagaac aattgttata attaaatgat aaggtagaat atttctgcat ataaattctg   1020
              gctggcgtgg aaatattctt attggtagaa acaactacac cctggtcatc atcctgcctt   1080
              tctctttatg gttacaatga tatacactgt ttgagatgag gataaaatac tctgagtcca   1140
              aaccgggccc ctctgctaac catgttcatg ccttcttctc tttcctacag ctcctgggca   1200
              acgtgctggt tgttgtgctg tctcatcatt ttggcaaaga attaagctta tactcgagct   1260
              ctagattggg aacccgggtc tctcgaattc gagatctcca ccatgcacag acctagacgt   1320
              cgtggaactc gtccacctcc actggcactg ctcgctgctc tcctcctggc tgcacgtggt   1380
              gctgatgcag aggtgcaggt gttggagtct gggggagact tggtacagcc tggggggtcc   1440
              ctgagactct cctgtgcagc ctctggattc acctttagtg cctatgccat gacctgggtc   1500
              cgccaggctc cagggaaggg gctggagtgg gtctcagcta ttagtggtag tggtggtagc   1560
              gcatactacg cagactccgt gaagggccgg ttcaccatct ccagagacaa ttccaagaac   1620
              acggtatatc tgcagatgaa cagcctgaga gccgaggaca cggccgtata ttactgtgcg   1680
              aaagatgggg cctggaaaat gtccggtttg gacgtctggg gccaagggac cacggtcatc   1740
              gtctcctcag cctccaccaa gggcccatcg gtcttccccc tggcgccctg ctccaggagc   1800
              acctccgaga gcacagccgc cctgggctgc ctggtcaagg actacttccc cgaaccggtg   1860
              acggtgtcgt ggaactcagg cgccctgacc agcggcgtgc acaccttccc ggctgtccta   1920
                                                  62

              cagtcctcag gactctactc cctcagcagc gtggtgaccg tgccctccag cagcttgggc   1980
<removed-date>
              acgaagacct acacctgcaa cgtagatcac aagcccagca acaccaaggt ggacaagaga   2040
              gttgagtcca aatatggtcc cccatgccca ccctgcccag cacctgagtt cctgggggga   2100
              ccatcagtct tcctgttccc cccaaaaccc aaggacactc tcatgatctc ccggacccct   2160
              gaggtcacgt gcgtggtggt ggacgtgagc caggaagacc ccgaggtcca gttcaactgg   2220
              tacgtggatg gcgtggaggt gcataatgcc aagacaaagc cgcgggagga gcagttcaac   2280
<removed-apn>
              agcacgtacc gtgtggtcag cgtcctcacc gtcctgcacc aggactggct gaacggcaag   2340
              gagtacaagt gcaaggtctc caacaaaggc ctcccgtcct ccatcgagaa aaccatctcc   2400
              aaagccaaag ggcagccccg agagccacag gtgtacaccc tgcccccatc ccaggaggag   2460
              atgaccaaga accaggtcag cctgacctgc ctggtcaaag gcttctaccc cagcgacatc   2520
              gccgtggagt gggagagcaa tgggcagccg gagaacaact acaagaccac gcctcccgtg   2580
              ctggactccg acggctcctt cttcctctac agcaggctca ccgtggacaa gagcaggtgg   2640
              caggagggga atgtcttctc atgctccgtg atgcatgagg ctctgcacaa ccactacaca   2700
              cagaagtccc tctccctgtc tctgggtaaa tgagcggccg ctaatcagcc ataccacatt   2760
              tgtagaggtt ttacttgctt taaaaaacct cccacacctc cccctgaacc tgaaacataa   2820
              aatgaatgca attgttgttg ttaacttgtt tattgcagct tataatggtt acaaataaag   2880
              caatagcatc acaaatttca caaataaagc atttttttca ctgcattcta gttgtggttt   2940
              gtccaaactc atcaatgtat cttatcatgt c                                  2971
              <210>   24
              <211>   7013
              <212>   DNA
              <213>   Artificial
              <220>
              <223>   Synthetic plasmid
              <400> 24
              tcgcgatgtg tgactagtta gttattaata gtaatcaatt acggggtcat tagttcatag    60
              cccatatatg gagttccgcg ttacataact tacggtaaat ggcccgcctg gctgaccgcc    120
              caacgacccc cgcccattga cgtcaataat gacgtatgtt cccatagtaa cgccaatagg    180
              gactttccat tgacgtcaat gggtggagta tttacggtaa actgcccact tggcagtaca    240
              tcaagtgtat catatgccaa gtacgccccc tattgacgtc aatgacggta aatggcccgc    300
              ctggcattat gcccagtaca tgaccttatg ggactttcct acttggcagt acatctacgt    360
                                                   63

              attagtcatc gctattacca tggtgatgcg gttttggcag tacatcaatg ggcgtggata    420
<removed-date>
              gcggtttgac tcacggggat ttccaagtct ccaccccatt gacgtcaatg ggagtttgtt    480
              ttggcaccaa aatcaacggg actttccaaa atgtcgtaac aactccgccc cattgacgca    540
              aatgggcggt aggcgtgtac ggtgggaggt ctatataagc agagctcatg atagaagcac    600
              tctactattc gtcgaccgat cctgagaact tcagggtgag tttggggacc cttgattgtt    660
              ctttcttttt cgctattgta aaattcatgt tatatggagg gggcaaagtt ttcagggtgt    720
<removed-apn>
              tgtttagaat gggaagatgt cccttgtatc accatggacc ctcatgataa ttttgtttct    780
              ttcactttct actctgttga caaccattgt ctcctcttat tttcttttca ttttctgtaa    840
              ctttttcgtt aaactttagc ttgcatttgt aacgaatttt taaattcact tttgtttatt    900
              tgtcagattg taagtacttt ctctaatcac ttttttttca aggcaatcag ggtatattat    960
              attgtacttc agcacagttt tagagaacaa ttgttataat taaatgataa ggtagaatat   1020
              ttctgcatat aaattctggc tggcgtggaa atattcttat tggtagaaac aactacaccc   1080
              tggtcatcat cctgcctttc tctttatggt tacaatgata tacactgttt gagatgagga   1140
              taaaatactc tgagtccaaa ccgggcccct ctgctaacca tgttcatgcc ttcttctctt   1200
              tcctacagct cctgggcaac gtgctggttg ttgtgctgtc tcatcatttt ggcaaagaat   1260
              taagcttata ctcgagctct agattgggaa cccgggtctc tcgaattcga gatctccacc   1320
              atgcacagac ctagacgtcg tggaactcgt ccacctccac tggcactgct cgctgctctc   1380
              ctcctggctg cacgtggtgc tgatgcagag gtgcaggtgt tggagtctgg gggagacttg   1440
              gtacagcctg gggggtccct gagactctcc tgtgcagcct ctggattcac ctttagtgcc   1500
              tatgccatga cctgggtccg ccaggctcca gggaaggggc tggagtgggt ctcagctatt   1560
              agtggtagtg gtggtagcgc atactacgca gactccgtga agggccggtt caccatctcc   1620
              agagacaatt ccaagaacac ggtatatctg cagatgaaca gcctgagagc cgaggacacg   1680
              gccgtatatt actgtgcgaa agatggggcc tggaaaatgt ccggtttgga cgtctggggc   1740
              caagggacca cggtcatcgt ctcctcagcc tccaccaagg gcccatcggt cttccccctg   1800
              gcgccctgct ccaggagcac ctccgagagc acagccgccc tgggctgcct ggtcaaggac   1860
              tacttccccg aaccggtgac ggtgtcgtgg aactcaggcg ccctgaccag cggcgtgcac   1920
              accttcccgg ctgtcctaca gtcctcagga ctctactccc tcagcagcgt ggtgaccgtg   1980
              ccctccagca gcttgggcac gaagacctac acctgcaacg tagatcacaa gcccagcaac   2040
              accaaggtgg acaagagagt tgagtccaaa tatggtcccc catgcccacc ctgcccagca   2100
                                                  64

              cctgagttcc tggggggacc atcagtcttc ctgttccccc caaaacccaa ggacactctc   2160
<removed-date>
              atgatctccc ggacccctga ggtcacgtgc gtggtggtgg acgtgagcca ggaagacccc   2220
              gaggtccagt tcaactggta cgtggatggc gtggaggtgc ataatgccaa gacaaagccg   2280
              cgggaggagc agttcaacag cacgtaccgt gtggtcagcg tcctcaccgt cctgcaccag   2340
              gactggctga acggcaagga gtacaagtgc aaggtctcca acaaaggcct cccgtcctcc   2400
              atcgagaaaa ccatctccaa agccaaaggg cagccccgag agccacaggt gtacaccctg   2460
<removed-apn>
              cccccatccc aggaggagat gaccaagaac caggtcagcc tgacctgcct ggtcaaaggc   2520
              ttctacccca gcgacatcgc cgtggagtgg gagagcaatg ggcagccgga gaacaactac   2580
              aagaccacgc ctcccgtgct ggactccgac ggctccttct tcctctacag caggctcacc   2640
              gtggacaaga gcaggtggca ggaggggaat gtcttctcat gctccgtgat gcatgaggct   2700
              ctgcacaacc actacacaca gaagtccctc tccctgtctc tgggtaaatg agcggccgct   2760
              aatcagccat accacatttg tagaggtttt acttgcttta aaaaacctcc cacacctccc   2820
              cctgaacctg aaacataaaa tgaatgcaat tgttgttgtt aacttgttta ttgcagctta   2880
              taatggttac aaataaagca atagcatcac aaatttcaca aataaagcat ttttttcact   2940
              gcattctagt tgtggtttgt ccaaactcat caatgtatct tatcatgtct accggtcctg   3000
              cagggcccct ctcttcatgt gagcaaaagg ccagcaaaag gccaggaacc gtaaaaaggc   3060
              cgcgttgctg gcgtttttcc ataggctccg cccccctgac gagcatcaca aaaatcgacg   3120
              ctcaagtcag aggtggcgaa acccgacagg actataaaga taccaggcgt ttccccctgg   3180
              aagctccctc gtgcgctctc ctgttccgac cctgccgctt accggatacc tgtccgcctt   3240
              tctcccttcg ggaagcgtgg cgctttctca atgctcacgc tgtaggtatc tcagttcggt   3300
              gtaggtcgtt cgctccaagc tgggctgtgt gcacgaaccc cccgttcagc ccgaccgctg   3360
              cgccttatcc ggtaactatc gtcttgagtc caacccggta agacacgact tatcgccact   3420
              ggcagcagcc actggtaaca ggattagcag agcgaggtat gtaggcggtg ctacagagtt   3480
              cttgaagtgg tggcctaact acggctacac tagaaggaca gtatttggta tctgcgctct   3540
              gctgaagcca gttaccttcg gaaaaagagt tggtagctct tgatccggca aacaaaccac   3600
              cgctggtagc ggtggttttt ttgtttgcaa gcagcagatt acgcgcagaa aaaaaggatc   3660
              tcaagaagat cctttgatct tttctacggg gtctgacgct cagtggaacg aaaactcacg   3720
              ttaagggatt ttggtcatgg gcgcgcctca tactcctgca ggcatgagat tatcaaaaag   3780
              gatcttcacc tagatccttt taaattaaaa atgaagtttt aaatcaatct aaagtatata   3840
                                                  65

              tgagtaaact tggtctgaca gttaccaatg cttaatcagt gaggcaccta tctcagcgat   3900
<removed-date>
              ctgtctattt cgttcatcca tagttgcctg actccccgtc gtgtagataa ctacgatacg   3960
              ggagggctta ccatctggcc ccagtgctgc aatgataccg cgagacccac gctcaccggc   4020
              tccagattta tcagcaataa accagccagc cggaagggcc gagcgcagaa gtggtcctgc   4080
              aactttatcc gcctccatcc agtctattaa ttgttgccgg gaagctagag taagtagttc   4140
              gccagttaat agtttgcgca acgttgttgc cattgctaca ggcatcgtgg tgtcacgctc   4200
<removed-apn>
              gtcgtttggt atggcttcat tcagctccgg ttcccaacga tcaaggcgag ttacatgatc   4260
              ccccatgttg tgcaaaaaag cggttagctc cttcggtcct ccgatcgttg tcagaagtaa   4320
              gttggccgca gtgttatcac tcatggttat ggcagcactg cataattctc ttactgtcat   4380
              gccatccgta agatgctttt ctgtgactgg tgagtactca accaagtcat tctgagaata   4440
              gtgtatgcgg cgaccgagtt gctcttgccc ggcgtcaata cgggataata ccgcgccaca   4500
              tagcagaact ttaaaagtgc tcatcattgg aaaacgttct tcggggcgaa aactctcaag   4560
              gatcttaccg ctgttgagat ccagttcgat gtaacccact cgtgcaccca actgatcttc   4620
              agcatctttt actttcacca gcgtttctgg gtgagcaaaa acaggaaggc aaaatgccgc   4680
              aaaaaaggga ataagggcga cacggaaatg ttgaatactc atactcttcc tttttcaata   4740
              ttattgaagc atttatcagg gttattgtct catgagcgga tacatatttg aatgtattta   4800
              gaaaaataaa caaatagggg ttccgcgcac atttccccga aaagtgccac ctgacgtcag   4860
              gtaccaagcc taggcctcca aaaaagcctc ctcactactt ctggaatagc tcagaggcag   4920
              aggcggcctc ggcctctgca taaataaaaa aaattagtca gccatggggc ggagaatggg   4980
              cggaactggg cggagttagg ggcgggatgg gcggagttag gggcgggact atggttgctg   5040
              actaattgag atgcatgctt tgcatacttc tgcctgctgg ggagcctggg gactttccac   5100
              acctggttgc tgactaattg agatgcatgc tttgcatact tctgcctgct ggggagcctg   5160
              gggactttcc acaccggatc caccatggat agatccggaa agcctgaact caccgcgacg   5220
              tctgtcgaga agtttctgat cgaaaagttc gacagcgtct ccgacctgat gcagctctcg   5280
              gagggcgaag aatctcgtgc tttcagcttc gatgtaggag ggcgtggata tgtcctgcgg   5340
              gtaaatagct gcgccgatgg tttctacaaa gatcgttatg tttatcggca ctttgcatcg   5400
              gccgcgctcc cgattccgga agtgcttgac attggggagt tcagcgagag cctgacctat   5460
              tgcatctccc gccgtgcaca gggtgtcacg ttgcaagacc tgcctgaaac cgaactgccc   5520
              gctgttctgc agccggtcgc ggaggccatg gatgcgatcg ctgcggccga tcttagccag   5580
                                                  66

              acgagcgggt tcggcccatt cggaccgcaa ggaatcggtc aatacactac atggcgtgat   5640
<removed-date>
              ttcatatgcg cgattgctga tccccatgtg tatcactggc aaactgtgat ggacgacacc   5700
              gtcagtgcgt ccgtcgcgca ggctctcgat gagctgatgc tttgggccga ggactgcccc   5760
              gaagtccggc acctcgtgca cgcggatttc ggctccaaca atgtcctgac ggacaatggc   5820
              cgcataacag cggtcattga ctggagcgag gcgatgttcg gggattccca atacgaggtc   5880
              gccaacatct tcttctggag gccgtggttg gcttgtatgg agcagcagac gcgctacttc   5940
<removed-apn>
              gagcggaggc atccggagct tgcaggatcg ccgcggctcc gggcgtatat gctccgcatt   6000
              ggtcttgacc aactctatca gagcttggtt gacggcaatt tcgatgatgc agcttgggcg   6060
              cagggtcgat gcgacgcaat cgtccgatcc ggagccggga ctgtcgggcg tacacaaatc   6120
              gcccgcagaa gcgcggccgt ctggaccgat ggctgtgtag aagtactcgc cgatagtgga   6180
              aaccgacgcc ccagcactcg tccgagggca aaggaataga cgcgtgctgt aagtctgcag   6240
              aaattgatga tctattaaac aataaagatg tccactaaaa tggaagtttt tcctgtcata   6300
              ctttgttaag aagggtgaga acagagtacc tacattttga atggaaggat tggagctacg   6360
              ggggtggggg tggggtggga ttagataaat gcctgctctt tactgaaggc tctttactat   6420
              tgctttatga taatgtttca tagttggata tcataattta aacaagcaaa accaaattaa   6480
              gggccagctc attcctccca ctcatgatct atggatctat agatctctcg tgcagctggg   6540
              gctctagggg gtatccccac gcgccctgta gcggcgcatt aagcgcggcg ggtgtggtgg   6600
              ttacgcgcag cgtgaccgct acacttgcca gcgccctagc gcccgctcct ttcgctttct   6660
              tcccttcctt tctcgccacg ttcgccggct ttccccgtca agctctaaat cgggggctcc   6720
              ctttagggtt ccgatttagt gctttacggc acctcgaccc caaaaaactt gattagggtg   6780
              atggttcacg tagtgggcca tcgccctgat agacggtttt tcgccctttg acgttggagt   6840
              ccacgttctt taatagtgga ctcttgttcc aaactggaac aacactcaac cctatctcgg   6900
              tctattcttt tgatttataa gggattttgc cgatttcggc ctattggtta aaaaatgagc   6960
              tgatttaaca aaaatttaac gcgaattaat tctgtggaat gtgtgtcagt tag          7013
              <210>   25
              <211>   2272
              <212>   DNA
              <213>   Artificial
              <220>
              <223>   Synthetic construct
              <400>   25
                                                  67

              tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata tggagttccg    60
<removed-date>
              cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc cccgcccatt    120
              gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc attgacgtca    180
              atgggtggag tatttacggt aaactgccca cttggcagta catcaagtgt atcatatgcc    240
              aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt atgcccagta    300
              catgacctta tgggactttc ctacttggca gtacatctac gtattagtca tcgctattac    360
<removed-apn>
              catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg actcacgggg    420
              atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc aaaatcaacg    480
              ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg gtaggcgtgt    540
              acggtgggag gtctatataa gcagagctca tgatagaagc actctactat tcgtcgaccg    600
              atcctgagaa cttcagggtg agtttgggga cccttgattg ttctttcttt ttcgctattg    660
              taaaattcat gttatatgga gggggcaaag ttttcagggt gttgtttaga atgggaagat    720
              gtcccttgta tcaccatgga ccctcatgat aattttgttt ctttcacttt ctactctgtt    780
              gacaaccatt gtctcctctt attttctttt cattttctgt aactttttcg ttaaacttta    840
              gcttgcattt gtaacgaatt tttaaattca cttttgttta tttgtcagat tgtaagtact    900
              ttctctaatc actttttttt caaggcaatc agggtatatt atattgtact tcagcacagt    960
              tttagagaac aattgttata attaaatgat aaggtagaat atttctgcat ataaattctg   1020
              gctggcgtgg aaatattctt attggtagaa acaactacac cctggtcatc atcctgcctt   1080
              tctctttatg gttacaatga tatacactgt ttgagatgag gataaaatac tctgagtcca   1140
              aaccgggccc ctctgctaac catgttcatg ccttcttctc tttcctacag ctcctgggca   1200
              acgtgctggt tgttgtgctg tctcatcatt ttggcaaaga attaagctta tactcgagct   1260
              ctagattggg aacccgggtc tctcgaattc gagatctcca ccatgcacag acctagacgt   1320
              cgtggaactc gtccacctcc actggcactg ctcgctgctc tcctcctggc tgcacgtggt   1380
              gctgatgcag acatccagat gacccagtct ccagcctccc tgtctgcatc tgttggagac   1440
              agagtcacca tcacttgtcg ggcgagtcag gacattagcg attatttagc ctggtatcag   1500
              cagaaaccag ggaaaattcc taggctcctg atctatacta catccacttt gcaatcaggg   1560
              gtcccatctc ggttccgtgg cagtgggtct gggacagatt tcactctcac catcagcagc   1620
              ctgcagcctg aagatgttgc aacttattac tgtcagaagt atgacagtgc cccgctcact   1680
              ttcggcggag ggaccaaggt ggagatcaaa cgaactgtgg ctgcaccatc tgtcttcatc   1740
                                                  68

              ttcccgccat ctgatgagca gttgaaatct ggaactgcct ctgttgtgtg cctgctgaat   1800
<removed-date>
              aacttctatc ccagagaggc caaagtacag tggaaggtgg ataacgccct ccaatcgggt   1860
              aactcccagg agagtgtcac agagcaggac agcaaggaca gcacctacag cctcagcagc   1920
              accctgacgc tgagcaaagc agactacgag aaacacaaag tctacgcctg cgaagtcacc   1980
              catcagggcc tgagctcgcc cgtcacaaag agcttcaaca ggggagagtg ttaggcggcc   2040
              gctaatcagc cataccacat ttgtagaggt tttacttgct ttaaaaaacc tcccacacct   2100
<removed-apn>
              ccccctgaac ctgaaacata aaatgaatgc aattgttgtt gttaacttgt ttattgcagc   2160
              ttataatggt tacaaataaa gcaatagcat cacaaatttc acaaataaag catttttttc   2220
              actgcattct agttgtggtt tgtccaaact catcaatgta tcttatcatg tc           2272
              <210>   26
              <211>   6335
              <212>   DNA
              <213>   Artificial
              <220>
              <223>   Synthetic plasmid
              <400> 26
              tcgagctcta gattgggaac ccgggtctct cgaattcgag atctccacca tgcacagacc    60
              tagacgtcgt ggaactcgtc cacctccact ggcactgctc gctgctctcc tcctggctgc    120
              acgtggtgct gatgcagaca tccagatgac ccagtctcca gcctccctgt ctgcatctgt    180
              tggagacaga gtcaccatca cttgtcgggc gagtcaggac attagcgatt atttagcctg    240
              gtatcagcag aaaccaggga aaattcctag gctcctgatc tatactacat ccactttgca    300
              atcaggggtc ccatctcggt tccgtggcag tgggtctggg acagatttca ctctcaccat    360
              cagcagcctg cagcctgaag atgttgcaac ttattactgt cagaagtatg acagtgcccc    420
              gctcactttc ggcggaggga ccaaggtgga gatcaaacga actgtggctg caccatctgt    480
              cttcatcttc ccgccatctg atgagcagtt gaaatctgga actgcctctg ttgtgtgcct    540
              gctgaataac ttctatccca gagaggccaa agtacagtgg aaggtggata acgccctcca    600
              atcgggtaac tcccaggaga gtgtcacaga gcaggacagc aaggacagca cctacagcct    660
              cagcagcacc ctgacgctga gcaaagcaga ctacgagaaa cacaaagtct acgcctgcga    720
              agtcacccat cagggcctga gctcgcccgt cacaaagagc ttcaacaggg gagagtgtta    780
              ggcggccgct aatcagccat accacatttg tagaggtttt acttgcttta aaaaacctcc    840
              cacacctccc cctgaacctg aaacataaaa tgaatgcaat tgttgttgtt aacttgttta    900
                                                  69

              ttgcagctta taatggttac aaataaagca atagcatcac aaatttcaca aataaagcat    960
<removed-date>
              ttttttcact gcattctagt tgtggtttgt ccaaactcat caatgtatct tatcatgtct   1020
              accggtaggg cccctctctt catgtgagca aaaggccagc aaaaggccag gaaccgtaaa   1080
              aaggccgcgt tgctggcgtt tttccatagg ctccgccccc ctgacgagca tcacaaaaat   1140
              cgacgctcaa gtcagaggtg gcgaaacccg acaggactat aaagatacca ggcgtttccc   1200
              cctggaagct ccctcgtgcg ctctcctgtt ccgaccctgc cgcttaccgg atacctgtcc   1260
<removed-apn>
              gcctttctcc cttcgggaag cgtggcgctt tctcaatgct cacgctgtag gtatctcagt   1320
              tcggtgtagg tcgttcgctc caagctgggc tgtgtgcacg aaccccccgt tcagcccgac   1380
              cgctgcgcct tatccggtaa ctatcgtctt gagtccaacc cggtaagaca cgacttatcg   1440
              ccactggcag cagccactgg taacaggatt agcagagcga ggtatgtagg cggtgctaca   1500
              gagttcttga agtggtggcc taactacggc tacactagaa ggacagtatt tggtatctgc   1560
              gctctgctga agccagttac cttcggaaaa agagttggta gctcttgatc cggcaaacaa   1620
              accaccgctg gtagcggtgg tttttttgtt tgcaagcagc agattacgcg cagaaaaaaa   1680
              ggatctcaag aagatccttt gatcttttct acggggtctg acgctcagtg gaacgaaaac   1740
              tcacgttaag ggattttggt catgggcgcg ggcatgagat tatcaaaaag gatcttcacc   1800
              tagatccttt taaattaaaa atgaagtttt aaatcaatct aaagtatata tgagtaaact   1860
              tggtctgaca gttaccaatg cttaatcagt gaggcaccta tctcagcgat ctgtctattt   1920
              cgttcatcca tagttgcctg actccccgtc gtgtagataa ctacgatacg ggagggctta   1980
              ccatctggcc ccagtgctgc aatgataccg cgagacccac gctcaccggc tccagattta   2040
              tcagcaataa accagccagc cggaagggcc gagcgcagaa gtggtcctgc aactttatcc   2100
              gcctccatcc agtctattaa ttgttgccgg gaagctagag taagtagttc gccagttaat   2160
              agtttgcgca acgttgttgc cattgctaca ggcatcgtgg tgtcacgctc gtcgtttggt   2220
              atggcttcat tcagctccgg ttcccaacga tcaaggcgag ttacatgatc ccccatgttg   2280
              tgcaaaaaag cggttagctc cttcggtcct ccgatcgttg tcagaagtaa gttggccgca   2340
              gtgttatcac tcatggttat ggcagcactg cataattctc ttactgtcat gccatccgta   2400
              agatgctttt ctgtgactgg tgagtactca accaagtcat tctgagaata gtgtatgcgg   2460
              cgaccgagtt gctcttgccc ggcgtcaata cgggataata ccgcgccaca tagcagaact   2520
              ttaaaagtgc tcatcattgg aaaacgttct tcggggcgaa aactctcaag gatcttaccg   2580
              ctgttgagat ccagttcgat gtaacccact cgtgcaccca actgatcttc agcatctttt   2640
                                                  70

              actttcacca gcgtttctgg gtgagcaaaa acaggaaggc aaaatgccgc aaaaaaggga   2700
<removed-date>
              ataagggcga cacggaaatg ttgaatactc atactcttcc tttttcaata ttattgaagc   2760
              atttatcagg gttattgtct catgagcgga tacatatttg aatgtattta gaaaaataaa   2820
              caaatagggg ttccgcgcac atttccccga aaagtgccac ctgacgtcag gtacacttag   2880
              gcgcgccatt agagttcctg caggctacat ggtaccaagc ctaggcctcc aaaaaagcct   2940
              cctcactact tctggaatag ctcagaggca gaggcggcct cggcctctgc ataaataaaa   3000
<removed-apn>
              aaaattagtc agccatgggg cggagaatgg gcggaactgg gcggagttag gggcgggatg   3060
              ggcggagtta ggggcgggac tatggttgct gactaattga gatgcatgct ttgcatactt   3120
              ctgcctgctg gggagcctgg ggactttcca cacctggttg ctgactaatt gagatgcatg   3180
              ctttgcatac ttctgcctgc tggggagcct ggggactttc cacaccggat ccaccatgga   3240
              tagatccgga aagcctgaac tcaccgcgac gtctgtcgag aagtttctga tcgaaaagtt   3300
              cgacagcgtc tccgacctga tgcagctctc ggagggcgaa gaatctcgtg ctttcagctt   3360
              cgatgtagga gggcgtggat atgtcctgcg ggtaaatagc tgcgccgatg gtttctacaa   3420
              agatcgttat gtttatcggc actttgcatc ggccgcgctc ccgattccgg aagtgcttga   3480
              cattggggag ttcagcgaga gcctgaccta ttgcatctcc cgccgtgcac agggtgtcac   3540
              gttgcaagac ctgcctgaaa ccgaactgcc cgctgttctg cagccggtcg cggaggccat   3600
              ggatgcgatc gctgcggccg atcttagcca gacgagcggg ttcggcccat tcggaccgca   3660
              aggaatcggt caatacacta catggcgtga tttcatatgc gcgattgctg atccccatgt   3720
              gtatcactgg caaactgtga tggacgacac cgtcagtgcg tccgtcgcgc aggctctcga   3780
              tgagctgatg ctttgggccg aggactgccc cgaagtccgg cacctcgtgc acgcggattt   3840
              cggctccaac aatgtcctga cggacaatgg ccgcataaca gcggtcattg actggagcga   3900
              ggcgatgttc ggggattccc aatacgaggt cgccaacatc ttcttctgga ggccgtggtt   3960
              ggcttgtatg gagcagcaga cgcgctactt cgagcggagg catccggagc ttgcaggatc   4020
              gccgcggctc cgggcgtata tgctccgcat tggtcttgac caactctatc agagcttggt   4080
              tgacggcaat ttcgatgatg cagcttgggc gcagggtcga tgcgacgcaa tcgtccgatc   4140
              cggagccggg actgtcgggc gtacacaaat cgcccgcaga agcgcggccg tctggaccga   4200
              tggctgtgta gaagtactcg ccgatagtgg aaaccgacgc cccagcactc gtccgagggc   4260
              aaaggaatag acgcgtgctg taagtctgca gaaattgatg atctattaaa caataaagat   4320
              gtccactaaa atggaagttt ttcctgtcat actttgttaa gaagggtgag aacagagtac   4380
                                                  71

              ctacattttg aatggaagga ttggagctac gggggtgggg gtggggtggg attagataaa   4440
<removed-date>
              tgcctgctct ttactgaagg ctctttacta ttgctttatg ataatgtttc atagttggat   4500
              atcataattt aaacaagcaa aaccaaatta agggccagct cattcctccc actcatgatc   4560
              tatggatcta tagatctctc gtgcagctgg ggctctaggg ggtatcccca cgcgccctgt   4620
              agcggcgcat taagcgcggc gggtgtggtg gttacgcgca gcgtgaccgc tacacttgcc   4680
              agcgccctag cgcccgctcc tttcgctttc ttcccttcct ttctcgccac gttcgccggc   4740
<removed-apn>
              tttccccgtc aagctctaaa tcgggggctc cctttagggt tccgatttag tgctttacgg   4800
              cacctcgacc ccaaaaaact tgattagggt gatggttcac gtagtgggcc atcgccctga   4860
              tagacggttt ttcgcccttt gacgttggag tccacgttct ttaatagtgg actcttgttc   4920
              caaactggaa caacactcaa ccctatctcg gtctattctt ttgatttata agggattttg   4980
              ccgatttcgg cctattggtt aaaaaatgag ctgatttaac aaaaatttaa cgcgaattaa   5040
              ttctgtggaa tgtgtgtcag ttagtcgcga tgtgtgacta gttagttatt aatagtaatc   5100
              aattacgggg tcattagttc atagcccata tatggagttc cgcgttacat aacttacggt   5160
              aaatggcccg cctggctgac cgcccaacga cccccgccca ttgacgtcaa taatgacgta   5220
              tgttcccata gtaacgccaa tagggacttt ccattgacgt caatgggtgg agtatttacg   5280
              gtaaactgcc cacttggcag tacatcaagt gtatcatatg ccaagtacgc cccctattga   5340
              cgtcaatgac ggtaaatggc ccgcctggca ttatgcccag tacatgacct tatgggactt   5400
              tcctacttgg cagtacatct acgtattagt catcgctatt accatggtga tgcggttttg   5460
              gcagtacatc aatgggcgtg gatagcggtt tgactcacgg ggatttccaa gtctccaccc   5520
              cattgacgtc aatgggagtt tgttttggca ccaaaatcaa cgggactttc caaaatgtcg   5580
              taacaactcc gccccattga cgcaaatggg cggtaggcgt gtacggtggg aggtctatat   5640
              aagcagagct catgatagaa gcactctact attcgtcgac cgatcctgag aacttcaggg   5700
              tgagtttggg gacccttgat tgttctttct ttttcgctat tgtaaaattc atgttatatg   5760
              gagggggcaa agttttcagg gtgttgttta gaatgggaag atgtcccttg tatcaccatg   5820
              gaccctcatg ataattttgt ttctttcact ttctactctg ttgacaacca ttgtctcctc   5880
              ttattttctt ttcattttct gtaacttttt cgttaaactt tagcttgcat ttgtaacgaa   5940
              tttttaaatt cacttttgtt tatttgtcag attgtaagta ctttctctaa tcactttttt   6000
              ttcaaggcaa tcagggtata ttatattgta cttcagcaca gttttagaga acaattgtta   6060
              taattaaatg ataaggtaga atatttctgc atataaattc tggctggcgt ggaaatattc   6120
                                                  72

              ttattggtag aaacaactac accctggtca tcatcctgcc tttctcttta tggttacaat   6180
<removed-date>
              gatatacact gtttgagatg aggataaaat actctgagtc caaaccgggc ccctctgcta   6240
              accatgttca tgccttcttc tctttcctac agctcctggg caacgtgctg gttgttgtgc   6300
              tgtctcatca ttttggcaaa gaattaagct tatac                              6335
              <210>   27
              <211>   452
<removed-apn>
              <212>   PRT
              <213>   Homo sapiens
              <400>   27
              Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
              1               5                   10                  15
              Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
                          20                  25                  30
              Asp Ile His Trp Val Arg Gln Ala Thr Gly Lys Gly Leu Glu Trp Val
                      35                  40                  45
              Ser Ala Ile Gly Pro Ala Gly Asp Thr Tyr Tyr Pro Gly Ser Val Lys
                  50                  55                  60
              Gly Arg Phe Thr Ile Ser Arg Glu Asn Ala Lys Asn Ser Leu Tyr Leu
              65                  70                  75                  80
              Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala
                              85                  90                  95
              Arg Gly Leu Ile Thr Phe Gly Gly Leu Ile Ala Pro Phe Asp Tyr Trp
                          100                 105                 110
              Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro
                      115                 120                 125
              Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr
                  130                 135                 140
              Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr
              145                 150                 155                 160
              Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro
                              165                 170                 175
                                                  73

<removed-date>
              Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr
                          180                 185                 190
              Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn
                      195                 200                 205
              His Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser
<removed-apn>
                  210                 215                 220
              Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu
              225                 230                 235                 240
              Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu
                              245                 250                 255
              Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser
                          260                 265                 270
              His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu
                      275                 280                 285
              Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr
                  290                 295                 300
              Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn
              305                 310                 315                 320
              Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro
                              325                 330                 335
              Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln
                          340                 345                 350
              Val Tyr Thr Leu Pro Pro Ser Arg Asp Glu Leu Thr Lys Asn Gln Val
                      355                 360                 365
              Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val
                  370                 375                 380
              Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro
              385                 390                 395                 400
                                                  74

              Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr
<removed-date>
                              405                 410                 415
              Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val
                          420                 425                 430
              Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu
                      435                 440                 445
<removed-apn>
              Ser Pro Gly Lys
                  450
              <210>   28
              <211>   112
              <212>   PRT
              <213>   Homo sapiens
              <400>   28
              Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser
              1               5                   10                  15
              Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr Asp Ile His Trp Val
                          20                  25                  30
              Arg Gln Ala Thr Gly Lys Gly Leu Glu Trp Val Ser Ala Ile Gly Pro
                      35                  40                  45
              Ala Gly Asp Thr Tyr Tyr Pro Gly Ser Val Lys Gly Arg Phe Thr Ile
                  50                  55                  60
              Ser Arg Glu Asn Ala Lys Asn Ser Leu Tyr Leu Gln Met Asn Ser Leu
              65                  70                  75                  80
              Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala Arg Gly Leu Ile Thr
                              85                  90                  95
              Phe Gly Gly Leu Ile Ala Pro Phe Asp Tyr Trp Gly Gln Gly Thr Leu
                          100                 105                 110
              <210>   29
              <211>   214
              <212>   PRT
              <213>   Homo sapiens
              <400>   29
                                                  75

              Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
<removed-date>
              1               5                   10                  15
              Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Thr
                          20                  25                  30
              Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
                      35                  40                  45
<removed-apn>
              Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
                  50                  55                  60
              Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
              65                  70                  75                  80
              Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Tyr Asp Asn Ser Gln
                              85                  90                  95
              Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
                          100                 105                 110
              Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
                      115                 120                 125
              Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
                  130                 135                 140
              Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
              145                 150                 155                 160
              Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
                              165                 170                 175
              Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
                          180                 185                 190
              Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
                      195                 200                 205
              Phe Asn Arg Gly Glu Cys
                  210
              <210>   30
              <211>   107
                                                  76

              <212>   PRT
<removed-date>
              <213>   Homo sapiens
              <400>   30
              Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly Glu
              1               5                   10                  15
              Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Thr Tyr
                          20                  25                  30
<removed-apn>
              Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile
                      35                  40                  45
              Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser Gly
                  50                  55                  60
              Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro
              65                  70                  75                  80
              Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Tyr Asp Asn Ser Gln Thr
                              85                  90                  95
              Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
                          100                 105
              <210>   31
              <211>   2986
              <212>   DNA
              <213>   Artificial
              <220>
              <223>   Synthetic construct
              <400> 31
              tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata tggagttccg   60
              cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc cccgcccatt   120
              gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc attgacgtca   180
              atgggtggag tatttacggt aaactgccca cttggcagta catcaagtgt atcatatgcc   240
              aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt atgcccagta   300
              catgacctta tgggactttc ctacttggca gtacatctac gtattagtca tcgctattac   360
              catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg actcacgggg   420
              atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc aaaatcaacg   480
                                                  77

              ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg gtaggcgtgt    540
<removed-date>
              acggtgggag gtctatataa gcagagctca tgatagaagc actctactat tcgtcgaccg    600
              atcctgagaa cttcagggtg agtttgggga cccttgattg ttctttcttt ttcgctattg    660
              taaaattcat gttatatgga gggggcaaag ttttcagggt gttgtttaga atgggaagat    720
              gtcccttgta tcaccatgga ccctcatgat aattttgttt ctttcacttt ctactctgtt    780
              gacaaccatt gtctcctctt attttctttt cattttctgt aactttttcg ttaaacttta    840
<removed-apn>
              gcttgcattt gtaacgaatt tttaaattca cttttgttta tttgtcagat tgtaagtact    900
              ttctctaatc actttttttt caaggcaatc agggtatatt atattgtact tcagcacagt    960
              tttagagaac aattgttata attaaatgat aaggtagaat atttctgcat ataaattctg   1020
              gctggcgtgg aaatattctt attggtagaa acaactacac cctggtcatc atcctgcctt   1080
              tctctttatg gttacaatga tatacactgt ttgagatgag gataaaatac tctgagtcca   1140
              aaccgggccc ctctgctaac catgttcatg ccttcttctc tttcctacag ctcctgggca   1200
              acgtgctggt tgttgtgctg tctcatcatt ttggcaaaga attaagctta tactcgagct   1260
              ctagattggg aacccgggtc tctcgaattc gagatctcca ccatgcacag acctagacgt   1320
              cgtggaactc gtccacctcc actggcactg ctcgctgctc tcctcctggc tgcacgtggt   1380
              gctgatgcag aggtgcagct ggtggagtct gggggaggct tggtacagcc gggggggtcc   1440
              ctgagactct cctgtgcagc ctctggattc accttcagta gctacgacat acactgggtc   1500
              cgtcaagcta caggaaaagg tctggagtgg gtctcagcta ttggtcctgc tggtgacaca   1560
              tactatccag gctccgtgaa gggccgattc accatctcca gagaaaatgc caagaactcc   1620
              ttgtatcttc aaatgaacag cctgagagcc ggggacacgg ctgtgtatta ctgtgcaaga   1680
              ggtttgatta cgtttggggg gcttatcgcc ccgtttgact actggggcca gggaaccctg   1740
              gtcaccgtct cctcagcctc caccaagggc ccatcggtct tccccctggc accctcctcc   1800
              aagagcacct ctgggggcac agcggccctg ggctgcctgg tcaaggacta cttccccgaa   1860
              ccggtgacgg tgtcgtggaa ctcaggcgcc ctgaccagcg gcgtgcacac cttcccggct   1920
              gtcctacagt cctcaggact ctactccctc agcagcgtgg tgaccgtgcc ctccagcagc   1980
              ttgggcaccc agacctacat ctgcaacgtg aatcacaagc ccagcaacac caaggtggac   2040
              aagaaagttg agcccaaatc ttgtgacaaa actcacacat gcccaccgtg cccagcacct   2100
              gaactcctgg ggggaccgtc agtcttcctc ttccccccaa aacccaagga caccctcatg   2160
              atctcccgga cccctgaggt cacatgcgtg gtggtggacg tgagccacga agaccctgag   2220
                                                  78

              gtcaagttca actggtacgt ggacggcgtg gaggtgcata atgccaagac aaagccgcgg   2280
<removed-date>
              gaggagcagt acaacagcac gtaccgtgtg gtcagcgtcc tcaccgtcct gcaccaggac   2340
              tggctgaatg gcaaggagta caagtgcaag gtctccaaca aagccctccc agcccccatc   2400
              gagaaaacca tctccaaagc caaagggcag ccccgagaac cacaggtgta caccctgccc   2460
              ccatcccggg atgagctgac caagaaccag gtcagcctga cctgcctggt caaaggcttc   2520
              tatcccagcg acatcgccgt ggagtgggag agcaatgggc agccggagaa caactacaag   2580
<removed-apn>
              accacgcctc ccgtgctgga ctccgacggc tccttcttcc tctacagcaa gctcaccgtg   2640
              gacaagagca ggtggcagca ggggaacgtc ttctcatgct ccgtgatgca tgaggctctg   2700
              cacaaccact acacgcagaa gtccctctcc ctgtctccgg gtaaatgagc ggccgctaat   2760
              cagccatacc acatttgtag aggttttact tgctttaaaa aacctcccac acctccccct   2820
              gaacctgaaa cataaaatga atgcaattgt tgttgttaac ttgtttattg cagcttataa   2880
              tggttacaaa taaagcaata gcatcacaaa tttcacaaat aaagcatttt tttcactgca   2940
              ttctagttgt ggtttgtcca aactcatcaa tgtatcttat catgtc                  2986
              <210>   32
              <211>   7028
              <212>   DNA
              <213>   Artificial
              <220>
              <223>   Synthetic plasmid
              <400> 32
              tcgcgatgtg tgactagtta gttattaata gtaatcaatt acggggtcat tagttcatag     60
              cccatatatg gagttccgcg ttacataact tacggtaaat ggcccgcctg gctgaccgcc    120
              caacgacccc cgcccattga cgtcaataat gacgtatgtt cccatagtaa cgccaatagg    180
              gactttccat tgacgtcaat gggtggagta tttacggtaa actgcccact tggcagtaca    240
              tcaagtgtat catatgccaa gtacgccccc tattgacgtc aatgacggta aatggcccgc    300
              ctggcattat gcccagtaca tgaccttatg ggactttcct acttggcagt acatctacgt    360
              attagtcatc gctattacca tggtgatgcg gttttggcag tacatcaatg ggcgtggata    420
              gcggtttgac tcacggggat ttccaagtct ccaccccatt gacgtcaatg ggagtttgtt    480
              ttggcaccaa aatcaacggg actttccaaa atgtcgtaac aactccgccc cattgacgca    540
              aatgggcggt aggcgtgtac ggtgggaggt ctatataagc agagctcatg atagaagcac    600
              tctactattc gtcgaccgat cctgagaact tcagggtgag tttggggacc cttgattgtt    660
                                                  79

              ctttcttttt cgctattgta aaattcatgt tatatggagg gggcaaagtt ttcagggtgt    720
<removed-date>
              tgtttagaat gggaagatgt cccttgtatc accatggacc ctcatgataa ttttgtttct    780
              ttcactttct actctgttga caaccattgt ctcctcttat tttcttttca ttttctgtaa    840
              ctttttcgtt aaactttagc ttgcatttgt aacgaatttt taaattcact tttgtttatt    900
              tgtcagattg taagtacttt ctctaatcac ttttttttca aggcaatcag ggtatattat    960
              attgtacttc agcacagttt tagagaacaa ttgttataat taaatgataa ggtagaatat   1020
<removed-apn>
              ttctgcatat aaattctggc tggcgtggaa atattcttat tggtagaaac aactacaccc   1080
              tggtcatcat cctgcctttc tctttatggt tacaatgata tacactgttt gagatgagga   1140
              taaaatactc tgagtccaaa ccgggcccct ctgctaacca tgttcatgcc ttcttctctt   1200
              tcctacagct cctgggcaac gtgctggttg ttgtgctgtc tcatcatttt ggcaaagaat   1260
              taagcttata ctcgagctct agattgggaa cccgggtctc tcgaattcga gatctccacc   1320
              atgcacagac ctagacgtcg tggaactcgt ccacctccac tggcactgct cgctgctctc   1380
              ctcctggctg cacgtggtgc tgatgcagag gtgcagctgg tggagtctgg gggaggcttg   1440
              gtacagccgg gggggtccct gagactctcc tgtgcagcct ctggattcac cttcagtagc   1500
              tacgacatac actgggtccg tcaagctaca ggaaaaggtc tggagtgggt ctcagctatt   1560
              ggtcctgctg gtgacacata ctatccaggc tccgtgaagg gccgattcac catctccaga   1620
              gaaaatgcca agaactcctt gtatcttcaa atgaacagcc tgagagccgg ggacacggct   1680
              gtgtattact gtgcaagagg tttgattacg tttggggggc ttatcgcccc gtttgactac   1740
              tggggccagg gaaccctggt caccgtctcc tcagcctcca ccaagggccc atcggtcttc   1800
              cccctggcac cctcctccaa gagcacctct gggggcacag cggccctggg ctgcctggtc   1860
              aaggactact tccccgaacc ggtgacggtg tcgtggaact caggcgccct gaccagcggc   1920
              gtgcacacct tcccggctgt cctacagtcc tcaggactct actccctcag cagcgtggtg   1980
              accgtgccct ccagcagctt gggcacccag acctacatct gcaacgtgaa tcacaagccc   2040
              agcaacacca aggtggacaa gaaagttgag cccaaatctt gtgacaaaac tcacacatgc   2100
              ccaccgtgcc cagcacctga actcctgggg ggaccgtcag tcttcctctt ccccccaaaa   2160
              cccaaggaca ccctcatgat ctcccggacc cctgaggtca catgcgtggt ggtggacgtg   2220
              agccacgaag accctgaggt caagttcaac tggtacgtgg acggcgtgga ggtgcataat   2280
              gccaagacaa agccgcggga ggagcagtac aacagcacgt accgtgtggt cagcgtcctc   2340
              accgtcctgc accaggactg gctgaatggc aaggagtaca agtgcaaggt ctccaacaaa   2400
                                                  80

              gccctcccag cccccatcga gaaaaccatc tccaaagcca aagggcagcc ccgagaacca   2460
<removed-date>
              caggtgtaca ccctgccccc atcccgggat gagctgacca agaaccaggt cagcctgacc   2520
              tgcctggtca aaggcttcta tcccagcgac atcgccgtgg agtgggagag caatgggcag   2580
              ccggagaaca actacaagac cacgcctccc gtgctggact ccgacggctc cttcttcctc   2640
              tacagcaagc tcaccgtgga caagagcagg tggcagcagg ggaacgtctt ctcatgctcc   2700
              gtgatgcatg aggctctgca caaccactac acgcagaagt ccctctccct gtctccgggt   2760
<removed-apn>
              aaatgagcgg ccgctaatca gccataccac atttgtagag gttttacttg ctttaaaaaa   2820
              cctcccacac ctccccctga acctgaaaca taaaatgaat gcaattgttg ttgttaactt   2880
              gtttattgca gcttataatg gttacaaata aagcaatagc atcacaaatt tcacaaataa   2940
              agcatttttt tcactgcatt ctagttgtgg tttgtccaaa ctcatcaatg tatcttatca   3000
              tgtctaccgg tcctgcaggg cccctctctt catgtgagca aaaggccagc aaaaggccag   3060
              gaaccgtaaa aaggccgcgt tgctggcgtt tttccatagg ctccgccccc ctgacgagca   3120
              tcacaaaaat cgacgctcaa gtcagaggtg gcgaaacccg acaggactat aaagatacca   3180
              ggcgtttccc cctggaagct ccctcgtgcg ctctcctgtt ccgaccctgc cgcttaccgg   3240
              atacctgtcc gcctttctcc cttcgggaag cgtggcgctt tctcaatgct cacgctgtag   3300
              gtatctcagt tcggtgtagg tcgttcgctc caagctgggc tgtgtgcacg aaccccccgt   3360
              tcagcccgac cgctgcgcct tatccggtaa ctatcgtctt gagtccaacc cggtaagaca   3420
              cgacttatcg ccactggcag cagccactgg taacaggatt agcagagcga ggtatgtagg   3480
              cggtgctaca gagttcttga agtggtggcc taactacggc tacactagaa ggacagtatt   3540
              tggtatctgc gctctgctga agccagttac cttcggaaaa agagttggta gctcttgatc   3600
              cggcaaacaa accaccgctg gtagcggtgg tttttttgtt tgcaagcagc agattacgcg   3660
              cagaaaaaaa ggatctcaag aagatccttt gatcttttct acggggtctg acgctcagtg   3720
              gaacgaaaac tcacgttaag ggattttggt catgggcgcg cctcatactc ctgcaggcat   3780
              gagattatca aaaaggatct tcacctagat ccttttaaat taaaaatgaa gttttaaatc   3840
              aatctaaagt atatatgagt aaacttggtc tgacagttac caatgcttaa tcagtgaggc   3900
              acctatctca gcgatctgtc tatttcgttc atccatagtt gcctgactcc ccgtcgtgta   3960
              gataactacg atacgggagg gcttaccatc tggccccagt gctgcaatga taccgcgaga   4020
              cccacgctca ccggctccag atttatcagc aataaaccag ccagccggaa gggccgagcg   4080
              cagaagtggt cctgcaactt tatccgcctc catccagtct attaattgtt gccgggaagc   4140
                                                  81

              tagagtaagt agttcgccag ttaatagttt gcgcaacgtt gttgccattg ctacaggcat   4200
<removed-date>
              cgtggtgtca cgctcgtcgt ttggtatggc ttcattcagc tccggttccc aacgatcaag   4260
              gcgagttaca tgatccccca tgttgtgcaa aaaagcggtt agctccttcg gtcctccgat   4320
              cgttgtcaga agtaagttgg ccgcagtgtt atcactcatg gttatggcag cactgcataa   4380
              ttctcttact gtcatgccat ccgtaagatg cttttctgtg actggtgagt actcaaccaa   4440
              gtcattctga gaatagtgta tgcggcgacc gagttgctct tgcccggcgt caatacggga   4500
<removed-apn>
              taataccgcg ccacatagca gaactttaaa agtgctcatc attggaaaac gttcttcggg   4560
              gcgaaaactc tcaaggatct taccgctgtt gagatccagt tcgatgtaac ccactcgtgc   4620
              acccaactga tcttcagcat cttttacttt caccagcgtt tctgggtgag caaaaacagg   4680
              aaggcaaaat gccgcaaaaa agggaataag ggcgacacgg aaatgttgaa tactcatact   4740
              cttccttttt caatattatt gaagcattta tcagggttat tgtctcatga gcggatacat   4800
              atttgaatgt atttagaaaa ataaacaaat aggggttccg cgcacatttc cccgaaaagt   4860
              gccacctgac gtcaggtacc aagcctaggc ctccaaaaaa gcctcctcac tacttctgga   4920
              atagctcaga ggcagaggcg gcctcggcct ctgcataaat aaaaaaaatt agtcagccat   4980
              ggggcggaga atgggcggaa ctgggcggag ttaggggcgg gatgggcgga gttaggggcg   5040
              ggactatggt tgctgactaa ttgagatgca tgctttgcat acttctgcct gctggggagc   5100
              ctggggactt tccacacctg gttgctgact aattgagatg catgctttgc atacttctgc   5160
              ctgctgggga gcctggggac tttccacacc ggatccacca tggatagatc cggaaagcct   5220
              gaactcaccg cgacgtctgt cgagaagttt ctgatcgaaa agttcgacag cgtctccgac   5280
              ctgatgcagc tctcggaggg cgaagaatct cgtgctttca gcttcgatgt aggagggcgt   5340
              ggatatgtcc tgcgggtaaa tagctgcgcc gatggtttct acaaagatcg ttatgtttat   5400
              cggcactttg catcggccgc gctcccgatt ccggaagtgc ttgacattgg ggagttcagc   5460
              gagagcctga cctattgcat ctcccgccgt gcacagggtg tcacgttgca agacctgcct   5520
              gaaaccgaac tgcccgctgt tctgcagccg gtcgcggagg ccatggatgc gatcgctgcg   5580
              gccgatctta gccagacgag cgggttcggc ccattcggac cgcaaggaat cggtcaatac   5640
              actacatggc gtgatttcat atgcgcgatt gctgatcccc atgtgtatca ctggcaaact   5700
              gtgatggacg acaccgtcag tgcgtccgtc gcgcaggctc tcgatgagct gatgctttgg   5760
              gccgaggact gccccgaagt ccggcacctc gtgcacgcgg atttcggctc caacaatgtc   5820
              ctgacggaca atggccgcat aacagcggtc attgactgga gcgaggcgat gttcggggat   5880
                                                  82

              tcccaatacg aggtcgccaa catcttcttc tggaggccgt ggttggcttg tatggagcag   5940
<removed-date>
              cagacgcgct acttcgagcg gaggcatccg gagcttgcag gatcgccgcg gctccgggcg   6000
              tatatgctcc gcattggtct tgaccaactc tatcagagct tggttgacgg caatttcgat   6060
              gatgcagctt gggcgcaggg tcgatgcgac gcaatcgtcc gatccggagc cgggactgtc   6120
              gggcgtacac aaatcgcccg cagaagcgcg gccgtctgga ccgatggctg tgtagaagta   6180
              ctcgccgata gtggaaaccg acgccccagc actcgtccga gggcaaagga atagacgcgt   6240
<removed-apn>
              gctgtaagtc tgcagaaatt gatgatctat taaacaataa agatgtccac taaaatggaa   6300
              gtttttcctg tcatactttg ttaagaaggg tgagaacaga gtacctacat tttgaatgga   6360
              aggattggag ctacgggggt gggggtgggg tgggattaga taaatgcctg ctctttactg   6420
              aaggctcttt actattgctt tatgataatg tttcatagtt ggatatcata atttaaacaa   6480
              gcaaaaccaa attaagggcc agctcattcc tcccactcat gatctatgga tctatagatc   6540
              tctcgtgcag ctggggctct agggggtatc cccacgcgcc ctgtagcggc gcattaagcg   6600
              cggcgggtgt ggtggttacg cgcagcgtga ccgctacact tgccagcgcc ctagcgcccg   6660
              ctcctttcgc tttcttccct tcctttctcg ccacgttcgc cggctttccc cgtcaagctc   6720
              taaatcgggg gctcccttta gggttccgat ttagtgcttt acggcacctc gaccccaaaa   6780
              aacttgatta gggtgatggt tcacgtagtg ggccatcgcc ctgatagacg gtttttcgcc   6840
              ctttgacgtt ggagtccacg ttctttaata gtggactctt gttccaaact ggaacaacac   6900
              tcaaccctat ctcggtctat tcttttgatt tataagggat tttgccgatt tcggcctatt   6960
              ggttaaaaaa tgagctgatt taacaaaaat ttaacgcgaa ttaattctgt ggaatgtgtg   7020
              tcagttag                                                            7028
              <210>   33
              <211>   2272
              <212>   DNA
              <213>   Artificial
              <220>
              <223>   Synthetic construct
              <400> 33
              tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata tggagttccg    60
              cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc cccgcccatt    120
              gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc attgacgtca    180
              atgggtggag tatttacggt aaactgccca cttggcagta catcaagtgt atcatatgcc    240
                                                  83

              aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt atgcccagta    300
<removed-date>
              catgacctta tgggactttc ctacttggca gtacatctac gtattagtca tcgctattac    360
              catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg actcacgggg    420
              atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc aaaatcaacg    480
              ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg gtaggcgtgt    540
              acggtgggag gtctatataa gcagagctca tgatagaagc actctactat tcgtcgaccg    600
<removed-apn>
              atcctgagaa cttcagggtg agtttgggga cccttgattg ttctttcttt ttcgctattg    660
              taaaattcat gttatatgga gggggcaaag ttttcagggt gttgtttaga atgggaagat    720
              gtcccttgta tcaccatgga ccctcatgat aattttgttt ctttcacttt ctactctgtt    780
              gacaaccatt gtctcctctt attttctttt cattttctgt aactttttcg ttaaacttta    840
              gcttgcattt gtaacgaatt tttaaattca cttttgttta tttgtcagat tgtaagtact    900
              ttctctaatc actttttttt caaggcaatc agggtatatt atattgtact tcagcacagt    960
              tttagagaac aattgttata attaaatgat aaggtagaat atttctgcat ataaattctg   1020
              gctggcgtgg aaatattctt attggtagaa acaactacac cctggtcatc atcctgcctt   1080
              tctctttatg gttacaatga tatacactgt ttgagatgag gataaaatac tctgagtcca   1140
              aaccgggccc ctctgctaac catgttcatg ccttcttctc tttcctacag ctcctgggca   1200
              acgtgctggt tgttgtgctg tctcatcatt ttggcaaaga attaagctta tactcgagct   1260
              ctagattggg aacccgggtc tctcgaattc gagatctcca ccatgcacag acctagacgt   1320
              cgtggaactc gtccacctcc actggcactg ctcgctgctc tcctcctggc tgcacgtggt   1380
              gctgatgcag aaattgtgtt gacgcagtct ccaggcaccc tgtctttgtc tccaggggaa   1440
              agagccaccc tctcctgcag ggccagtcag agtgttagca gcacctactt agcctggtac   1500
              cagcagaaac ctggccaggc tcccaggctc ctcatctatg gtgcatccag cagggccact   1560
              ggcatcccag acaggttcag tggcagtggg tctgggacag acttcactct caccatcagc   1620
              agactggagc ctgaagattt tgcagtgtat tactgtcagc attatgataa ctcacaaacg   1680
              ttcggccaag ggaccaaggt ggagatcaaa cgaactgtgg ctgcaccatc tgtcttcatc   1740
              ttcccgccat ctgatgagca gttgaaatct ggaactgcct ctgttgtgtg cctgctgaat   1800
              aacttctatc ccagagaggc caaagtacag tggaaggtgg ataacgccct ccaatcgggt   1860
              aactcccagg agagtgtcac agagcaggac agcaaggaca gcacctacag cctcagcagc   1920
              accctgacgc tgagcaaagc agactacgag aaacacaaag tctacgcctg cgaagtcacc   1980
                                                  84

              catcagggcc tgagctcgcc cgtcacaaag agcttcaaca ggggagagtg ttaggcggcc   2040
<removed-date>
              gctaatcagc cataccacat ttgtagaggt tttacttgct ttaaaaaacc tcccacacct   2100
              ccccctgaac ctgaaacata aaatgaatgc aattgttgtt gttaacttgt ttattgcagc   2160
              ttataatggt tacaaataaa gcaatagcat cacaaatttc acaaataaag catttttttc   2220
              actgcattct agttgtggtt tgtccaaact catcaatgta tcttatcatg tc           2272
<removed-apn>
              <210>   34
              <211>   6335
              <212>   DNA
              <213>   Artificial
              <220>
              <223>   Synthetic plasmid
              <400> 34
              tcgagctcta gattgggaac ccgggtctct cgaattcgag atctccacca tgcacagacc    60
              tagacgtcgt ggaactcgtc cacctccact ggcactgctc gctgctctcc tcctggctgc    120
              acgtggtgct gatgcagaaa ttgtgttgac gcagtctcca ggcaccctgt ctttgtctcc    180
              aggggaaaga gccaccctct cctgcagggc cagtcagagt gttagcagca cctacttagc    240
              ctggtaccag cagaaacctg gccaggctcc caggctcctc atctatggtg catccagcag    300
              ggccactggc atcccagaca ggttcagtgg cagtgggtct gggacagact tcactctcac    360
              catcagcaga ctggagcctg aagattttgc agtgtattac tgtcagcatt atgataactc    420
              acaaacgttc ggccaaggga ccaaggtgga gatcaaacga actgtggctg caccatctgt    480
              cttcatcttc ccgccatctg atgagcagtt gaaatctgga actgcctctg ttgtgtgcct    540
              gctgaataac ttctatccca gagaggccaa agtacagtgg aaggtggata acgccctcca    600
              atcgggtaac tcccaggaga gtgtcacaga gcaggacagc aaggacagca cctacagcct    660
              cagcagcacc ctgacgctga gcaaagcaga ctacgagaaa cacaaagtct acgcctgcga    720
              agtcacccat cagggcctga gctcgcccgt cacaaagagc ttcaacaggg gagagtgtta    780
              ggcggccgct aatcagccat accacatttg tagaggtttt acttgcttta aaaaacctcc    840
              cacacctccc cctgaacctg aaacataaaa tgaatgcaat tgttgttgtt aacttgttta    900
              ttgcagctta taatggttac aaataaagca atagcatcac aaatttcaca aataaagcat    960
              ttttttcact gcattctagt tgtggtttgt ccaaactcat caatgtatct tatcatgtct   1020
              accggtaggg cccctctctt catgtgagca aaaggccagc aaaaggccag gaaccgtaaa   1080
              aaggccgcgt tgctggcgtt tttccatagg ctccgccccc ctgacgagca tcacaaaaat   1140
                                                  85

              cgacgctcaa gtcagaggtg gcgaaacccg acaggactat aaagatacca ggcgtttccc   1200
<removed-date>
              cctggaagct ccctcgtgcg ctctcctgtt ccgaccctgc cgcttaccgg atacctgtcc   1260
              gcctttctcc cttcgggaag cgtggcgctt tctcaatgct cacgctgtag gtatctcagt   1320
              tcggtgtagg tcgttcgctc caagctgggc tgtgtgcacg aaccccccgt tcagcccgac   1380
              cgctgcgcct tatccggtaa ctatcgtctt gagtccaacc cggtaagaca cgacttatcg   1440
              ccactggcag cagccactgg taacaggatt agcagagcga ggtatgtagg cggtgctaca   1500
<removed-apn>
              gagttcttga agtggtggcc taactacggc tacactagaa ggacagtatt tggtatctgc   1560
              gctctgctga agccagttac cttcggaaaa agagttggta gctcttgatc cggcaaacaa   1620
              accaccgctg gtagcggtgg tttttttgtt tgcaagcagc agattacgcg cagaaaaaaa   1680
              ggatctcaag aagatccttt gatcttttct acggggtctg acgctcagtg gaacgaaaac   1740
              tcacgttaag ggattttggt catgggcgcg ggcatgagat tatcaaaaag gatcttcacc   1800
              tagatccttt taaattaaaa atgaagtttt aaatcaatct aaagtatata tgagtaaact   1860
              tggtctgaca gttaccaatg cttaatcagt gaggcaccta tctcagcgat ctgtctattt   1920
              cgttcatcca tagttgcctg actccccgtc gtgtagataa ctacgatacg ggagggctta   1980
              ccatctggcc ccagtgctgc aatgataccg cgagacccac gctcaccggc tccagattta   2040
              tcagcaataa accagccagc cggaagggcc gagcgcagaa gtggtcctgc aactttatcc   2100
              gcctccatcc agtctattaa ttgttgccgg gaagctagag taagtagttc gccagttaat   2160
              agtttgcgca acgttgttgc cattgctaca ggcatcgtgg tgtcacgctc gtcgtttggt   2220
              atggcttcat tcagctccgg ttcccaacga tcaaggcgag ttacatgatc ccccatgttg   2280
              tgcaaaaaag cggttagctc cttcggtcct ccgatcgttg tcagaagtaa gttggccgca   2340
              gtgttatcac tcatggttat ggcagcactg cataattctc ttactgtcat gccatccgta   2400
              agatgctttt ctgtgactgg tgagtactca accaagtcat tctgagaata gtgtatgcgg   2460
              cgaccgagtt gctcttgccc ggcgtcaata cgggataata ccgcgccaca tagcagaact   2520
              ttaaaagtgc tcatcattgg aaaacgttct tcggggcgaa aactctcaag gatcttaccg   2580
              ctgttgagat ccagttcgat gtaacccact cgtgcaccca actgatcttc agcatctttt   2640
              actttcacca gcgtttctgg gtgagcaaaa acaggaaggc aaaatgccgc aaaaaaggga   2700
              ataagggcga cacggaaatg ttgaatactc atactcttcc tttttcaata ttattgaagc   2760
              atttatcagg gttattgtct catgagcgga tacatatttg aatgtattta gaaaaataaa   2820
              caaatagggg ttccgcgcac atttccccga aaagtgccac ctgacgtcag gtacacttag   2880
                                                  86

              gcgcgccatt agagttcctg caggctacat ggtaccaagc ctaggcctcc aaaaaagcct   2940
<removed-date>
              cctcactact tctggaatag ctcagaggca gaggcggcct cggcctctgc ataaataaaa   3000
              aaaattagtc agccatgggg cggagaatgg gcggaactgg gcggagttag gggcgggatg   3060
              ggcggagtta ggggcgggac tatggttgct gactaattga gatgcatgct ttgcatactt   3120
              ctgcctgctg gggagcctgg ggactttcca cacctggttg ctgactaatt gagatgcatg   3180
              ctttgcatac ttctgcctgc tggggagcct ggggactttc cacaccggat ccaccatgga   3240
<removed-apn>
              tagatccgga aagcctgaac tcaccgcgac gtctgtcgag aagtttctga tcgaaaagtt   3300
              cgacagcgtc tccgacctga tgcagctctc ggagggcgaa gaatctcgtg ctttcagctt   3360
              cgatgtagga gggcgtggat atgtcctgcg ggtaaatagc tgcgccgatg gtttctacaa   3420
              agatcgttat gtttatcggc actttgcatc ggccgcgctc ccgattccgg aagtgcttga   3480
              cattggggag ttcagcgaga gcctgaccta ttgcatctcc cgccgtgcac agggtgtcac   3540
              gttgcaagac ctgcctgaaa ccgaactgcc cgctgttctg cagccggtcg cggaggccat   3600
              ggatgcgatc gctgcggccg atcttagcca gacgagcggg ttcggcccat tcggaccgca   3660
              aggaatcggt caatacacta catggcgtga tttcatatgc gcgattgctg atccccatgt   3720
              gtatcactgg caaactgtga tggacgacac cgtcagtgcg tccgtcgcgc aggctctcga   3780
              tgagctgatg ctttgggccg aggactgccc cgaagtccgg cacctcgtgc acgcggattt   3840
              cggctccaac aatgtcctga cggacaatgg ccgcataaca gcggtcattg actggagcga   3900
              ggcgatgttc ggggattccc aatacgaggt cgccaacatc ttcttctgga ggccgtggtt   3960
              ggcttgtatg gagcagcaga cgcgctactt cgagcggagg catccggagc ttgcaggatc   4020
              gccgcggctc cgggcgtata tgctccgcat tggtcttgac caactctatc agagcttggt   4080
              tgacggcaat ttcgatgatg cagcttgggc gcagggtcga tgcgacgcaa tcgtccgatc   4140
              cggagccggg actgtcgggc gtacacaaat cgcccgcaga agcgcggccg tctggaccga   4200
              tggctgtgta gaagtactcg ccgatagtgg aaaccgacgc cccagcactc gtccgagggc   4260
              aaaggaatag acgcgtgctg taagtctgca gaaattgatg atctattaaa caataaagat   4320
              gtccactaaa atggaagttt ttcctgtcat actttgttaa gaagggtgag aacagagtac   4380
              ctacattttg aatggaagga ttggagctac gggggtgggg gtggggtggg attagataaa   4440
              tgcctgctct ttactgaagg ctctttacta ttgctttatg ataatgtttc atagttggat   4500
              atcataattt aaacaagcaa aaccaaatta agggccagct cattcctccc actcatgatc   4560
              tatggatcta tagatctctc gtgcagctgg ggctctaggg ggtatcccca cgcgccctgt   4620
                                                  87

              agcggcgcat taagcgcggc gggtgtggtg gttacgcgca gcgtgaccgc tacacttgcc   4680
<removed-date>
              agcgccctag cgcccgctcc tttcgctttc ttcccttcct ttctcgccac gttcgccggc   4740
              tttccccgtc aagctctaaa tcgggggctc cctttagggt tccgatttag tgctttacgg   4800
              cacctcgacc ccaaaaaact tgattagggt gatggttcac gtagtgggcc atcgccctga   4860
              tagacggttt ttcgcccttt gacgttggag tccacgttct ttaatagtgg actcttgttc   4920
              caaactggaa caacactcaa ccctatctcg gtctattctt ttgatttata agggattttg   4980
<removed-apn>
              ccgatttcgg cctattggtt aaaaaatgag ctgatttaac aaaaatttaa cgcgaattaa   5040
              ttctgtggaa tgtgtgtcag ttagtcgcga tgtgtgacta gttagttatt aatagtaatc   5100
              aattacgggg tcattagttc atagcccata tatggagttc cgcgttacat aacttacggt   5160
              aaatggcccg cctggctgac cgcccaacga cccccgccca ttgacgtcaa taatgacgta   5220
              tgttcccata gtaacgccaa tagggacttt ccattgacgt caatgggtgg agtatttacg   5280
              gtaaactgcc cacttggcag tacatcaagt gtatcatatg ccaagtacgc cccctattga   5340
              cgtcaatgac ggtaaatggc ccgcctggca ttatgcccag tacatgacct tatgggactt   5400
              tcctacttgg cagtacatct acgtattagt catcgctatt accatggtga tgcggttttg   5460
              gcagtacatc aatgggcgtg gatagcggtt tgactcacgg ggatttccaa gtctccaccc   5520
              cattgacgtc aatgggagtt tgttttggca ccaaaatcaa cgggactttc caaaatgtcg   5580
              taacaactcc gccccattga cgcaaatggg cggtaggcgt gtacggtggg aggtctatat   5640
              aagcagagct catgatagaa gcactctact attcgtcgac cgatcctgag aacttcaggg   5700
              tgagtttggg gacccttgat tgttctttct ttttcgctat tgtaaaattc atgttatatg   5760
              gagggggcaa agttttcagg gtgttgttta gaatgggaag atgtcccttg tatcaccatg   5820
              gaccctcatg ataattttgt ttctttcact ttctactctg ttgacaacca ttgtctcctc   5880
              ttattttctt ttcattttct gtaacttttt cgttaaactt tagcttgcat ttgtaacgaa   5940
              tttttaaatt cacttttgtt tatttgtcag attgtaagta ctttctctaa tcactttttt   6000
              ttcaaggcaa tcagggtata ttatattgta cttcagcaca gttttagaga acaattgtta   6060
              taattaaatg ataaggtaga atatttctgc atataaattc tggctggcgt ggaaatattc   6120
              ttattggtag aaacaactac accctggtca tcatcctgcc tttctcttta tggttacaat   6180
              gatatacact gtttgagatg aggataaaat actctgagtc caaaccgggc ccctctgcta   6240
              accatgttca tgccttcttc tctttcctac agctcctggg caacgtgctg gttgttgtgc   6300
              tgtctcatca ttttggcaaa gaattaagct tatac                              6335
                                                  88

<removed-date>
              <210>   35
              <211>   449
              <212>   PRT
              <213>   Homo sapiens
              <400>   35
              Gln Val Gln Leu Gln Gln Ser Gly Ala Gly Leu Leu Lys Pro Ser Glu
              1               5                   10                  15
<removed-apn>
              Thr Leu Ser Leu Thr Cys Thr Val Tyr Gly Gly Ser Phe Ser Ile His
                          20                  25                  30
              His Trp Thr Trp Ile Arg His Pro Pro Gly Lys Gly Leu Glu Trp Ile
                      35                  40                  45
              Gly Glu Ile Asn His Arg Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys
                  50                  55                  60
              Ser Arg Val Thr Ile Ser Ile Asp Thr Ser Lys Asn Gln Phe Ser Leu
              65                  70                  75                  80
              Lys Leu Ser Ala Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala
                              85                  90                  95
              Arg Gly Leu Arg Phe Leu Asp Trp Leu Ser Ser Tyr Phe Asp Tyr Trp
                          100                 105                 110
              Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro
                      115                 120                 125
              Ser Val Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser Thr
                  130                 135                 140
              Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr
              145                 150                 155                 160
              Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro
                              165                 170                 175
              Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr
                          180                 185                 190
              Val Pro Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val Asp
                      195                 200                 205
                                                  89

<removed-date>
              His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys Tyr
                  210                 215                 220
              Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Leu Gly Gly Pro
              225                 230                 235                 240
              Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser
<removed-apn>
                              245                 250                 255
              Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asp
                          260                 265                 270
              Pro Glu Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn
                      275                 280                 285
              Ala Lys Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val
                  290                 295                 300
              Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu
              305                 310                 315                 320
              Tyr Lys Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu Lys
                              325                 330                 335
              Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr
                          340                 345                 350
              Leu Pro Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr
                      355                 360                 365
              Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu
                  370                 375                 380
              Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu
              385                 390                 395                 400
              Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp Lys
                              405                 410                 415
              Ser Arg Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His Glu
                          420                 425                 430
                                                  90

              Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu Gly
<removed-date>
                      435                 440                 445
              Lys
              <210>   36
              <211>   103
              <212>   PRT
<removed-apn>
              <213>   Homo sapiens
              <400>   36
              Gln Ser Gly Ala Gly Leu Leu Lys Pro Ser Glu Thr Leu Ser Leu Thr
              1               5                   10                  15
              Cys Thr Val Tyr Gly Gly Ser Phe Ser Ile His His Trp Thr Trp Ile
                          20                  25                  30
              Arg His Pro Pro Gly Lys Gly Leu Glu Trp Ile Gly Glu Ile Asn His
                      35                  40                  45
              Arg Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys Ser Arg Val Thr Ile
                  50                  55                  60
              Ser Ile Asp Thr Ser Lys Asn Gln Phe Ser Leu Lys Leu Ser Ala Val
              65                  70                  75                  80
              Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala Arg Gly Leu Arg Phe
                              85                  90                  95
              Leu Asp Trp Leu Ser Ser Tyr
                          100
              <210>   37
              <211>   214
              <212>   PRT
              <213>   Homo sapiens
              <400>   37
              Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
              1               5                   10                  15
              Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Asp Tyr
                          20                  25                  30
                                                  91

              Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Val Pro Asn Leu Leu Ile
<removed-date>
                      35                  40                  45
              Tyr Ala Ala Ser Ala Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
                  50                  55                  60
              Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
              65                  70                  75                  80
<removed-apn>
              Glu Asp Val Ala Thr Tyr Tyr Cys Gln Asn Tyr Asn Thr Ala Pro Leu
                              85                  90                  95
              Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
                          100                 105                 110
              Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
                      115                 120                 125
              Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
                  130                 135                 140
              Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
              145                 150                 155                 160
              Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
                              165                 170                 175
              Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
                          180                 185                 190
              Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
                      195                 200                 205
              Phe Asn Arg Gly Glu Cys
                  210
              <210>   38
              <211>   107
              <212>   PRT
              <213>   Homo sapiens
              <400>   38
              Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp
              1               5                   10                  15
                                                  92

<removed-date>
              Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Asp Tyr Leu
                          20                  25                  30
              Ala Trp Tyr Gln Gln Lys Pro Gly Lys Val Pro Asn Leu Leu Ile Tyr
                      35                  40                  45
              Ala Ala Ser Ala Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly Ser
                  50                  55                  60
<removed-apn>
              Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu
              65                  70                  75                  80
              Asp Val Ala Thr Tyr Tyr Cys Gln Asn Tyr Asn Thr Ala Pro Leu Thr
                              85                  90                  95
              Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg
                          100                 105
              <210>   39
              <211>   2977
              <212>   DNA
              <213>   Artificial
              <220>
              <223>   Synthetic construct
              <400> 39
              tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata tggagttccg   60
              cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc cccgcccatt   120
              gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc attgacgtca   180
              atgggtggag tatttacggt aaactgccca cttggcagta catcaagtgt atcatatgcc   240
              aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt atgcccagta   300
              catgacctta tgggactttc ctacttggca gtacatctac gtattagtca tcgctattac   360
              catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg actcacgggg   420
              atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc aaaatcaacg   480
              ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg gtaggcgtgt   540
              acggtgggag gtctatataa gcagagctca tgatagaagc actctactat tcgtcgaccg   600
              atcctgagaa cttcagggtg agtttgggga cccttgattg ttctttcttt ttcgctattg   660
              taaaattcat gttatatgga gggggcaaag ttttcagggt gttgtttaga atgggaagat   720
                                                  93

              gtcccttgta tcaccatgga ccctcatgat aattttgttt ctttcacttt ctactctgtt    780
<removed-date>
              gacaaccatt gtctcctctt attttctttt cattttctgt aactttttcg ttaaacttta    840
              gcttgcattt gtaacgaatt tttaaattca cttttgttta tttgtcagat tgtaagtact    900
              ttctctaatc actttttttt caaggcaatc agggtatatt atattgtact tcagcacagt    960
              tttagagaac aattgttata attaaatgat aaggtagaat atttctgcat ataaattctg   1020
              gctggcgtgg aaatattctt attggtagaa acaactacac cctggtcatc atcctgcctt   1080
<removed-apn>
              tctctttatg gttacaatga tatacactgt ttgagatgag gataaaatac tctgagtcca   1140
              aaccgggccc ctctgctaac catgttcatg ccttcttctc tttcctacag ctcctgggca   1200
              acgtgctggt tgttgtgctg tctcatcatt ttggcaaaga attaagctta tactcgagct   1260
              ctagattggg aacccgggtc tctcgaattc gagatctcca ccatgcacag acctagacgt   1320
              cgtggaactc gtccacctcc actggcactg ctcgctgctc tcctcctggc tgcacgtggt   1380
              gctgatgcac aggtacagct gcagcagtcg ggcgcaggac tgttgaagcc ttcggagacc   1440
              ctgtccctca cctgcactgt ctatggtgga tccttcagta ttcatcactg gacctggatc   1500
              cgccatcccc cagggaaggg gctggagtgg attggggaga tcaatcatcg tggaagcacc   1560
              aactacaacc cgtccctcaa gagtcgagtc accatatcaa tagacacgtc caagaaccag   1620
              ttctccctga agctgagcgc tgtgaccgcc gcggacacgg ctgtatatta ctgtgcgaga   1680
              ggcttacgat ttttggactg gttatcgtcc tactttgact actggggcca gggaaccctg   1740
              gtcaccgtct cctcagcctc caccaagggc ccatcggtct tccccctggc gccctgctcc   1800
              aggagcacct ccgagagcac agccgccctg ggctgcctgg tcaaggacta cttccccgaa   1860
              ccggtgacgg tgtcgtggaa ctcaggcgcc ctgaccagcg gcgtgcacac cttcccggct   1920
              gtcctacagt cctcaggact ctactccctc agcagcgtgg tgaccgtgcc ctccagcagc   1980
              ttgggcacga agacctacac ctgcaacgta gatcacaagc ccagcaacac caaggtggac   2040
              aagagagttg agtccaaata tggtccccca tgcccaccct gcccagcacc tgagttcctg   2100
              gggggaccat cagtcttcct gttcccccca aaacccaagg acactctcat gatctcccgg   2160
              acccctgagg tcacgtgcgt ggtggtggac gtgagccagg aagaccccga ggtccagttc   2220
              aactggtacg tggatggcgt ggaggtgcat aatgccaaga caaagccgcg ggaggagcag   2280
              ttcaacagca cgtaccgtgt ggtcagcgtc ctcaccgtcc tgcaccagga ctggctgaac   2340
              ggcaaggagt acaagtgcaa ggtctccaac aaaggcctcc cgtcctccat cgagaaaacc   2400
              atctccaaag ccaaagggca gccccgagag ccacaggtgt acaccctgcc cccatcccag   2460
                                                  94

              gaggagatga ccaagaacca ggtcagcctg acctgcctgg tcaaaggctt ctaccccagc   2520
<removed-date>
              gacatcgccg tggagtggga gagcaatggg cagccggaga acaactacaa gaccacgcct   2580
              cccgtgctgg actccgacgg ctccttcttc ctctacagca ggctcaccgt ggacaagagc   2640
              aggtggcagg aggggaatgt cttctcatgc tccgtgatgc atgaggctct gcacaaccac   2700
              tacacacaga agtccctctc cctgtctctg ggtaaatgag cggccgctaa tcagccatac   2760
              cacatttgta gaggttttac ttgctttaaa aaacctccca cacctccccc tgaacctgaa   2820
<removed-apn>
              acataaaatg aatgcaattg ttgttgttaa cttgtttatt gcagcttata atggttacaa   2880
              ataaagcaat agcatcacaa atttcacaaa taaagcattt ttttcactgc attctagttg   2940
              tggtttgtcc aaactcatca atgtatctta tcatgtc                            2977
              <210>   40
              <211>   7019
              <212>   DNA
              <213>   Artificial
              <220>
              <223>   Synthetic plasmid
              <400> 40
              tcgcgatgtg tgactagtta gttattaata gtaatcaatt acggggtcat tagttcatag    60
              cccatatatg gagttccgcg ttacataact tacggtaaat ggcccgcctg gctgaccgcc    120
              caacgacccc cgcccattga cgtcaataat gacgtatgtt cccatagtaa cgccaatagg    180
              gactttccat tgacgtcaat gggtggagta tttacggtaa actgcccact tggcagtaca    240
              tcaagtgtat catatgccaa gtacgccccc tattgacgtc aatgacggta aatggcccgc    300
              ctggcattat gcccagtaca tgaccttatg ggactttcct acttggcagt acatctacgt    360
              attagtcatc gctattacca tggtgatgcg gttttggcag tacatcaatg ggcgtggata    420
              gcggtttgac tcacggggat ttccaagtct ccaccccatt gacgtcaatg ggagtttgtt    480
              ttggcaccaa aatcaacggg actttccaaa atgtcgtaac aactccgccc cattgacgca    540
              aatgggcggt aggcgtgtac ggtgggaggt ctatataagc agagctcatg atagaagcac    600
              tctactattc gtcgaccgat cctgagaact tcagggtgag tttggggacc cttgattgtt    660
              ctttcttttt cgctattgta aaattcatgt tatatggagg gggcaaagtt ttcagggtgt    720
              tgtttagaat gggaagatgt cccttgtatc accatggacc ctcatgataa ttttgtttct    780
              ttcactttct actctgttga caaccattgt ctcctcttat tttcttttca ttttctgtaa    840
              ctttttcgtt aaactttagc ttgcatttgt aacgaatttt taaattcact tttgtttatt    900
                                                  95

              tgtcagattg taagtacttt ctctaatcac ttttttttca aggcaatcag ggtatattat    960
<removed-date>
              attgtacttc agcacagttt tagagaacaa ttgttataat taaatgataa ggtagaatat   1020
              ttctgcatat aaattctggc tggcgtggaa atattcttat tggtagaaac aactacaccc   1080
              tggtcatcat cctgcctttc tctttatggt tacaatgata tacactgttt gagatgagga   1140
              taaaatactc tgagtccaaa ccgggcccct ctgctaacca tgttcatgcc ttcttctctt   1200
              tcctacagct cctgggcaac gtgctggttg ttgtgctgtc tcatcatttt ggcaaagaat   1260
<removed-apn>
              taagcttata ctcgagctct agattgggaa cccgggtctc tcgaattcga gatctccacc   1320
              atgcacagac ctagacgtcg tggaactcgt ccacctccac tggcactgct cgctgctctc   1380
              ctcctggctg cacgtggtgc tgatgcacag gtacagctgc agcagtcggg cgcaggactg   1440
              ttgaagcctt cggagaccct gtccctcacc tgcactgtct atggtggatc cttcagtatt   1500
              catcactgga cctggatccg ccatccccca gggaaggggc tggagtggat tggggagatc   1560
              aatcatcgtg gaagcaccaa ctacaacccg tccctcaaga gtcgagtcac catatcaata   1620
              gacacgtcca agaaccagtt ctccctgaag ctgagcgctg tgaccgccgc ggacacggct   1680
              gtatattact gtgcgagagg cttacgattt ttggactggt tatcgtccta ctttgactac   1740
              tggggccagg gaaccctggt caccgtctcc tcagcctcca ccaagggccc atcggtcttc   1800
              cccctggcgc cctgctccag gagcacctcc gagagcacag ccgccctggg ctgcctggtc   1860
              aaggactact tccccgaacc ggtgacggtg tcgtggaact caggcgccct gaccagcggc   1920
              gtgcacacct tcccggctgt cctacagtcc tcaggactct actccctcag cagcgtggtg   1980
              accgtgccct ccagcagctt gggcacgaag acctacacct gcaacgtaga tcacaagccc   2040
              agcaacacca aggtggacaa gagagttgag tccaaatatg gtcccccatg cccaccctgc   2100
              ccagcacctg agttcctggg gggaccatca gtcttcctgt tccccccaaa acccaaggac   2160
              actctcatga tctcccggac ccctgaggtc acgtgcgtgg tggtggacgt gagccaggaa   2220
              gaccccgagg tccagttcaa ctggtacgtg gatggcgtgg aggtgcataa tgccaagaca   2280
              aagccgcggg aggagcagtt caacagcacg taccgtgtgg tcagcgtcct caccgtcctg   2340
              caccaggact ggctgaacgg caaggagtac aagtgcaagg tctccaacaa aggcctcccg   2400
              tcctccatcg agaaaaccat ctccaaagcc aaagggcagc cccgagagcc acaggtgtac   2460
              accctgcccc catcccagga ggagatgacc aagaaccagg tcagcctgac ctgcctggtc   2520
              aaaggcttct accccagcga catcgccgtg gagtgggaga gcaatgggca gccggagaac   2580
              aactacaaga ccacgcctcc cgtgctggac tccgacggct ccttcttcct ctacagcagg   2640
                                                  96

              ctcaccgtgg acaagagcag gtggcaggag gggaatgtct tctcatgctc cgtgatgcat   2700
<removed-date>
              gaggctctgc acaaccacta cacacagaag tccctctccc tgtctctggg taaatgagcg   2760
              gccgctaatc agccatacca catttgtaga ggttttactt gctttaaaaa acctcccaca   2820
              cctccccctg aacctgaaac ataaaatgaa tgcaattgtt gttgttaact tgtttattgc   2880
              agcttataat ggttacaaat aaagcaatag catcacaaat ttcacaaata aagcattttt   2940
              ttcactgcat tctagttgtg gtttgtccaa actcatcaat gtatcttatc atgtctaccg   3000
<removed-apn>
              gtcctgcagg gcccctctct tcatgtgagc aaaaggccag caaaaggcca ggaaccgtaa   3060
              aaaggccgcg ttgctggcgt ttttccatag gctccgcccc cctgacgagc atcacaaaaa   3120
              tcgacgctca agtcagaggt ggcgaaaccc gacaggacta taaagatacc aggcgtttcc   3180
              ccctggaagc tccctcgtgc gctctcctgt tccgaccctg ccgcttaccg gatacctgtc   3240
              cgcctttctc ccttcgggaa gcgtggcgct ttctcaatgc tcacgctgta ggtatctcag   3300
              ttcggtgtag gtcgttcgct ccaagctggg ctgtgtgcac gaaccccccg ttcagcccga   3360
              ccgctgcgcc ttatccggta actatcgtct tgagtccaac ccggtaagac acgacttatc   3420
              gccactggca gcagccactg gtaacaggat tagcagagcg aggtatgtag gcggtgctac   3480
              agagttcttg aagtggtggc ctaactacgg ctacactaga aggacagtat ttggtatctg   3540
              cgctctgctg aagccagtta ccttcggaaa aagagttggt agctcttgat ccggcaaaca   3600
              aaccaccgct ggtagcggtg gtttttttgt ttgcaagcag cagattacgc gcagaaaaaa   3660
              aggatctcaa gaagatcctt tgatcttttc tacggggtct gacgctcagt ggaacgaaaa   3720
              ctcacgttaa gggattttgg tcatgggcgc gcctcatact cctgcaggca tgagattatc   3780
              aaaaaggatc ttcacctaga tccttttaaa ttaaaaatga agttttaaat caatctaaag   3840
              tatatatgag taaacttggt ctgacagtta ccaatgctta atcagtgagg cacctatctc   3900
              agcgatctgt ctatttcgtt catccatagt tgcctgactc cccgtcgtgt agataactac   3960
              gatacgggag ggcttaccat ctggccccag tgctgcaatg ataccgcgag acccacgctc   4020
              accggctcca gatttatcag caataaacca gccagccgga agggccgagc gcagaagtgg   4080
              tcctgcaact ttatccgcct ccatccagtc tattaattgt tgccgggaag ctagagtaag   4140
              tagttcgcca gttaatagtt tgcgcaacgt tgttgccatt gctacaggca tcgtggtgtc   4200
              acgctcgtcg tttggtatgg cttcattcag ctccggttcc caacgatcaa ggcgagttac   4260
              atgatccccc atgttgtgca aaaaagcggt tagctccttc ggtcctccga tcgttgtcag   4320
              aagtaagttg gccgcagtgt tatcactcat ggttatggca gcactgcata attctcttac   4380
                                                  97

              tgtcatgcca tccgtaagat gcttttctgt gactggtgag tactcaacca agtcattctg   4440
<removed-date>
              agaatagtgt atgcggcgac cgagttgctc ttgcccggcg tcaatacggg ataataccgc   4500
              gccacatagc agaactttaa aagtgctcat cattggaaaa cgttcttcgg ggcgaaaact   4560
              ctcaaggatc ttaccgctgt tgagatccag ttcgatgtaa cccactcgtg cacccaactg   4620
              atcttcagca tcttttactt tcaccagcgt ttctgggtga gcaaaaacag gaaggcaaaa   4680
              tgccgcaaaa aagggaataa gggcgacacg gaaatgttga atactcatac tcttcctttt   4740
<removed-apn>
              tcaatattat tgaagcattt atcagggtta ttgtctcatg agcggataca tatttgaatg   4800
              tatttagaaa aataaacaaa taggggttcc gcgcacattt ccccgaaaag tgccacctga   4860
              cgtcaggtac caagcctagg cctccaaaaa agcctcctca ctacttctgg aatagctcag   4920
              aggcagaggc ggcctcggcc tctgcataaa taaaaaaaat tagtcagcca tggggcggag   4980
              aatgggcgga actgggcgga gttaggggcg ggatgggcgg agttaggggc gggactatgg   5040
              ttgctgacta attgagatgc atgctttgca tacttctgcc tgctggggag cctggggact   5100
              ttccacacct ggttgctgac taattgagat gcatgctttg catacttctg cctgctgggg   5160
              agcctgggga ctttccacac cggatccacc atggatagat ccggaaagcc tgaactcacc   5220
              gcgacgtctg tcgagaagtt tctgatcgaa aagttcgaca gcgtctccga cctgatgcag   5280
              ctctcggagg gcgaagaatc tcgtgctttc agcttcgatg taggagggcg tggatatgtc   5340
              ctgcgggtaa atagctgcgc cgatggtttc tacaaagatc gttatgttta tcggcacttt   5400
              gcatcggccg cgctcccgat tccggaagtg cttgacattg gggagttcag cgagagcctg   5460
              acctattgca tctcccgccg tgcacagggt gtcacgttgc aagacctgcc tgaaaccgaa   5520
              ctgcccgctg ttctgcagcc ggtcgcggag gccatggatg cgatcgctgc ggccgatctt   5580
              agccagacga gcgggttcgg cccattcgga ccgcaaggaa tcggtcaata cactacatgg   5640
              cgtgatttca tatgcgcgat tgctgatccc catgtgtatc actggcaaac tgtgatggac   5700
              gacaccgtca gtgcgtccgt cgcgcaggct ctcgatgagc tgatgctttg ggccgaggac   5760
              tgccccgaag tccggcacct cgtgcacgcg gatttcggct ccaacaatgt cctgacggac   5820
              aatggccgca taacagcggt cattgactgg agcgaggcga tgttcgggga ttcccaatac   5880
              gaggtcgcca acatcttctt ctggaggccg tggttggctt gtatggagca gcagacgcgc   5940
              tacttcgagc ggaggcatcc ggagcttgca ggatcgccgc ggctccgggc gtatatgctc   6000
              cgcattggtc ttgaccaact ctatcagagc ttggttgacg gcaatttcga tgatgcagct   6060
              tgggcgcagg gtcgatgcga cgcaatcgtc cgatccggag ccgggactgt cgggcgtaca   6120
                                                  98

              caaatcgccc gcagaagcgc ggccgtctgg accgatggct gtgtagaagt actcgccgat   6180
<removed-date>
              agtggaaacc gacgccccag cactcgtccg agggcaaagg aatagacgcg tgctgtaagt   6240
              ctgcagaaat tgatgatcta ttaaacaata aagatgtcca ctaaaatgga agtttttcct   6300
              gtcatacttt gttaagaagg gtgagaacag agtacctaca ttttgaatgg aaggattgga   6360
              gctacggggg tgggggtggg gtgggattag ataaatgcct gctctttact gaaggctctt   6420
              tactattgct ttatgataat gtttcatagt tggatatcat aatttaaaca agcaaaacca   6480
<removed-apn>
              aattaagggc cagctcattc ctcccactca tgatctatgg atctatagat ctctcgtgca   6540
              gctggggctc tagggggtat ccccacgcgc cctgtagcgg cgcattaagc gcggcgggtg   6600
              tggtggttac gcgcagcgtg accgctacac ttgccagcgc cctagcgccc gctcctttcg   6660
              ctttcttccc ttcctttctc gccacgttcg ccggctttcc ccgtcaagct ctaaatcggg   6720
              ggctcccttt agggttccga tttagtgctt tacggcacct cgaccccaaa aaacttgatt   6780
              agggtgatgg ttcacgtagt gggccatcgc cctgatagac ggtttttcgc cctttgacgt   6840
              tggagtccac gttctttaat agtggactct tgttccaaac tggaacaaca ctcaacccta   6900
              tctcggtcta ttcttttgat ttataaggga ttttgccgat ttcggcctat tggttaaaaa   6960
              atgagctgat ttaacaaaaa tttaacgcga attaattctg tggaatgtgt gtcagttag    7019
              <210>   41
              <211>   2272
              <212>   DNA
              <213>   Artificial
              <220>
              <223>   Synthetic construct
              <400> 41
              tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata tggagttccg     60
              cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc cccgcccatt    120
              gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc attgacgtca    180
              atgggtggag tatttacggt aaactgccca cttggcagta catcaagtgt atcatatgcc    240
              aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt atgcccagta    300
              catgacctta tgggactttc ctacttggca gtacatctac gtattagtca tcgctattac    360
              catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg actcacgggg    420
              atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc aaaatcaacg    480
              ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg gtaggcgtgt    540
                                                  99

              acggtgggag gtctatataa gcagagctca tgatagaagc actctactat tcgtcgaccg    600
<removed-date>
              atcctgagaa cttcagggtg agtttgggga cccttgattg ttctttcttt ttcgctattg    660
              taaaattcat gttatatgga gggggcaaag ttttcagggt gttgtttaga atgggaagat    720
              gtcccttgta tcaccatgga ccctcatgat aattttgttt ctttcacttt ctactctgtt    780
              gacaaccatt gtctcctctt attttctttt cattttctgt aactttttcg ttaaacttta    840
              gcttgcattt gtaacgaatt tttaaattca cttttgttta tttgtcagat tgtaagtact    900
<removed-apn>
              ttctctaatc actttttttt caaggcaatc agggtatatt atattgtact tcagcacagt    960
              tttagagaac aattgttata attaaatgat aaggtagaat atttctgcat ataaattctg   1020
              gctggcgtgg aaatattctt attggtagaa acaactacac cctggtcatc atcctgcctt   1080
              tctctttatg gttacaatga tatacactgt ttgagatgag gataaaatac tctgagtcca   1140
              aaccgggccc ctctgctaac catgttcatg ccttcttctc tttcctacag ctcctgggca   1200
              acgtgctggt tgttgtgctg tctcatcatt ttggcaaaga attaagctta tactcgagct   1260
              ctagattggg aacccgggtc tctcgaattc gagatctcca ccatgcacag acctagacgt   1320
              cgtggaactc gtccacctcc actggcactg ctcgctgctc tcctcctggc tgcacgtggt   1380
              gctgatgcag acatccagat gacccagtct ccatcctccc tgtctgcatc tgtaggagac   1440
              agagtcacca tcacttgccg ggcgagtcag ggcattagcg attatttagc ctggtatcag   1500
              cagaaaccag ggaaagttcc taacctcctg atctatgctg cgtccgcttt acaatcaggg   1560
              gtcccatctc gtttcagtgg cagtggatct gggacagatt tcactctcac catcagcagc   1620
              ctgcagcctg aggatgttgc aacttattac tgtcaaaatt ataacactgc cccgctcact   1680
              ttcggcgggg ggaccaaggt ggaaatcaaa cgaactgtgg ctgcaccatc tgtcttcatc   1740
              ttcccgccat ctgatgagca gttgaaatct ggaactgcct ctgttgtgtg cctgctgaat   1800
              aacttctatc ccagagaggc caaagtacag tggaaggtgg ataacgccct ccaatcgggt   1860
              aactcccagg agagtgtcac agagcaggac agcaaggaca gcacctacag cctcagcagc   1920
              accctgacgc tgagcaaagc agactacgag aaacacaaag tctacgcctg cgaagtcacc   1980
              catcagggcc tgagctcgcc cgtcacaaag agcttcaaca ggggagagtg ttaggcggcc   2040
              gctaatcagc cataccacat ttgtagaggt tttacttgct ttaaaaaacc tcccacacct   2100
              ccccctgaac ctgaaacata aaatgaatgc aattgttgtt gttaacttgt ttattgcagc   2160
              ttataatggt tacaaataaa gcaatagcat cacaaatttc acaaataaag catttttttc   2220
              actgcattct agttgtggtt tgtccaaact catcaatgta tcttatcatg tc           2272
                                                  100

<removed-date>
              <210>   42
              <211>   6335
              <212>   DNA
              <213>   Artificial
              <220>
              <223>   Synthetic plasmid
              <400> 42
              tcgagctcta gattgggaac ccgggtctct cgaattcgag atctccacca tgcacagacc    60
<removed-apn>
              tagacgtcgt ggaactcgtc cacctccact ggcactgctc gctgctctcc tcctggctgc    120
              acgtggtgct gatgcagaca tccagatgac ccagtctcca tcctccctgt ctgcatctgt    180
              aggagacaga gtcaccatca cttgccgggc gagtcagggc attagcgatt atttagcctg    240
              gtatcagcag aaaccaggga aagttcctaa cctcctgatc tatgctgcgt ccgctttaca    300
              atcaggggtc ccatctcgtt tcagtggcag tggatctggg acagatttca ctctcaccat    360
              cagcagcctg cagcctgagg atgttgcaac ttattactgt caaaattata acactgcccc    420
              gctcactttc ggcgggggga ccaaggtgga aatcaaacga actgtggctg caccatctgt    480
              cttcatcttc ccgccatctg atgagcagtt gaaatctgga actgcctctg ttgtgtgcct    540
              gctgaataac ttctatccca gagaggccaa agtacagtgg aaggtggata acgccctcca    600
              atcgggtaac tcccaggaga gtgtcacaga gcaggacagc aaggacagca cctacagcct    660
              cagcagcacc ctgacgctga gcaaagcaga ctacgagaaa cacaaagtct acgcctgcga    720
              agtcacccat cagggcctga gctcgcccgt cacaaagagc ttcaacaggg gagagtgtta    780
              ggcggccgct aatcagccat accacatttg tagaggtttt acttgcttta aaaaacctcc    840
              cacacctccc cctgaacctg aaacataaaa tgaatgcaat tgttgttgtt aacttgttta    900
              ttgcagctta taatggttac aaataaagca atagcatcac aaatttcaca aataaagcat    960
              ttttttcact gcattctagt tgtggtttgt ccaaactcat caatgtatct tatcatgtct   1020
              accggtaggg cccctctctt catgtgagca aaaggccagc aaaaggccag gaaccgtaaa   1080
              aaggccgcgt tgctggcgtt tttccatagg ctccgccccc ctgacgagca tcacaaaaat   1140
              cgacgctcaa gtcagaggtg gcgaaacccg acaggactat aaagatacca ggcgtttccc   1200
              cctggaagct ccctcgtgcg ctctcctgtt ccgaccctgc cgcttaccgg atacctgtcc   1260
              gcctttctcc cttcgggaag cgtggcgctt tctcaatgct cacgctgtag gtatctcagt   1320
              tcggtgtagg tcgttcgctc caagctgggc tgtgtgcacg aaccccccgt tcagcccgac   1380
              cgctgcgcct tatccggtaa ctatcgtctt gagtccaacc cggtaagaca cgacttatcg   1440
                                                  101

              ccactggcag cagccactgg taacaggatt agcagagcga ggtatgtagg cggtgctaca   1500
<removed-date>
              gagttcttga agtggtggcc taactacggc tacactagaa ggacagtatt tggtatctgc   1560
              gctctgctga agccagttac cttcggaaaa agagttggta gctcttgatc cggcaaacaa   1620
              accaccgctg gtagcggtgg tttttttgtt tgcaagcagc agattacgcg cagaaaaaaa   1680
              ggatctcaag aagatccttt gatcttttct acggggtctg acgctcagtg gaacgaaaac   1740
              tcacgttaag ggattttggt catgggcgcg ggcatgagat tatcaaaaag gatcttcacc   1800
<removed-apn>
              tagatccttt taaattaaaa atgaagtttt aaatcaatct aaagtatata tgagtaaact   1860
              tggtctgaca gttaccaatg cttaatcagt gaggcaccta tctcagcgat ctgtctattt   1920
              cgttcatcca tagttgcctg actccccgtc gtgtagataa ctacgatacg ggagggctta   1980
              ccatctggcc ccagtgctgc aatgataccg cgagacccac gctcaccggc tccagattta   2040
              tcagcaataa accagccagc cggaagggcc gagcgcagaa gtggtcctgc aactttatcc   2100
              gcctccatcc agtctattaa ttgttgccgg gaagctagag taagtagttc gccagttaat   2160
              agtttgcgca acgttgttgc cattgctaca ggcatcgtgg tgtcacgctc gtcgtttggt   2220
              atggcttcat tcagctccgg ttcccaacga tcaaggcgag ttacatgatc ccccatgttg   2280
              tgcaaaaaag cggttagctc cttcggtcct ccgatcgttg tcagaagtaa gttggccgca   2340
              gtgttatcac tcatggttat ggcagcactg cataattctc ttactgtcat gccatccgta   2400
              agatgctttt ctgtgactgg tgagtactca accaagtcat tctgagaata gtgtatgcgg   2460
              cgaccgagtt gctcttgccc ggcgtcaata cgggataata ccgcgccaca tagcagaact   2520
              ttaaaagtgc tcatcattgg aaaacgttct tcggggcgaa aactctcaag gatcttaccg   2580
              ctgttgagat ccagttcgat gtaacccact cgtgcaccca actgatcttc agcatctttt   2640
              actttcacca gcgtttctgg gtgagcaaaa acaggaaggc aaaatgccgc aaaaaaggga   2700
              ataagggcga cacggaaatg ttgaatactc atactcttcc tttttcaata ttattgaagc   2760
              atttatcagg gttattgtct catgagcgga tacatatttg aatgtattta gaaaaataaa   2820
              caaatagggg ttccgcgcac atttccccga aaagtgccac ctgacgtcag gtacacttag   2880
              gcgcgccatt agagttcctg caggctacat ggtaccaagc ctaggcctcc aaaaaagcct   2940
              cctcactact tctggaatag ctcagaggca gaggcggcct cggcctctgc ataaataaaa   3000
              aaaattagtc agccatgggg cggagaatgg gcggaactgg gcggagttag gggcgggatg   3060
              ggcggagtta ggggcgggac tatggttgct gactaattga gatgcatgct ttgcatactt   3120
              ctgcctgctg gggagcctgg ggactttcca cacctggttg ctgactaatt gagatgcatg   3180
                                                  102

              ctttgcatac ttctgcctgc tggggagcct ggggactttc cacaccggat ccaccatgga   3240
<removed-date>
              tagatccgga aagcctgaac tcaccgcgac gtctgtcgag aagtttctga tcgaaaagtt   3300
              cgacagcgtc tccgacctga tgcagctctc ggagggcgaa gaatctcgtg ctttcagctt   3360
              cgatgtagga gggcgtggat atgtcctgcg ggtaaatagc tgcgccgatg gtttctacaa   3420
              agatcgttat gtttatcggc actttgcatc ggccgcgctc ccgattccgg aagtgcttga   3480
              cattggggag ttcagcgaga gcctgaccta ttgcatctcc cgccgtgcac agggtgtcac   3540
<removed-apn>
              gttgcaagac ctgcctgaaa ccgaactgcc cgctgttctg cagccggtcg cggaggccat   3600
              ggatgcgatc gctgcggccg atcttagcca gacgagcggg ttcggcccat tcggaccgca   3660
              aggaatcggt caatacacta catggcgtga tttcatatgc gcgattgctg atccccatgt   3720
              gtatcactgg caaactgtga tggacgacac cgtcagtgcg tccgtcgcgc aggctctcga   3780
              tgagctgatg ctttgggccg aggactgccc cgaagtccgg cacctcgtgc acgcggattt   3840
              cggctccaac aatgtcctga cggacaatgg ccgcataaca gcggtcattg actggagcga   3900
              ggcgatgttc ggggattccc aatacgaggt cgccaacatc ttcttctgga ggccgtggtt   3960
              ggcttgtatg gagcagcaga cgcgctactt cgagcggagg catccggagc ttgcaggatc   4020
              gccgcggctc cgggcgtata tgctccgcat tggtcttgac caactctatc agagcttggt   4080
              tgacggcaat ttcgatgatg cagcttgggc gcagggtcga tgcgacgcaa tcgtccgatc   4140
              cggagccggg actgtcgggc gtacacaaat cgcccgcaga agcgcggccg tctggaccga   4200
              tggctgtgta gaagtactcg ccgatagtgg aaaccgacgc cccagcactc gtccgagggc   4260
              aaaggaatag acgcgtgctg taagtctgca gaaattgatg atctattaaa caataaagat   4320
              gtccactaaa atggaagttt ttcctgtcat actttgttaa gaagggtgag aacagagtac   4380
              ctacattttg aatggaagga ttggagctac gggggtgggg gtggggtggg attagataaa   4440
              tgcctgctct ttactgaagg ctctttacta ttgctttatg ataatgtttc atagttggat   4500
              atcataattt aaacaagcaa aaccaaatta agggccagct cattcctccc actcatgatc   4560
              tatggatcta tagatctctc gtgcagctgg ggctctaggg ggtatcccca cgcgccctgt   4620
              agcggcgcat taagcgcggc gggtgtggtg gttacgcgca gcgtgaccgc tacacttgcc   4680
              agcgccctag cgcccgctcc tttcgctttc ttcccttcct ttctcgccac gttcgccggc   4740
              tttccccgtc aagctctaaa tcgggggctc cctttagggt tccgatttag tgctttacgg   4800
              cacctcgacc ccaaaaaact tgattagggt gatggttcac gtagtgggcc atcgccctga   4860
              tagacggttt ttcgcccttt gacgttggag tccacgttct ttaatagtgg actcttgttc   4920
                                                  103

              caaactggaa caacactcaa ccctatctcg gtctattctt ttgatttata agggattttg   4980
<removed-date>
              ccgatttcgg cctattggtt aaaaaatgag ctgatttaac aaaaatttaa cgcgaattaa   5040
              ttctgtggaa tgtgtgtcag ttagtcgcga tgtgtgacta gttagttatt aatagtaatc   5100
              aattacgggg tcattagttc atagcccata tatggagttc cgcgttacat aacttacggt   5160
              aaatggcccg cctggctgac cgcccaacga cccccgccca ttgacgtcaa taatgacgta   5220
              tgttcccata gtaacgccaa tagggacttt ccattgacgt caatgggtgg agtatttacg   5280
<removed-apn>
              gtaaactgcc cacttggcag tacatcaagt gtatcatatg ccaagtacgc cccctattga   5340
              cgtcaatgac ggtaaatggc ccgcctggca ttatgcccag tacatgacct tatgggactt   5400
              tcctacttgg cagtacatct acgtattagt catcgctatt accatggtga tgcggttttg   5460
              gcagtacatc aatgggcgtg gatagcggtt tgactcacgg ggatttccaa gtctccaccc   5520
              cattgacgtc aatgggagtt tgttttggca ccaaaatcaa cgggactttc caaaatgtcg   5580
              taacaactcc gccccattga cgcaaatggg cggtaggcgt gtacggtggg aggtctatat   5640
              aagcagagct catgatagaa gcactctact attcgtcgac cgatcctgag aacttcaggg   5700
              tgagtttggg gacccttgat tgttctttct ttttcgctat tgtaaaattc atgttatatg   5760
              gagggggcaa agttttcagg gtgttgttta gaatgggaag atgtcccttg tatcaccatg   5820
              gaccctcatg ataattttgt ttctttcact ttctactctg ttgacaacca ttgtctcctc   5880
              ttattttctt ttcattttct gtaacttttt cgttaaactt tagcttgcat ttgtaacgaa   5940
              tttttaaatt cacttttgtt tatttgtcag attgtaagta ctttctctaa tcactttttt   6000
              ttcaaggcaa tcagggtata ttatattgta cttcagcaca gttttagaga acaattgtta   6060
              taattaaatg ataaggtaga atatttctgc atataaattc tggctggcgt ggaaatattc   6120
              ttattggtag aaacaactac accctggtca tcatcctgcc tttctcttta tggttacaat   6180
              gatatacact gtttgagatg aggataaaat actctgagtc caaaccgggc ccctctgcta   6240
              accatgttca tgccttcttc tctttcctac agctcctggg caacgtgctg gttgttgtgc   6300
              tgtctcatca ttttggcaaa gaattaagct tatac                              6335
              <210>   43
              <211>   115
              <212>   PRT
              <213>   Artificial
              <220>
              <223>   consensus sequence
                                                  104

              <220>
<removed-date>
              <221>   MISC_FEATURE
              <222>   (1)..(1)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (11)..(11)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
<removed-apn>
              <221>   MISC_FEATURE
              <222>   (28)..(28)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (30)..(30)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (34)..(35)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (93)..(93)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (93)..(93)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (96)..(96)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (100)..(100)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   misc_feature
              <222>   (111)..(111)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (114)..(114)
              <223>   Xaa can be any naturally occurring amino acid
              <400>   43
              Xaa Asp Val Trp Gly Gln Gly Thr Thr Val Xaa Val Ser Ser Ala Ser
                                                   105

              1                5                  10                  15
<removed-date>
              Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Xaa Ser Xaa Ser Thr
                          20                  25                  30
              Ser Xaa Xaa Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro
                      35                  40                  45
<removed-apn>
              Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val
                  50                  55                  60
              His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser
              65                  70                  75                  80
              Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Xaa Thr Tyr Xaa
                              85                  90                  95
              Cys Asn Val Xaa His Lys Pro Ser Asn Thr Lys Val Asp Lys Xaa Val
                          100                 105                 110
              Glu Xaa Lys
                      115
              <210>   44
              <211>   225
              <212>   PRT
              <213>   Artificial
              <220>
              <223>   consensus sequence
              <220>
              <221>   MISC_FEATURE
              <222>   (13)..(13)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (47)..(47)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (53)..(53)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (75)..(75)
                                                   106

              <223>   Xaa can be any naturally occurring amino acid
<removed-date>
              <220>
              <221>   MISC_FEATURE
              <222>   (106)..(106)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (109)..(110)
              <223>   Xaa can be any naturally occurring amino acid
<removed-apn>
              <220>
              <221>   MISC_FEATURE
              <222>   (134)..(135)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   misc_feature
              <222>   (137)..(137)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (188)..(188)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (198)..(198)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (224)..(224)
              <223>   Xaa can be any naturally occurring amino acid
              <400>   44
              Tyr Gly Pro Pro Cys Pro Pro Cys Pro Ala Pro Glu Xaa Leu Gly Gly
              1               5                   10                  15
              Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
                          20                  25                  30
              Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser Xaa Glu
                      35                  40                  45
              Asp Pro Glu Val Xaa Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
                  50                  55                  60
              Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Xaa Asn Ser Thr Tyr Arg
              65                  70                  75                  80
                                                   107

<removed-date>
              Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
                              85                  90                  95
              Glu Tyr Lys Cys Lys Val Ser Asn Lys Xaa Leu Pro Xaa Xaa Ile Glu
                          100                 105                 110
              Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
                      115                 120                 125
<removed-apn>
              Thr Leu Pro Pro Ser Xaa Xaa Glu Xaa Thr Lys Asn Gln Val Ser Leu
                  130                 135                 140
              Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
              145                 150                 155                 160
              Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
                              165                 170                 175
              Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Xaa Leu Thr Val Asp
                          180                 185                 190
              Lys Ser Arg Trp Gln Xaa Gly Asn Val Phe Ser Cys Ser Val Met His
                      195                 200                 205
              Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Xaa
                  210                 215                 220
              Gly
              225
              <210>   45
              <211>   60
              <212>   PRT
              <213>   Artificial
              <220>
              <223>   consensus sequence
              <220>
              <221>   MISC_FEATURE
              <222>   (13)..(14)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (16)..(16)
                                                   108

              <223>   Xaa can be any naturally occurring amino acid
<removed-date>
              <220>
              <221>   MISC_FEATURE
              <222>   (21)..(22)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (24)..(27)
              <223>   Xaa can be any naturally occurring amino acid
<removed-apn>
              <220>
              <221>   MISC_FEATURE
              <222>   (31)..(31)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (34)..(34)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (48)..(48)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   misc_feature
              <222>   (50)..(50)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (54)..(54)
              <223>   Xaa can be any naturally occurring amino acid
              <220>
              <221>   MISC_FEATURE
              <222>   (56)..(56)
              <223>   Xaa can be any naturally occurring amino acid
              <400>   45
              Ser Asp Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Xaa Xaa Pro Xaa
              1               5                   10                  15
              Leu Leu Ile Tyr Xaa Xaa Ser Xaa Xaa Xaa Xaa Gly Val Pro Xaa Arg
                          20                  25                  30
              Phe Xaa Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Xaa
                      35                  40                  45
              Leu Xaa Pro Glu Asp Xaa Ala Xaa Tyr Tyr Cys Gln
                  50                  55                  60
                                                   109

<removed-date>
              <210>   46
              <211>   118
              <212>   PRT
              <213>   Artificial
              <220>
              <223>   consensus sequence
<removed-apn>
              <220>
              <221>   MISC_FEATURE
              <222>   (4)..(4)
              <223>   Xaa can be any naturally occurring amino acid
              <400>   46
              Thr Phe Gly Xaa Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala
              1               5                   10                  15
              Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
                          20                  25                  30
              Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
                      35                  40                  45
              Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
                  50                  55                  60
              Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
              65                  70                  75                  80
              Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
                              85                  90                  95
              Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
                          100                 105                 110
              Phe Asn Arg Gly Glu Cys
                      115
                                                   110

